,Start Date,Start Price,End Date,End Price,Weekly Returns,Bin Label,News,Basics
0,2023-06-04,214.62979125976562,2023-06-11,215.3088836669922,0.003164017461139146,U1,"[{""date"": ""20230604022807"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of June 4"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Click here to read the complete list.""}, {""date"": ""20230604074800"", ""headline"": ""Amgen presents new LUMAKRAS CodeBreaK 200 CNS data at ASCO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230604120000"", ""headline"": ""AMGEN PRESENTS NEW LUMAKRAS\u00ae (SOTORASIB) CODEBREAK 200 CNS DATA AT ASCO 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the presentation of new data from the CodeBreaK clinical trial program, the most comprehensive global development program in patients with KRAS G12C-mutated cancers, at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place June 2-6 in Chicago. The research presented reinforces the efficacy of LUMAKRAS\u00ae/LUMYKRAS\u00ae (sotorasib) in advanced non-small cell lung cancer (NSCLC) and metastatic colorectal cancer (mCRC). Additionally, data from SCA""}, {""date"": ""20230605022500"", ""headline"": ""Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230605101450"", ""headline"": ""Analysis-Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast"", ""summary"": ""Johnson & Johnson's legal settlement with Amgen Inc to delay a biosimilar version of its blockbuster psoriasis treatment Stelara until January 2025 could make the  drug a larger contributor to J&J\u2019s 2024 and 2025 sales than Wall Street is forecasting.  Stelara, introduced in 2009, has been J&J\u2019s top-selling drug since 2019, with sales reaching $9.7 billion in 2022.  Its patents begin to expire this year, opening the door to a cheaper biosimilar entering the market, and raising expectations that the company would need to lower the $13,000 per month price of Stelara.""}, {""date"": ""20230605120000"", ""headline"": ""Even Mark Cuban Can\u2019t Fix This Broken Drug System"", ""summary"": ""Coherus BioSciences\u2019 partnership to offer deeply discounted biosimilar Humira can go only so far in reducing overall prices.""}, {""date"": ""20230605123200"", ""headline"": ""Here's How Much $1000 Invested In Amgen 15 Years Ago Would Be Worth Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230605125300"", ""headline"": ""Iveric Bio gains after holder vote on Astellas takeover set for July 6"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230605125535"", ""headline"": ""Stocks making the biggest moves midday: Palo Alto Networks, 3M, Amedisys, Target and more"", ""summary"": ""These are among the stocks posting the largest moves in midday trading Monday. ""}, {""date"": ""20230605163800"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 1.75% to $221.88 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230605204340"", ""headline"": ""Dow Jones Today: Apple Headset Can\u2019t Lift Index"", ""summary"": ""The Dow Jones Industrial Average fell 0.6%, or about 200 points, as markets cooled off from Friday's blistering rally. Amgen rose more than any other stock, but Intel led the index lower.""}, {""date"": ""20230606120000"", ""headline"": ""Lina Khan Is Upending One of Wall Street\u2019s Favorite Trades"", ""summary"": ""(Bloomberg) -- Lina Khan is the most aggressive trustbuster the US has had in decades. Roughly two years into her tenure, Wall Street is still learning the hard way just how far she\u2019ll take her fight against some of America\u2019s most powerful businesses.Most Read from BloombergUkraine Dam Blast Blamed on Russia Tips War Into New PhasePGA Tour Bows to Saudi Rival in Shock Combination With LIV GolfSEC\u2019s Coinbase Lawsuit Heralds Deepening US Crypto CrackdownApple Headset Looks Sleek in Person But Batt""}, {""date"": ""20230606122512"", ""headline"": ""U.S. Wide-Moat Stocks On Sale - The June 2023 Heat Map"", ""summary"": ""Our 3-step process focuses on wide-moat stocks (as per Morningstar\u00e2\u0080\u0099s rating). Click here to see the heat map of the most investable candidates for June 2023.""}, {""date"": ""20230606134007"", ""headline"": ""Are You a Value Investor? This 1 Stock Could Be the Perfect Pick"", ""summary"": ""The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.""}, {""date"": ""20230606163900"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 0.30% to $221.22 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230606184425"", ""headline"": ""Buy 3 June Dogs Of The Dow, Watch 4"", ""summary"": ""Analyst one-year targets showed ten highest-yield Dow stocks producing 13.64% more gain from $5k invested in the lowest-priced five. Learn more about our stock lists.""}, {""date"": ""20230607105200"", ""headline"": ""See How Amgen Ranks Among Analysts' Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230607105200"", ""headline"": ""Video: Dow Analyst Moves: AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230607163900"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Amgen Inc. inched 0.01% higher to $221.25 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""20230608034000"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230608053900"", ""headline"": ""The 3 Best Long-Term Dividend Stocks to Buy in June"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230608090123"", ""headline"": ""DJD: Attractive Valuation, Average Quality And Return"", ""summary"": ""DJD holds 27 stocks of the Dow Jones paying a dividend. Valuation and dividend growth look attractive, but quality and historical return are average. Read more here.""}, {""date"": ""20230608103500"", ""headline"": ""July 28th Options Now Available For Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230608161500"", ""headline"": ""Is AbbVie or Amgen the Better Bargain Buy Right Now?"", ""summary"": ""Due to the highly competitive nature of the pharmaceutical industry, it is no easy task to replace the aging stars in a drug portfolio.  Teva Pharmaceutical (NYSE: TEVA) illustrates this point nicely.  In the middle of the last decade, Teva lost exclusivity for its multiple sclerosis medication Copaxone.""}, {""date"": ""20230608172708"", ""headline"": ""Ideaya Biosciences: Lots Of 'Shots On Goal' And Upcoming Potential Catalysts"", ""summary"": ""Ideaya Biosciences is moving forward a large pipeline of drug candidates based on its focus on synthetic lethality. Click here to read more on IDYA stock.""}, {""date"": ""20230608232136"", ""headline"": ""Amgen: Big Yield And Dividend Growth On Sale Now"", ""summary"": ""Amgen's products are inelastic and should grow with the population over time. Click here to see why AMGN stock is a Buy.""}, {""date"": ""20230609015700"", ""headline"": ""Seagen gains as antitrust deadline for Pfizer purchase nears on Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230609034000"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230609140030"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Shares Could Be 44% Below Their Intrinsic Value Estimate"", ""summary"": ""Key Insights Amgen's estimated fair value is US$394 based on 2 Stage Free Cash Flow to Equity Current share price of...""}, {""date"": ""20230609200000"", ""headline"": ""AMGEN TO PRESENT AT THE GOLDMAN SACHS 44TH ANNUAL GLOBAL HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 44th Annual Global Healthcare Conference at 2:20 p.m. ET on Wednesday, June 14, 2023. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors, and the general public.""}, {""date"": ""20230609215023"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) closed at $218.82 in the latest trading session, marking a -0.88% move from the prior day.""}]",{}
1,2023-06-11,215.3088836669922,2023-06-18,226.0369415283203,0.049826359593785785,U5,"[{""date"": ""20230612040048"", ""headline"": ""Big Pharma dealmaking recovers with $85bn M&A splurge"", ""summary"": ""Pharmaceutical and biotech companies spent $85bn on acquisitions in the first five months of the year, marking a dramatic recovery in dealmaking as they seek to replenish their drug pipelines.  The surge in M&A, compared to just $35.6bn in deals in the same period of 2022 and $49.1bn the year before, according to Stifel, an investment bank, is being fuelled by large cash reserves amassed by Big Pharma during the coronavirus pandemic and investor concerns about future growth prospects.  At the start of year, the world\u2019s largest pharmaceutical companies held more than $1.4tn in dealmaking firepower, according to an analysis by EY.""}, {""date"": ""20230612070300"", ""headline"": ""Teva, Alvotech in pact with Johnson & Johnson over Stelara knockoff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230612091800"", ""headline"": ""Video: Dow Movers: AMGN, CRM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230612105500"", ""headline"": ""5 Stocks to Buy With Explosive 500% Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230612143053"", ""headline"": ""Pharma: M&A strategy gets dose of bitter medicine"", ""summary"": ""Medicines price gouger Martin Shkreli was one of a kind.  Illumina bought cancer test developer Grail for $8bn in 2021, even though US and EU authorities complained the US gene sequencer could deny crucial inputs to Grail\u2019s rivals.  On Monday, its boss Francis deSouza resigned after a proxy fight with activist investor Carl Icahn over Illumina\u2019s decision to proceed.""}, {""date"": ""20230612163900"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.64% to $217.36 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230613025700"", ""headline"": ""Deep Value Moments"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230613075003"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: April And May Review"", ""summary"": ""My passive income stream increased by 25.59% YoY in April 2023 and 40.02% YoY in May 2023, with a YTD growth of 29.99%. See the full April & May update here.""}, {""date"": ""20230613105215"", ""headline"": ""Top 20 Most Profitable Pharmaceutical Companies In The World"", ""summary"": ""In this article, we will be covering the top 20 most profitable pharmaceutical companies in the world. If you wish to see the top ones, head straight to the Top 5 Most Profitable Pharmaceutical Companies In The World. Undoubtedly, the pharmaceutical industry stands as one of the most financially rewarding and essential sectors worldwide, leading [\u2026]""}, {""date"": ""20230613204527"", ""headline"": ""Dow Jones Today: Inflation Down, Index Up"", ""summary"": ""The Dow Jones Industrial Average rose 0.4%, or about 145 points, after May\u2019s inflation report encouraged investors the Federal Reserve will keep interest rates steady at least until July.""}, {""date"": ""20230614070300"", ""headline"": ""BTIG starts Virdian at buy, cites market potential for thyroid eye drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230614075700"", ""headline"": ""Amgen reportedly hires Moderna chief medical officer as new CMO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230614145000"", ""headline"": ""Medifast: A Revamp Is Necessary, An Embrace Of GLP-1s Can Help"", ""summary"": ""Medifast is currently deploying positive cash flow dollars to maintenance of over 8% yielding dividend and to share repurchases. Find out why MED stock is a Strong Buy.""}, {""date"": ""20230614162906"", ""headline"": ""Amgen Inc. (AMGN) Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Goldman Sachs 44th Annual Global Healthcare Conference June 14, 2023 2:20 PM ETCompany ParticipantsRobert Bradway - Chairman and Chief Executive...""}, {""date"": ""20230614163900"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.13% higher to $222.28 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...""}, {""date"": ""20230615143800"", ""headline"": ""Microsoft, Amgen share gains lead Dow's nearly 450-point rally"", ""summary"": ""Led by strong returns for shares of Microsoft and Amgen, the Dow Jones Industrial Average is rallying Thursday afternoon. The Dow is trading 445 points...""}, {""date"": ""20230615163900"", ""headline"": ""Amgen Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Amgen Inc. rose 2.77% to $228.44 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230615204126"", ""headline"": ""Dow Jones Today: Microsoft Leads Index Higher"", ""summary"": ""The Dow Jones Industrial Average rose 1.3%, or about 430 points, after retail sales data showed Americans are still upping their spending, a sign of resilience amid slowing inflation.""}, {""date"": ""20230616001512"", ""headline"": ""How Amgen Makes Money"", ""summary"": ""Amgen produces drugs to treat several conditions and markets them worldwide. Learn its revenue-earning structure and how it makes money.""}, {""date"": ""20230616024000"", ""headline"": ""Noteworthy Friday Option Activity: AMGN, WW, SCHW"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230616114500"", ""headline"": ""AbbVie's (ABBV) Skyrizi Meets Ulcerative Colitis Study Goals"", ""summary"": ""AbbVie's (ABBV) Skyrizi achieves statistical significance with its primary endpoint of clinical remission in a late-stage study as a maintenance treatment for ulcerative colitis.""}, {""date"": ""20230616123000"", ""headline"": ""This Biotech Is About to Eat AbbVie's Market Share, but Is It a Buy?"", ""summary"": ""Assuming it does, it's not going to be stealing a fry from the corner of AbbVie's plate -- it's going for a big-mouth chomp of the cheeseburger with all the fixings.  AbbVie shareholders are doubtless bracing themselves.  Coherus develops new oncology drugs with a combination of in-licensing candidates and its own research and development (R&D) activities, but it also currently sells biosimilar drugs that are copies of medicines developed by other companies.""}, {""date"": ""20230616163900"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.53% higher to $229.66 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20230616215018"", ""headline"": ""Amgen (AMGN) Gains As Market Dips: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $229.66, marking a +0.53% move from the previous day.""}, {""date"": ""20230617040933"", ""headline"": ""Verizon: Fear, Greed, Top Dividend Dog Of The Dow"", ""summary"": ""Verizon shares offer a well-covered 7.2% dividend yield and currently trade at an attractive price relative to the value. Click here to read more on VZ stock.""}, {""date"": ""20230617120036"", ""headline"": ""A great week that adds to Amgen Inc.'s (NASDAQ:AMGN) one-year returns, institutional investors who own 77% must be happy"", ""summary"": ""Key Insights Institutions' substantial holdings in Amgen implies that they have significant influence over the...""}, {""date"": ""20230618205610"", ""headline"": ""How to Retire Rich: Biotech Stocks Edition"", ""summary"": ""Among the most difficult endeavors when it comes to deciphering the best retirement planning stocks is to identify companies that will remain relevant for years, if not decades to come. While no guarantees exist for anything, those who focus on investing in biotech own a clear advantage. Almost surely, the underlying sector \u2013 which falls under the broad healthcare industry \u2013 is permanently relevant. Further, I submitted a query on ChatGPT to extract key reasons why biotech stocks for retirement""}]",{}
2,2023-06-18,226.0369415283203,2023-06-25,223.52716064453125,-0.011103410207285114,D2,"[{""date"": ""20230618205610"", ""headline"": ""How to Retire Rich: Biotech Stocks Edition"", ""summary"": ""Among the most difficult endeavors when it comes to deciphering the best retirement planning stocks is to identify companies that will remain relevant for years, if not decades to come. While no guarantees exist for anything, those who focus on investing in biotech own a clear advantage. Almost surely, the underlying sector \u2013 which falls under the broad healthcare industry \u2013 is permanently relevant. Further, I submitted a query on ChatGPT to extract key reasons why biotech stocks for retirement""}, {""date"": ""20230619090000"", ""headline"": ""Tech Ruled The First Half Of 2023, The Industry You Need To Watch In The Second Half"", ""summary"": ""Tech stocks have staged a massive comeback in 2023, but value investors should consider looking into currently unloved sectors like healthcare. See my top picks.""}, {""date"": ""20230620070002"", ""headline"": ""Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court "", ""summary"": ""The lawsuits are the opening salvo in a historic and potentially decisive battle over Medicare's efforts to bring rising drug prices under control. ""}, {""date"": ""20230620120200"", ""headline"": ""Cantor Fitzgerald biotech/biopharma to hold a luncheon meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230620120500"", ""headline"": ""Cantor Fitzgerald biotech/biopharma to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230620163900"", ""headline"": ""Amgen Inc. stock falls Tuesday, still outperforms market"", ""summary"": ""Shares of Amgen Inc. slid 0.47% to $228.59 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230620213946"", ""headline"": ""Tracking John Paulson's Paulson & Company Portfolio - Q1 2023 Update"", ""summary"": ""John Paulson's 13F portfolio value increased by around 8% from approximately $1.11B to $1.20B in Q1 2023. Read more on stake increases and decreases here.""}, {""date"": ""20230621080400"", ""headline"": ""Amgen's Blincyto granted full approval for leukemia by FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230621083200"", ""headline"": ""Amgen wins full approval for leukemia therapy Blincyto"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230621093100"", ""headline"": ""Amgen Gets FDA Approval for Blincyto Supplemental Biologics License Application"", ""summary"": ""By Chris Wack Amgen said Wednesday that the U.S. Food and Drug Administration has approved its supplemental biologics license application for Blincyto, a...""}, {""date"": ""20230621100800"", ""headline"": ""Top pharma lobby sues U.S. govt. over Medicare drug pricing negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230621121200"", ""headline"": ""IN BRIEF: Amgen jubilant as FDA approves Blincyto leukemia drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230621123500"", ""headline"": ""If You Invested $1000 In This Stock 15 Years Ago, You Would Have $4,900 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230621130000"", ""headline"": ""FDA GRANTS FULL APPROVAL FOR BLINCYTO\u00ae (BLINATUMOMAB) TO TREAT MINIMAL RESIDUAL DISEASE-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for BLINCYTO\u00ae (blinatumomab) for the treatment of adults and pediatric patients with CD19-positive B-cell precursor acute lymphoblastic leukemia (B-ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1%, based on additional data from two Phase 3 studies that were submitted. The approval conver""}, {""date"": ""20230621163900"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.68% to $227.04 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""20230621171012"", ""headline"": ""Leveraging AI in Drug Discovery: Elizabeth Schwarzbach of BigHat Biosciences, Live from NYSE"", ""summary"": ""IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange with Elizabeth Schwarzbach, Chief Business Officer of BigHat Biosciences. She spoke to IPO Edge Editor-in-Chief [\u2026]""}, {""date"": ""20230622104000"", ""headline"": ""August 4th Options Now Available For Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230622134000"", ""headline"": ""Amgen's (AMGN) Blincyto sBLA Gets FDA Nod in Treating Leukemia"", ""summary"": ""Amgen (AMGN) announces full approval of its sBLA for Blincyto as an immune-oncology therapy for treating adults and pediatric patients with CD19-positive B-cell precursor acute lymphoblastic leukemia.""}, {""date"": ""20230622163900"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. rallied 1.15% to $229.66 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230622194602"", ""headline"": ""Spectrum's Rolvedon A Differentiator In A $3B/Yr Market"", ""summary"": ""Spectrum and Assertio's merger would lead to a diversified product portfolio and a combination of two unique marketing strategies. Click here to read more.""}, {""date"": ""20230622204817"", ""headline"": ""California, other states join FTC bid to block Amgen deal"", ""summary"": ""The states of California, New York, Illinois, Minnesota,  Washington and Wisconsin have joined a Federal Trade Commission (FTC) lawsuit to stop Amgen's $27.8 billion deal to buy Horizon Therapeutics, according to a court filing on Thursday.  Washington Attorney General Bob Ferguson said his state had joined the lawsuit because \""monopolies harm consumers\"" and the merger could allow Amgen to \""dominate\"" prescription drug markets.  The group of six states filed an amended complaint Thursday, joining the FTC which last month filed suit opposing the deal because it would give Amgen \""monopoly positions\"" for medicines used to treat thyroid eye disease and chronic refractory gout.""}, {""date"": ""20230622230024"", ""headline"": ""UPDATE 1-California, other states join FTC bid to block Amgen deal"", ""summary"": ""The states of California, New York, Illinois, Minnesota,  Washington and Wisconsin have joined a Federal Trade Commission (FTC) lawsuit to stop Amgen's $27.8 billion deal to buy Horizon Therapeutics, according to a court filing on Thursday.  Washington Attorney General Bob Ferguson said his state had joined the lawsuit because \""monopolies harm consumers\"" and the merger could allow Amgen to \""dominate\"" prescription drug markets.  The group of six states filed an amended complaint Thursday, joining the FTC which last month filed suit opposing the deal because it would give Amgen \""monopoly positions\"" for medicines used to treat thyroid eye disease and chronic refractory gout.""}, {""date"": ""20230623034000"", ""headline"": ""What You Missed On Wall Street On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230623084300"", ""headline"": ""California, others join FTC challenge of Amgen deal to buy Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230623110100"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230623161632"", ""headline"": ""UnitedHealth unit to add Boehringer's Humira biosimilar to reimbursement list"", ""summary"": ""Boehringer Ingelheim's biosimilar of AbbVie Inc's blockbuster arthritis drug Humira will be included in the reimbursement list of UnitedHealth Group Inc's OptumRx unit, the German drugmaker said on Friday.  It will be offered on OptumRx's commercial formulary as a preferred brand, Boehringer said.""}, {""date"": ""20230623163900"", ""headline"": ""Amgen Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 1.11% to $227.11 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230623215023"", ""headline"": ""Amgen (AMGN) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $227.11, moving -1.11% from the previous trading session.""}, {""date"": ""20230624112000"", ""headline"": ""4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire"", ""summary"": ""Buy 'em and then just get out of the way. Time and these companies' long-term strength will take care of the rest.""}, {""date"": ""20230625045900"", ""headline"": ""Russian Insurrection Crushed: 5 Stocks That Continue To Have Exposure To The Country"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230625110300"", ""headline"": ""What is behind big pharma's underperformance?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
3,2023-06-25,223.52716064453125,2023-07-02,218.5174560546875,-0.02241206203039703,D3,"[{""date"": ""20230625045900"", ""headline"": ""Russian Insurrection Crushed: 5 Stocks That Continue To Have Exposure To The Country"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230625110300"", ""headline"": ""What is behind big pharma's underperformance?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626040400"", ""headline"": ""7 Analysts Have This to Say About Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626075700"", ""headline"": ""Amgen price target lowered to $260 from $270 at Argus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626091500"", ""headline"": ""Video: Dow Movers: AMGN, NKE"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626104000"", ""headline"": ""Dow falls 109 points on losses for Amgen, Johnson & Johnson shares"", ""summary"": ""Behind losses for shares of Amgen and Johnson & Johnson, the Dow Jones Industrial Average is down Monday morning. The Dow was most recently trading 109...""}, {""date"": ""20230626111700"", ""headline"": ""A Look Into Amgen Inc's Price Over Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230626163900"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 1.05% to $224.73 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230626210300"", ""headline"": ""Why Amgen Stock Slumped on Monday"", ""summary"": ""Amgen (NASDAQ: AMGN) stock came under renewed pressure on Monday, several days after more regulators piled on to block a major acquisition announced by the company.  As a result, Amgen's share price sank by slightly over 1%, which was more than double the percentage-rate decline of the S&P 500 index on the day.  The person taking the scissors to his Amgen price target was Argus Research's David Toung.""}, {""date"": ""20230627024000"", ""headline"": ""Notable Tuesday Option Activity: AMGN, GIS, AMKR"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230627032300"", ""headline"": ""Eli Lilly (NYSE:LLY) Touts Superior Results of Weight Loss Shot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230627045300"", ""headline"": ""Next-Gen Weight-Loss Drugs Set To Up The Game From Ozempic  And Mounjaro: WSJ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230627051300"", ""headline"": ""Pharmaceutical companies are developing drugs to surpass Ozempic, WSJ reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230627060100"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY) and Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230627110040"", ""headline"": ""Does Amgen (NASDAQ:AMGN) Have A Healthy Balance Sheet?"", ""summary"": ""Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...""}, {""date"": ""20230627163900"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. sank 0.94% to $222.61 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230627175035"", ""headline"": ""Argus Research Maintains AMGEN (AMGN) Buy Recommendation"", ""summary"": """"}, {""date"": ""20230627204158"", ""headline"": ""Dow Jones Today: Index Ends 6-Day Losing Streak"", ""summary"": ""Tech and retail stocks helped lift the Dow Jones, while Walgreens plummeted after lowering its earnings outlook""}, {""date"": ""20230628025200"", ""headline"": ""How Is The Market Feeling About Amgen?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230628102500"", ""headline"": ""Cantor Fitzgerald biotech/biopharma to hold a luncheon meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230628112500"", ""headline"": ""Cantor Fitzgerald biotech/biopharma to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230628114500"", ""headline"": ""Cantor biotech/biopharma analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230628161016"", ""headline"": ""Avantor: Promising Long-Term Buy With Potential For Opportunistic Entry"", ""summary"": ""Avantor faces near-term challenges amid macro headwinds and revenue growth uncertainties due to continuing COVID roll-off. Read my analysis of AVTR stock here.""}, {""date"": ""20230628163900"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 0.58% to $221.31 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230628170107"", ""headline"": ""The New M&A Rules That Would Delay Million-Dollar Deals"", ""summary"": ""(Bloomberg) -- The US antitrust agencies are requiring firms to turn over much more information about their transactions than before in an overhaul to merger rules that could delay deals by months. Most Read from BloombergPutin Claims He\u2019s Back in Control. Russia\u2019s Elite Isn\u2019t SureSwitzerland Blocks Sale of Leopard 1 Tanks Bound for UkraineQatar Group Now Confident of Winning Manchester United RaceSweden Police Give Permit to Koran Burning Near Stockholm MosqueUBS Preparing to Cut Over Half of C""}, {""date"": ""20230629024600"", ""headline"": ""Pfizer sees second request as likely in FTC's review of Seagen deal - analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230629041200"", ""headline"": ""Morgan Stanley shakes up its global dividend portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230629121000"", ""headline"": ""Amgen Out, Rio Tinto In As Morgan Stanley Shuffles Dividend Deck"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230629124100"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230629140000"", ""headline"": ""5 High-Yielding Dividend Stocks That Are Bargain Buys"", ""summary"": ""If you're in search of bargain stocks to buy, the healthcare industry is a great place to start looking.  Among them are Johnson & Johnson (NYSE: JNJ),\u00a0AbbVie\u00a0(NYSE: ABBV), Bristol Myers Squibb (NYSE: BMY),\u00a0Amgen (NASDAQ: AMGN), and\u00a0Pfizer (NYSE: PFE) -- all of which pay dividends and offer great value.""}, {""date"": ""20230629163900"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.07% to $221.16 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230629164500"", ""headline"": ""What Will Amgen Buy Next?"", ""summary"": ""Biotech heavyweight Amgen (NASDAQ: AMGN) will probably continue to be an active player in the merger and acquisition (M&A) scene, regardless of what happens with its proposed $28 billion buyout of Horizon Therapeutics (NASDAQ: HZNP).  If this acquisition goes through, for instance, Amgen will probably be limited to smaller deals under $10 billion.""}, {""date"": ""20230629181706"", ""headline"": ""Moody's: Pharma outlook stable for next 12-18 months, but with caveats"", ""summary"": ""Moody's, in a note, sees a stable outlook for the drug industry. But there are a few headwinds that might mess up the semi-optimistic picture.""}, {""date"": ""20230630040117"", ""headline"": ""Cheaper competition for Humira is hitting the market, but savings will depend on your insurance"", ""summary"": ""Patients who take the autoimmune disease treatment Humira may see some price relief when several lower-cost, biosimilar versions of the AbbVie drug reach the U.S. market in July. \n  But lower pharmacy bills may not happen right away \u2014 or at all ...""}, {""date"": ""20230630040300"", ""headline"": ""Amgen Inc. Dividend Stock Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230630082548"", ""headline"": ""Amgen: A Healthcare Bargain With A 4% Yield"", ""summary"": ""Amgen's stock price decline has already priced in much of the bad news, making it an attractive investment. Click here to read my analysis of the AMGN stock.""}, {""date"": ""20230630110800"", ""headline"": ""15 Stocks Up, 15 Stocks Down: A Look At The Dow Jones Industrial Average Halfway Through 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230630114500"", ""headline"": ""Medicare revises guidance on drug price negotiations amid lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230630124200"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230630163900"", ""headline"": ""Amgen Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.39% higher to $222.02 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230630215019"", ""headline"": ""Amgen (AMGN) Gains But Lags Market: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $222.02, marking a +0.39% move from the previous day.""}, {""date"": ""20230701100900"", ""headline"": ""Organon launches biosimilar of AbbVie's Humira"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230702140012"", ""headline"": ""Insiders At Amgen Sold US$1.9m In Stock, Alluding To Potential Weakness"", ""summary"": ""Many Amgen Inc. ( NASDAQ:AMGN ) insiders ditched their stock over the past year, which may be of interest to the...""}]","{""assetTurnoverTTM"": 0.3454, ""bookValue"": 6781, ""cashRatio"": 2.0031584488506757, ""currentRatio"": 2.7712, ""ebitPerShare"": 4.9981, ""eps"": 2.568, ""ev"": 146076.7, ""fcfMargin"": 0.5494, ""fcfPerShareTTM"": 18.1028, ""grossMargin"": 0.7405, ""inventoryTurnoverTTM"": 1.4331, ""longtermDebtTotalAsset"": 0.6578, ""longtermDebtTotalCapital"": 0.869, ""longtermDebtTotalEquity"": 8.7564, ""netDebtToTotalCapital"": 0.3995, ""netDebtToTotalEquity"": 4.0254, ""netMargin"": 0.1974, ""operatingMargin"": 0.3842, ""payoutRatioTTM"": 0.5457, ""pb"": 17.5167, ""peTTM"": 14.8867, ""pfcfTTM"": 12.2644, ""pretaxMargin"": 0.231, ""psTTM"": 4.4685, ""quickRatio"": 2.4801, ""receivablesTurnoverTTM"": 4.7651, ""roaTTM"": 0.1037, ""roeTTM"": 1.6415, ""roicTTM"": 0.1449, ""rotcTTM"": 0.1759, ""salesPerShare"": 13.0093, ""sgaToSale"": 0.2595, ""totalDebtToEquity"": 9.0759, ""totalDebtToTotalAsset"": 0.6818, ""totalDebtToTotalCapital"": 0.9008, ""totalRatio"": 1.0812, ""period"": ""2023-06-30""}"
4,2023-07-02,218.5174560546875,2023-07-09,215.2006072998047,-0.015178873188294473,D2,"[{""date"": ""20230702140012"", ""headline"": ""Insiders At Amgen Sold US$1.9m In Stock, Alluding To Potential Weakness"", ""summary"": ""Many Amgen Inc. ( NASDAQ:AMGN ) insiders ditched their stock over the past year, which may be of interest to the...""}, {""date"": ""20230703071000"", ""headline"": ""Not A Market For The Dogs Of The Dow"", ""summary"": ""With the first half of 2023 coming to a close this past Friday, the equity markets rewarded investors with strong performance.""}, {""date"": ""20230703164900"", ""headline"": ""Top Analyst Reports for Apple, Verizon & Amgen"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Verizon Communications Inc. (VZ) and Amgen Inc. (AMGN).""}, {""date"": ""20230703175145"", ""headline"": ""India's Biocon Biologics launches biosimilar for AbbVie's Humira in US"", ""summary"": ""India's Biocon Biologics said on Monday it has launched a biosimilar version of AbbVie's blockbuster rheumatoid arthritis drug Humira in the United States.  The launch of the copycat version, branded as Hulio, adds to a list of biosimilars introduced by drugmakers on Monday by Coherus Biosciences and Germany's Fresenius.  Boehringer Ingelheim and Swiss drugmaker Sandoz launched their Humira biosimilars on Saturday.""}, {""date"": ""20230704101409"", ""headline"": ""FTC : Amgen-Horizon Deal Would Cement Monopoly For Treatment Of Two Diseases"", ""summary"": ""Commission pauses major biopharma transaction involving drugs priced in the hundreds of thousands of dollars. As part of the Federal Trade Commission's promised campaign to protect competition in the...""}, {""date"": ""20230705060900"", ""headline"": ""Why the 5 Highest-Yielding Nasdaq Stocks Could Rip Higher With the Red-Hot Summer Rally"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230705094200"", ""headline"": ""5 Top Dividend Stocks For July 2023"", ""summary"": ""The S&P 500 gained 16% through the first half of 2023. Click here to read more about the five dividend stocks to consider buying in July 2023.""}, {""date"": ""20230705100000"", ""headline"": ""Why I'm Buying DIA This Month Instead Of VOO"", ""summary"": ""We explore the idea of alternating new investments between VOO and DIA to make tax loss harvesting easier. Explore more about tax loss harvesting here.""}, {""date"": ""20230705120100"", ""headline"": ""Celltrion launches biosimilar of AbbVie's Humira in US"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230705122800"", ""headline"": ""The Zacks Analyst Blog Highlights Apple, Verizon Communications, Amgen, Charles Schwab and The Cigna Group"", ""summary"": ""Apple, Verizon Communications, Amgen, Charles Schwab and The Cigna Group are part of the Zacks top Analyst Blog.""}, {""date"": ""20230705163900"", ""headline"": ""Amgen Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.39% higher to $225.88 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""20230705192041"", ""headline"": ""Cramer examines the worst performers from the first half of 2023, explains why the market seems narrow"", ""summary"": ""CNBC's Jim Cramer told investors on Wednesday that if they're waiting for the market to broaden for a rally, they might be waiting forever.""}, {""date"": ""20230705195852"", ""headline"": ""Go with what's working instead of waiting for what is not working, says Jim Cramer"", ""summary"": ""'Mad Money' host Jim Cramer takes a closer look at market underperformers and what they say about the economy at large.""}, {""date"": ""20230706002453"", ""headline"": ""3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025"", ""summary"": ""Investing in the biotech sector is mostly about risk and reward. When a company achieves FDA approval on a drug or therapeutic, it frequently has a source of revenue and profit that can last for years. And investors who buy and hold these stocks are typically rewarded with handsome total returns. Even penny stocks can become triple-digit return biotech stocks. However, that payoff can take a long time. Just getting a drug through the clinical trial stage can take several years. And some candidat""}, {""date"": ""20230706051400"", ""headline"": ""Amgen: Are Its Golden Days Over?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706093103"", ""headline"": ""U.S. Wide-Moat Stocks On Sale - The July 2023 Heat Map"", ""summary"": ""Our 3-step process focuses on wide-moat stocks. We're only interested in targets attractively valued in historical comparison. Read what investors need to know.""}, {""date"": ""20230706103200"", ""headline"": ""AMGN August 25th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706105100"", ""headline"": ""Treasury Yields Spiking As Market Looks Ahead To Jobs Data, Raising Valuation Concerns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230706105300"", ""headline"": ""4 Big Pharma Stocks On Sale Right Now "", ""summary"": ""The key is to buy a basket of the cheap ones, so that gains in a few of them can offset disappointing performance in others.""}, {""date"": ""20230706145300"", ""headline"": ""4 Big Pharma Stocks On Sale Right Now"", ""summary"": ""The key is to buy a basket of the cheap ones, so that gains in a few of them can offset disappointing performance in others.""}, {""date"": ""20230706163900"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 1.28% to $222.98 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230707031200"", ""headline"": ""Rose's Income Garden 80 Stock Portfolio: Update H1 2023 Green With 7 June Raises"", ""summary"": ""Rose's Income Garden portfolio saw 39 companies pay dividends in June, with seven raises and one cut. Click here for a detailed analysis.""}, {""date"": ""20230707042613"", ""headline"": ""Amgen: Is The 3.79% Dividend Yield Worth The Fuss?"", ""summary"": ""Amgen offers an attractive 3.79% dividend yield, with a dividend payout that reached $4.2 billion in FY 2022. Read more about AMGN stock here.""}, {""date"": ""20230707071300"", ""headline"": ""Wall Street Analysts Are Bullish on Top Healthcare Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230707075900"", ""headline"": ""Amgen price target lowered to $275 from $325 at Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230707113857"", ""headline"": ""Bristol-Myers Squibb: Battling Exclusivity Headwinds"", ""summary"": ""Bristol-Myers Squibb Company is battling the loss of exclusivity of Revlimid with some new product growth engines. Click for more on BMY stock.""}, {""date"": ""20230707120038"", ""headline"": ""Amgen (NASDAQ:AMGN) shareholders have earned a 5.8% CAGR over the last five years"", ""summary"": ""Amgen Inc. ( NASDAQ:AMGN ) shareholders might be concerned after seeing the share price drop 12% in the last quarter...""}, {""date"": ""20230707122100"", ""headline"": ""What Does Amgen's Debt Look Like?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230707134500"", ""headline"": ""2 Struggling Dividend Growth Stocks That Could Make You Richer"", ""summary"": ""Despite lingering economic issues, the broader stock market has recovered this year.  Take AbbVie (NYSE: ABBV) and Amgen (NASDAQ: AMGN), two drugmakers that have significantly underperformed the stock market this year.  AbbVie started the year with a lot to prove.""}, {""date"": ""20230707163900"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 1.94% to $218.65 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230707171840"", ""headline"": ""Buy 3 July Dogs Of The Dow, Watch 6"", ""summary"": ""Analyst 1-year targets showed 10 highest-yield Dow stocks producing 1.62% LESS gain from $5k invested in the lowest-priced 5. Click for our exclusive stock lists.""}, {""date"": ""20230707215022"", ""headline"": ""Amgen (AMGN) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $218.65, marking a -1.94% move from the previous day.""}, {""date"": ""20230709070200"", ""headline"": ""Fly Intel: Top five weekend stock stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709072600"", ""headline"": ""Pfizer among big pharma stocks on sale right now, Barron's says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709080500"", ""headline"": ""New M&A rules likely to delay deals by months, add significant costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709110000"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3454, ""bookValue"": 6781, ""cashRatio"": 2.0031584488506757, ""currentRatio"": 2.7712, ""ebitPerShare"": 4.9981, ""eps"": 2.568, ""ev"": 146076.7, ""fcfMargin"": 0.5494, ""fcfPerShareTTM"": 18.1028, ""grossMargin"": 0.7405, ""inventoryTurnoverTTM"": 1.4331, ""longtermDebtTotalAsset"": 0.6578, ""longtermDebtTotalCapital"": 0.869, ""longtermDebtTotalEquity"": 8.7564, ""netDebtToTotalCapital"": 0.3995, ""netDebtToTotalEquity"": 4.0254, ""netMargin"": 0.1974, ""operatingMargin"": 0.3842, ""payoutRatioTTM"": 0.5457, ""pb"": 17.5167, ""peTTM"": 14.8867, ""pfcfTTM"": 12.2644, ""pretaxMargin"": 0.231, ""psTTM"": 4.4685, ""quickRatio"": 2.4801, ""receivablesTurnoverTTM"": 4.7651, ""roaTTM"": 0.1037, ""roeTTM"": 1.6415, ""roicTTM"": 0.1449, ""rotcTTM"": 0.1759, ""salesPerShare"": 13.0093, ""sgaToSale"": 0.2595, ""totalDebtToEquity"": 9.0759, ""totalDebtToTotalAsset"": 0.6818, ""totalDebtToTotalCapital"": 0.9008, ""totalRatio"": 1.0812, ""period"": ""2023-06-30""}"
5,2023-07-09,215.2006072998047,2023-07-16,223.84210205078125,0.04015553143369033,U5,"[{""date"": ""20230709070200"", ""headline"": ""Fly Intel: Top five weekend stock stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709072600"", ""headline"": ""Pfizer among big pharma stocks on sale right now, Barron's says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709080500"", ""headline"": ""New M&A rules likely to delay deals by months, add significant costs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230709110000"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710014500"", ""headline"": ""B. Riley biotechnology analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710084700"", ""headline"": ""Amgen (AMGN) Gets a Hold from RBC Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710095100"", ""headline"": ""AbbVie's R&D Pipeline: Driving Long-Term Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230710095800"", ""headline"": ""Dow up 182 points on gains for Amgen, Walgreens Boots stocks"", ""summary"": ""The Dow Jones Industrial Average is climbing Monday morning with shares of Amgen and Walgreens Boots leading the way for the index. The Dow is trading 182...""}, {""date"": ""20230710100800"", ""headline"": ""These companies have beaten the Rule of 40 year after year"", ""summary"": ""Morgan Stanley applied a VC filter to the stock market. Here's what it found.""}, {""date"": ""20230710111600"", ""headline"": ""Dow up nearly 100 points on gains in shares of Amgen, Walgreens Boots"", ""summary"": ""Buoyed by positive momentum for shares of Amgen and Walgreens Boots, the Dow Jones Industrial Average is climbing Monday morning. Shares of Amgen and...""}, {""date"": ""20230710124700"", ""headline"": ""AbbVie slips as Cigna adds more Humira biosimilars for coverage"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711042100"", ""headline"": ""Amgen price target lowered to $210 from $225 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711043500"", ""headline"": ""Barclays Sticks to Its Sell Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711093900"", ""headline"": ""European Regulator Expands Ozempic Probe To Include Other Weight Loss Drugs Over Suicide Risks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711104100"", ""headline"": ""iRobot, Seagen, Horizon gain amid Microsoft win in Activision case"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230711122705"", ""headline"": ""Barclays Maintains AMGEN (AMGN) Underweight Recommendation"", ""summary"": """"}, {""date"": ""20230711130017"", ""headline"": ""Is There An Opportunity With Amgen Inc.'s (NASDAQ:AMGN) 45% Undervaluation?"", ""summary"": ""Key Insights The projected fair value for Amgen is US$407 based on 2 Stage Free Cash Flow to Equity Amgen is estimated...""}, {""date"": ""20230711161320"", ""headline"": ""EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs"", ""summary"": ""The European Medicines Agency didn't specify which additional GLP-1 drugs are now being investigated, but it could potentially include Eli Lilly's Mounjaro. ""}, {""date"": ""20230711163900"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.39% to $223.86 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230711172324"", ""headline"": ""We've only seen the beginning of Moderna's story, says Goldman Sachs' Salveen Richter"", ""summary"": ""Salveen Richter, Goldman Sachs lead biotech analyst, joins 'Closing Bell Overtime' to discuss the biotech sector and how investors should play in the space.""}, {""date"": ""20230712010600"", ""headline"": ""Analyst Expectations for Amgen's Future"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230712053300"", ""headline"": ""Amgen price target lowered to $200 from $220 at Credit Suisse"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230712060000"", ""headline"": ""ClearBridge Small Cap Growth Strategy Q2 2023 Portfolio Manager Commentary"", ""summary"": ""The growth rally expanded to smaller stocks in the second quarter. Click here to read the full fund letter.""}, {""date"": ""20230712130007"", ""headline"": ""Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know"", ""summary"": ""Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""20230712152252"", ""headline"": ""Credit Suisse Maintains AMGEN (AMGN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20230712155900"", ""headline"": ""Drugmakers\u2019 deal making will plow ahead despite antitrust scrutiny, analysts say"", ""summary"": ""Big pharma goes shopping as \""patent cliff\"" puts more than $225 billion in revenues at risk.""}, {""date"": ""20230712181900"", ""headline"": ""Let's Check the Safety and Efficacy of Amgen's Charts Ahead of Earnings"", ""summary"": ""AMGN's quarterly report is due in early August, so will buying the stock now pose any side effects?""}, {""date"": ""20230713061309"", ""headline"": ""Preserving The Patent Bargain : U.S. Supreme Court Limits Amgen's Monopoly"", ""summary"": ""Amgen Inc. et al. v Sanofi et al, No. 21-757  On May 18, 2023, the Supreme Court of the United States  issued a long-awaited decision regarding the scope of the enablement requirement in Section 112...""}, {""date"": ""20230713131417"", ""headline"": ""Lucy Scientific Scores Richard Nanula as CEO After Senior Roles at Disney, Amgen, Starwood"", ""summary"": ""By Daniella Parra Psychotropic industry innovator Lucy Scientific Discovery Inc. (Nasdaq: LSDI), has appointed Richard Nanula, former CFO at Amgen Inc. (Nasdaq: AMGN) and The Walt Disney Co. (NYSE: DIS), as its new CEO. With a career spanning senior executive positions at global giants like Starwood Hotels and Resorts, now part of Marriott International, Inc. [\u2026]""}, {""date"": ""20230713164000"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.88% higher to $227.66 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230713173744"", ""headline"": ""The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?"", ""summary"": ""An overweight world is hungry for obesity treatments, driving big forecasts for weight loss drugs. For now, two pharmaceutical stocks own the market.""}, {""date"": ""20230713181053"", ""headline"": ""Is Amgen's Dividend Safe?"", ""summary"": ""Despite multiple headwinds, the biotech's dividend appears to be a safe play for income investors.""}, {""date"": ""20230713220020"", ""headline"": ""Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $227.66, moving +0.88% from the previous trading session.""}, {""date"": ""20230714012600"", ""headline"": ""SCHD vs. VYM: Which is the Better Dividend ETF?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714020200"", ""headline"": ""Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714032200"", ""headline"": ""Venturing Beyond The Magic Kingdom: Former Disney CFO And Fortune 500 Veteran Takes The Reins At Lucy Scientific"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714035503"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: June 2023 Review"", ""summary"": ""The significant dividend growth is attributed to rapid rise in interest rates over past 12-18 months, with cash position now yielding nearly 5%. Read more here.""}, {""date"": ""20230714045900"", ""headline"": ""ClearBridge Large Cap Value Strategy Q2 2023 Portfolio Manager Commentary"", ""summary"": ""U.S. equities continued to make gains in Q2, driven by excitement over generative AI and improving market sentiment.""}, {""date"": ""20230714063300"", ""headline"": ""Zai Lab treats first patient in mainland China in Phase 3 FORTITUDE-101 study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714115100"", ""headline"": ""(AMGN) - Analyzing Amgen's Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230714125000"", ""headline"": ""2 Best Biotech Stocks to Buy Right Now"", ""summary"": ""Many investors appreciate and rely on the regular cash flow that dividend stocks can generate for them.  Investors should seek out businesses with current products that can finance dividends, and future products that can sustain those dividends.  Here are two companies that could do just that, which income seeking investors should consider purchasing for their portfolios.""}, {""date"": ""20230714160003"", ""headline"": ""MOORE KUEHN ENCOURAGES AMGEN INC. INVESTORS TO CONTACT LAW FIRM"", ""summary"": ""NEW YORK, July 14, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a securities and shareholder law firm located on Wall Street, is investigating potential claims against:\n\n    \n                \n           ...""}, {""date"": ""20230714164000"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slumped 0.10% to $227.43 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20230714201500"", ""headline"": ""Dividend Income Update June 2023"", ""summary"": ""The beginning of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. ""}, {""date"": ""20230716110100"", ""headline"": ""Eli Lilly, Merck among top pharma picks in Barclays Q2 preview"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3454, ""bookValue"": 6781, ""cashRatio"": 2.0031584488506757, ""currentRatio"": 2.7712, ""ebitPerShare"": 4.9981, ""eps"": 2.568, ""ev"": 146076.7, ""fcfMargin"": 0.5494, ""fcfPerShareTTM"": 18.1028, ""grossMargin"": 0.7405, ""inventoryTurnoverTTM"": 1.4331, ""longtermDebtTotalAsset"": 0.6578, ""longtermDebtTotalCapital"": 0.869, ""longtermDebtTotalEquity"": 8.7564, ""netDebtToTotalCapital"": 0.3995, ""netDebtToTotalEquity"": 4.0254, ""netMargin"": 0.1974, ""operatingMargin"": 0.3842, ""payoutRatioTTM"": 0.5457, ""pb"": 17.5167, ""peTTM"": 14.8867, ""pfcfTTM"": 12.2644, ""pretaxMargin"": 0.231, ""psTTM"": 4.4685, ""quickRatio"": 2.4801, ""receivablesTurnoverTTM"": 4.7651, ""roaTTM"": 0.1037, ""roeTTM"": 1.6415, ""roicTTM"": 0.1449, ""rotcTTM"": 0.1759, ""salesPerShare"": 13.0093, ""sgaToSale"": 0.2595, ""totalDebtToEquity"": 9.0759, ""totalDebtToTotalAsset"": 0.6818, ""totalDebtToTotalCapital"": 0.9008, ""totalRatio"": 1.0812, ""period"": ""2023-06-30""}"
6,2023-07-16,223.84210205078125,2023-07-23,231.11553955078125,0.03249360791988076,U4,"[{""date"": ""20230716110100"", ""headline"": ""Eli Lilly, Merck among top pharma picks in Barclays Q2 preview"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230717164100"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.18% higher to $227.84 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230717215021"", ""headline"": ""Amgen (AMGN) Gains But Lags Market: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $227.84, marking a +0.18% move from the previous day.""}, {""date"": ""20230718102203"", ""headline"": ""3 Biotech Stocks for Getting Rich in 2023"", ""summary"": ""The biotech industry is constantly evolving due to being on the cutting edge of the healthcare industry\u2019s research and development. Large biotech companies such as Johnson and Johnson (NYSE:JNJ), Merck (NYSE:MRK), and AbbVie (NYSE:ABBV) offer investors steady and continual growth as well as decent dividends. But, a large portion of the industry involves much more volatile stocks. Many companies\u2019 significant volatility in the biotech market attracts investors looking for a stock that will experie""}, {""date"": ""20230718164000"", ""headline"": ""Amgen Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. rose 2.08% to $232.57 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230718171521"", ""headline"": ""Regional banks, Dow Theory: Key technical levels to watch"", ""summary"": ""PNC Financial kicked off regional bank earnings with a mixed report. Freedom Capital Markets Chief Global Strategist Jay Woods breaks down what price levels he is watching for the regional banks. For the broader market, with the Dow Jones Industrials Average and the Dow Transports making new 52-week highs, Woods says \""that's as bullish as you can get\"" for stocks.""}, {""date"": ""20230718202356"", ""headline"": ""Softbank, Amgen-Backed Neumora Therapeutics Unveils Plans For Three Phase 3 Studies For Major Depressive Disorder"", ""summary"": ""Neumora Therapeutics unveiled plans for three late-stage studies for its major depressive disorder (MDD) candidate Navacaprant. The U.S.-based clinical-stage biopharmaceutical is backed by Softbank Group Corp (OTC: SFTBY) (OTC: SFTBF) and Amgen Inc (NASDAQ: AMGN) via a $100 million equity investment. Neumora's KOASTAL Phase 3 program, comprising three Phase 3 studies, is designed to evaluate 80 mg of the once-daily navacaprant (NMRA-140) oral monotherapy for MDD. The U.S. trial, the KOASTAL-1 st""}, {""date"": ""20230719012500"", ""headline"": ""Amgen, FTC said they are no ongoing talks to settle over Horizon Therapeutics deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719013600"", ""headline"": ""Amgen, FTC said there are no ongoing talks to settle over Horizon Therapeutics deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719014100"", ""headline"": ""Amgen, FTC said there are no ongoing talks, though open to settlement over Horizon"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719024300"", ""headline"": ""Tesla On Tap: \""Mega-cap\"" Reporting Season Gets Underway After Close With EV Giant's Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230719083000"", ""headline"": ""ClearBridge Large Cap Value ESG Strategy Q3 2023 Portfolio Manager Commentary"", ""summary"": ""ClearBridge takes a fundamental-driven approach to proxies. Click here to read the full fund letter.""}, {""date"": ""20230719093000"", ""headline"": ""Prediction: This Beaten-Down Stock Will Be a Biotech Giant by 2030"", ""summary"": ""When you think of biotech giants, you may think of Amgen or Biogen. These companies have brought significant treatments to market over time -- and have generated billions of dollars in earnings, too. Most investors would be happy to find the next company set to follow in their footsteps.""}, {""date"": ""20230719163900"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.22% to $232.05 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230719212104"", ""headline"": ""12 Highest Yielding Dow Jones Dividend Stocks"", ""summary"": ""In this article, we discuss 12 highest yielding Dow Jones dividend stocks. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Highest Yielding Dow Jones Dividend Stocks. The Dow Jones Industrial Average, commonly referred to as the Dow, is one of the most [\u2026]""}, {""date"": ""20230720010100"", ""headline"": ""Lawmakers reintroduce bill to offer Medicare coverage for weight loss drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720010400"", ""headline"": ""See Which Of The Latest 13F Filers Holds Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720012900"", ""headline"": ""Key Horizon drug Tepezza has hearing loss warning added to labeling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230720164000"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.51% higher to $233.23 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""20230721031500"", ""headline"": ""M&A Scrutiny May Constrain Large Companies"", ""summary"": ""The FTC\u00e2\u0080\u0099s recent push against some large M&A deals may ultimately limit the ability of major companies to take advantage of business development opportunities.""}, {""date"": ""20230721061300"", ""headline"": ""Mirati fails to win EU backing for lung cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230721120054"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 77% of the company"", ""summary"": ""Key Insights Institutions' substantial holdings in Amgen implies that they have significant influence over the...""}, {""date"": ""20230721163900"", ""headline"": ""Amgen Inc. stock underperforms Friday when compared to competitors despite daily gains"", ""summary"": ""Shares of Amgen Inc. inched 0.68% higher to $234.82 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230721193128"", ""headline"": ""The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023"", ""summary"": ""Pharma stocks experienced an abysmal first half due to various factors. Rotation from defensive to cyclical sectors, drug price negotiations and upcoming patent cliffs have muddied the outlook. As a result, they have underperformed, creating undervalued pharma stocks to buy. Overall, the VanEck Pharmaceutical ETF (NASDAQ:PPH) is flat for the year. Only a few stocks have performed well. For instance, as of this writing, Eli Lilly (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) are up 23% and 16.67%, r""}]",{}
7,2023-07-23,231.11553955078125,2023-07-30,232.6410675048828,0.006600715629363263,U1,"[{""date"": ""20230724123834"", ""headline"": ""Amgen: Huge Potential With Biosimilars And GLP-1"", ""summary"": ""Amgen is now down nearly 20% since last November as money continues to rotate from defensive sectors into tech. Click here to read my latest analysis of AMGN stock.""}, {""date"": ""20230724130006"", ""headline"": ""Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20230724152300"", ""headline"": ""Mirati (MRTX) Down 7% on CHMP's Opinion on Krazati Filing"", ""summary"": ""Per the CHMP, Mirati's (MRTX) regulatory filing for Krazati in KRASG12C mutated NSCLC does not fulfill certain requirements to support a conditional marketing authorization.""}, {""date"": ""20230724164000"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.26% higher to $235.42 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230724215021"", ""headline"": ""Amgen (AMGN) Gains But Lags Market: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $235.42, moving +0.26% from the previous trading session.""}, {""date"": ""20230725092715"", ""headline"": ""Bicara Therapeutics Expands Management Team with the Appointment of David Raben, M.D., as Chief Medical Officer"", ""summary"": ""CAMBRIDGE - Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response, today announced the appointment of David...""}, {""date"": ""20230725112100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Biogen (BIIB)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230725115609"", ""headline"": ""Janux: Merck Deal, Loads Of Cash, Solid Early Data"", ""summary"": ""Janux Therapeutics is a small company with a deal from Merck & Co. and some solid early data. Click here for my look at JANX stock prospects.""}, {""date"": ""20230725144959"", ""headline"": ""Oppenheimer Reiterates AMGEN (AMGN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20230725151500"", ""headline"": ""2 Cheap High-Yield Dividend Stocks to Buy Now"", ""summary"": ""High-yield dividend stocks can offer remarkable benefits for investors who aim to maximize their returns over the long run.  One sector that has many attractive high-yield dividend stocks is healthcare.  Many healthcare companies can afford to pay generous dividends to their shareholders and still invest in growth opportunities.""}, {""date"": ""20230725164000"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slumped 0.05% to $235.31 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230726073900"", ""headline"": ""AbbVie says Skyrizi beat Amgen\u2019s Otezla in plaque psoriasis trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726081200"", ""headline"": ""Seven Humira Biosimilars: Increased Competition In Arthritis Drug Market Sparks Need For Reform Of Drug Pricing Intermediaries"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726110200"", ""headline"": ""AbbVie under pressure ahead of Q2 results amid Humira cliff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726113100"", ""headline"": ""AbbVie's Skyrizi Achieves Superiority Versus Amgen's Drug In Head-to-Head Study In Moderate Plaque Psoriasis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230726160646"", ""headline"": ""AbbVie may see less pain from Humira sales decline as rival lags"", ""summary"": ""AbbVie Inc is likely to beat Wall Street sales estimates for Humira in the second quarter as the only copycat in the U.S. market for the blockbuster arthritis drug struggled to gain traction.  Humira sales are likely to decline when the company reports on Thursday but that would mostly be due to the discounts AbbVie has offered to shield itself from prescription share erosion, analysts have said.  The first biosimilar of one of the world's biggest selling drug, Amjevita from Amgen Inc, has not been able to switch Humira patients as much as analysts had estimated since its launch in January.""}, {""date"": ""20230726164000"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. dropped 0.04% to $235.21 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20230726220349"", ""headline"": ""Building The Dividend Growth Portfolio In 2023"", ""summary"": ""My US dividend growth portfolio, constructed in 2015, has outperformed the market by over 2% annually. Check out my dividend growth portfolio in 2023.""}, {""date"": ""20230727023300"", ""headline"": ""Check Out What Whales Are Doing With AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727081300"", ""headline"": ""Inside AbbVie: Signs of stabilization in Humira sales?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727103300"", ""headline"": ""AMGN September 8th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230727154500"", ""headline"": ""How AbbVie\u2019s Humira Still Reigns, Despite New Competition"", ""summary"": ""Revenue for blockbuster arthritis drug declined in the second quarter, largely due to discounts for middlemen.""}, {""date"": ""20230727164000"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Shares of Amgen Inc. inched 0.36% higher to $236.05 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...""}, {""date"": ""20230727170500"", ""headline"": ""AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises '23 View"", ""summary"": ""AbbVie's (ABBV) second-quarter 2023 earnings and sales beat estimates. The company raises its EPS guidance. Stock rises post the announcement.""}, {""date"": ""20230727181601"", ""headline"": ""INVESTIGATION ALERT : Scott+Scott Attorneys at Law LLP Investigates Amgen Inc's Directors and Officers for Breach of Fiduciary Duties \u2013 AMGN"", ""summary"": ""Scott+Scott Attorneys at Law LLP , an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Amgen Inc.   breached their fiduciary...""}, {""date"": ""20230728010400"", ""headline"": ""Catalyst watch: Amazon earnings, jobs report and will Apple talk AI?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728010900"", ""headline"": ""Catalyst Watch: Amazon earnings, jobs report, and will Apple talk AI?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728013800"", ""headline"": ""Earnings week ahead: Amazon, Apple, Pfizer, Starbucks, Uber and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728031100"", ""headline"": ""The Dow Breaks 13-Day Winning Streak, Fed Raises Interest Rates To 2001 Levels And AI Is The Buzzword For Big Tech Earnings: The Week In The Markets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230728101211"", ""headline"": ""Big Pharma's Balancing Act : Navigating Patent Thickets In The Age Of Biosimilars"", ""summary"": ""The rise of biosimilars is transforming the pharmaceutical landscape, and Big Pharma is keenly aware that the fate of their blockbuster biologic drugs' exclusivity is at stake. These drugs, which...""}, {""date"": ""20230728120046"", ""headline"": ""Amgen (NASDAQ:AMGN) Seems To Use Debt Quite Sensibly"", ""summary"": ""Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...""}, {""date"": ""20230728122014"", ""headline"": ""Unveiling AbbVie's Hidden Risks: Cautionary Notes For Investors"", ""summary"": ""AbbVie's Q2 2023 financial results exceeded expectations, driven by strong sales of innovative drugs Skyrizi and Rinvoq. Click here to read more.""}, {""date"": ""20230728164000"", ""headline"": ""Amgen Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.14% higher to $236.37 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230728200200"", ""headline"": ""With Hurricane Season Looming, Florida Faces an Insurance Meltdown "", ""summary"": ""Florida has long had hurricanes. But climate change is kicking in, the population of the state is growing, and private insurers are leaving the state. The...""}]",{}
8,2023-07-30,232.6410675048828,2023-08-06,239.4420623779297,0.029233853446378966,U3,"[{""date"": ""20230731045100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Icon (ICLR) and Edwards Lifesciences (EW)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731051300"", ""headline"": ""Amgen To Report Q2 Earnings: Here's What To Expect"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731102400"", ""headline"": ""Rising Stars, Falling Trends: July's Industry ETF Winners And Losers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230731144342"", ""headline"": ""August MDA Breakout Stocks Week 31 - 2023: High-Frequency Gainers To Give You An Edge"", ""summary"": ""Breakout Stocks for Week 31 curated by the MDA model for 10% short-term upside and additional model selections. Read more to see the full update.""}, {""date"": ""20230731150900"", ""headline"": ""Amgen (AMGN) to Report Q2 Earnings: Here's What to Expect"", ""summary"": ""Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.""}, {""date"": ""20230731164000"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.94% to $234.15 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230731164500"", ""headline"": ""Pfizer Stock Wavers Despite Earnings Beat. Revenue and Outlook Aren\u2019t So Good."", ""summary"": ""The company is seeking new sources of revenue because patent expirations are expected to hit seven of its key products by the end of the decade.""}, {""date"": ""20230731200000"", ""headline"": ""AMGEN ANNOUNCES WEBCAST OF 2023 SECOND QUARTER FINANCIAL RESULTS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Thursday, August 3, 2023, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 1:30 p.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.""}, {""date"": ""20230801021700"", ""headline"": ""Looking At Amgen's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801034100"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801034800"", ""headline"": ""Amgen declares $2.13 dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230801200000"", ""headline"": ""AMGEN ANNOUNCES 2023 THIRD QUARTER DIVIDEND"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.13 per share dividend for the third quarter of 2023. The dividend will be paid on September 8, 2023, to all stockholders of record as of the close of business on August 18, 2023.""}, {""date"": ""20230802012600"", ""headline"": ""Amgen looks to Q2 top, bottom line beats after missing in Q1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802034400"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802113100"", ""headline"": ""Video: Daily Dividend Report: AMGN, SYK, GD, KHC, KMB"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230802161600"", ""headline"": ""NEW YORK MARKET CLOSE: Fitch downgrade sparks retreat on Wall Street"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803003400"", ""headline"": ""GLOBAL BRIEFING: China's services see strong growth in July"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803010000"", ""headline"": ""Stocks Mitigate Losses Ahead Of Apple, Amazon Earnings; Treasury Yields Rocket On Debt Frenzy: Thursday's Market Drivers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803013600"", ""headline"": ""Notable companies reporting after market close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803015700"", ""headline"": ""September 22nd Options Now Available For Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803030200"", ""headline"": ""Amgen reports Q2 adjusted EPS $5.00, consensus $4.08"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803030300"", ""headline"": ""Amgen raises FY23 adjusted EPS view to $17.80-$18.80 from $17.60-$18.70"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803030500"", ""headline"": ""Amgen sees FY23 CapEx about $925M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803031100"", ""headline"": ""Amgen Non-GAAP EPS of $5.00 beats by $0.51, revenue of $6.98B beats by $300M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803031500"", ""headline"": ""Amgen stock jumps after the biotech\u2019s record earnings beats expectations, and full-year outlook is raised"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803034100"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803035600"", ""headline"": ""Amgen (AMGN) Gets a Hold from Mizuho Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803040000"", ""headline"": ""Amgen guides 2023 EPS above consensus while revenue in-line"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803040200"", ""headline"": ""Amgen stock jumps after record earnings beat expectations, and biotech raises full-year outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803041100"", ""headline"": ""Amgen says FTC has ignored commitments it made to address Horizon deal concerns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803050400"", ""headline"": ""Amgen says FTC has ignored commitments it made to address Horizon deal concerns (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803055700"", ""headline"": ""US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230803110012"", ""headline"": ""Amgen Insiders Sold US$1.9m Of Shares Suggesting Hesitancy"", ""summary"": ""Over the past year, many Amgen Inc. ( NASDAQ:AMGN ) insiders sold a significant stake in the company which may have...""}, {""date"": ""20230803120000"", ""headline"": ""3 Dividend Stocks That Hiked Payouts by 60% in Just 5 Years"", ""summary"": ""Want a good dividend stock to own?  When it comes to long-term dividend income, it's important to consider businesses that are growing and that have the potential to increase their payouts, allowing your dividend income to rise over the years.  Three companies that have been generously increasing their dividend payments over the past five years include Amgen\u00a0(NASDAQ: AMGN),\u00a0Microsoft\u00a0(NASDAQ: MSFT), and\u00a0Mondelez International (NASDAQ: MDLZ).""}, {""date"": ""20230803161300"", ""headline"": ""Amgen stock jumps after record earnings beat expectations, and biotech raises full-year outlook "", ""summary"": ""Amgen's stock jumped in after-hours trading Thursday, after the biotechnology giant reported record second-quarter earnings that rose above expectations.""}, {""date"": ""20230803162105"", ""headline"": ""Amgen 2Q Profit Up as Revenue Rises 6%"", ""summary"": ""By Brenda Le\u00f3n \n\n\n  Amgen posted higher profit and revenue in the second quarter, helped by an increase in product sales across most therapeutic categories. \n\n  The Thousand Oaks, Calif.-based...""}, {""date"": ""20230803170816"", ""headline"": ""Stocks making the biggest moves after hours: Apple, Amazon, Airbnb, Coinbase and more"", ""summary"": ""These are the stocks posting the largest moves in extended trading. ""}, {""date"": ""20230803180250"", ""headline"": ""Stock futures rise slightly as investors weigh Big Tech earnings, await key jobs data: Live updates"", ""summary"": ""The three major indexes are on pace for week-to-date losses.""}, {""date"": ""20230803200100"", ""headline"": ""AMGEN REPORTS SECOND QUARTER FINANCIAL RESULTS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2023.""}, {""date"": ""20230803200347"", ""headline"": ""Amgen quarterly revenue rises 6%, profit beats Street estimates"", ""summary"": ""(Reuters) -Amgen, which is facing U.S. Federal Trade Commission (FTC) delays to its planned acquisition of Horizon Therapeutics, on Thursday reported higher quarterly profit on strong sales of treatments for cholesterol, osteoporosis and other drugs.  The biotech company, which slightly raised its outlook for full-year revenue and profit, said it currently expects the Horizon deal to close by mid-December.  For the second quarter, Amgen reported revenue of $6.99 billion, up 6% from a year earlier, exceeding analysts' estimates of $6.68 billion, according to Refinitiv data.""}, {""date"": ""20230803210302"", ""headline"": ""Amgen earnings beat estimates on revenue, adjusted EPS"", ""summary"": ""Amgen beat on estimates with its Q2 earnings. Yahoo Finance Health Care Reporter Anjalee Khemlani joins the Live show to discuss the report, including Amjevita and LUMAKRAS sales numbers.""}, {""date"": ""20230803211605"", ""headline"": ""Amgen Inc. (AMGN) Q2 2023 Earnings Call Transcript"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ETCompany ParticipantsArvind Sood \u00e2\u0080\u0093 Vice President of Investor RelationsBob Bradway \u00e2\u0080\u0093 Chairman and...""}, {""date"": ""20230803212445"", ""headline"": ""UPDATE 1-Amgen quarterly revenue rises 6%, profit beats Street estimates"", ""summary"": ""Amgen, which is facing U.S. Federal Trade Commission (FTC) delays to its planned acquisition of Horizon Therapeutics, on Thursday reported higher quarterly profit on strong sales of treatments for cholesterol, osteoporosis and other drugs.  The biotech company, which slightly raised its outlook for full-year revenue and profit, said it currently expects the Horizon deal to close by mid-December.  For the second quarter, Amgen reported revenue of $6.99 billion, up 6% from a year earlier, exceeding analysts' estimates of $6.68 billion, according to Refinitiv data.""}, {""date"": ""20230803213224"", ""headline"": ""The Small Drawback In Amgen's Earnings Beat, According To One Analyst"", ""summary"": ""Amgen beat second-quarter expectations Thursday and raised its outlook for the year, helping push Amgen stock higher in late action.""}, {""date"": ""20230803213516"", ""headline"": ""Amgen (AMGN) Q2 Earnings and Revenues Top Estimates"", ""summary"": ""Amgen (AMGN) delivered earnings and revenue surprises of 12.61% and 5.41%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""20230803233006"", ""headline"": ""Amgen (AMGN) Reports Q2 Earnings: What Key Metrics Have to Say"", ""summary"": ""While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.""}, {""date"": ""20230804014000"", ""headline"": ""Amazon shares rally 10%, but Apple\u2019s dip, and other stocks on the move"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804015000"", ""headline"": ""Looking Into Amgen's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804024717"", ""headline"": ""Amgen Inc. 2023 Q2 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Amgen Inc.""}, {""date"": ""20230804030600"", ""headline"": ""Amgen (AMGN) Gets a Sell from Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804034100"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804061800"", ""headline"": ""Dividend Roundup: IBM, Walmart, BP, Kimberly-Clark, and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804064600"", ""headline"": ""Amgen (AMGN) Gets a Hold from BMO Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804065200"", ""headline"": ""Amgen second quarter profit grows amid Repatha and Evenity boost"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804080921"", ""headline"": ""Amgen raises full-year earnings and revenue outlook"", ""summary"": ""Investing.com -- Shares in Amgen (NASDAQ:AMGN) rose in premarket U.S. trading on Friday after the U.S. biotech company improved its annual earnings and revenue forecast, and said it expects to close its planned multibillion-dollar acquisition of Horizon Therapeutics (NASDAQ:HZNP) by mid-December.""}, {""date"": ""20230804082300"", ""headline"": ""Amgen Raises FY23 Outlook, Discloses Brief Readout From Tarlatamab Lung Cancer, Lumakras Colorectal Cancer Studies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804084600"", ""headline"": ""Amgen, Microsoft share gains lead Dow's 175-point climb"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804113100"", ""headline"": ""Amgen, Microsoft share gains contribute to Dow's 265-point jump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804125700"", ""headline"": ""Amgen, Intel share gains contribute to Dow's 175-point jump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230804134324"", ""headline"": ""Amgen Is 'Confident' It Can Wrap The Horizon Takeover By December"", ""summary"": ""Amgen stock jumped Friday after topping Wall Street's second-quarter views, but investors remain zeroed in on the takeover of Horizon.""}, {""date"": ""20230804134500"", ""headline"": ""If You Had Invested $5,000 in Amgen in 2013, This Is How Much You Would Have Today"", ""summary"": ""Pharmaceutical giant Amgen (NASDAQ: AMGN)\u00a0is a component within the S&P 500 index.  Since its founding in 1980, Amgen has devoted itself to fostering a culture of innovation.  In fact, Amgen's total revenue has steadily grown from $18.7 billion in 2013 to a projected $26.6 billion in 2023.""}, {""date"": ""20230804161200"", ""headline"": ""Amgen (AMGN) Q2 Earnings Beat Estimates, 2023 View Raised"", ""summary"": ""Amgen (AMGN) beats Q2 estimates for earnings and sales. It slightly raises its earnings and sales guidance for 2023.""}, {""date"": ""20230804162052"", ""headline"": ""US STOCKS-Wall St rises on Amazon boost; bond yields fall"", ""summary"": ""Wall Street rose and bond yields fell on Friday after July jobs data showed a slowing in the U.S. labor market with wage gains, while Amazon's stellar earnings countered Apple's tepid sales forecast.  The yield on the 10-year benchmark note dipped on Friday after the jobs data, but still remained above 4%, partly boosting some megacap stocks.  \""At this point in some ways the jobs data doesn't do much to the Fed. The drama is now pivoting from the Fed to the Treasury,\"" said David Russell, vice president of market intelligence at TradeStation.""}, {""date"": ""20230804163258"", ""headline"": ""Is Amgen Inc (AMGN) Stock Fairly Valued? An In-depth Analysis"", ""summary"": ""Amgen Inc (NASDAQ:AMGN) recently recorded a daily gain of 5.81%, with an Earnings Per Share (EPS) (EPS) of $14.71.  Given these figures, a pertinent question arises: is Amgen (NASDAQ:AMGN) fairly valued?  Amgen is a leading biotechnology company specializing in human therapeutics, notably in renal disease and cancer supportive-care products.""}, {""date"": ""20230804172458"", ""headline"": ""RBC Capital Maintains AMGEN (AMGN) Sector Perform Recommendation"", ""summary"": """"}, {""date"": ""20230804175805"", ""headline"": ""Amgen Inc: A Strong Contender in the Drug Manufacturers Industry with a GF Score of 85"", ""summary"": ""Amgen Inc (NASDAQ:AMGN), a leading player in the drug manufacturers industry, is currently trading at $245.67 with a market capitalization of $131.27 billion.  According to the GF Score, Amgen has a score of 85 out of 100, indicating good outperformance potential.  This article will delve into the components of the GF Score and compare Amgen's performance with its main competitors.""}, {""date"": ""20230804181250"", ""headline"": ""US STOCKS-U.S. stocks rises on Amazon boost; bond yields fall"", ""summary"": ""Wall Street gained and bond yields fell on Friday after July jobs data showed a slowing in the U.S. labor market with wage gains.  Data for June additions was revised lower to 185,000 jobs, from 209,000 reported previously.""}, {""date"": ""20230804191232"", ""headline"": ""Dow Jones Reverses Lower On Reports Of Cyberattack; Fortinet Slammed After Earnings"", ""summary"": ""The Dow Jones faded off highs on reports that hospital systems in multiple states were hit by a cyberattack. Apple tanked on earnings.""}, {""date"": ""20230804204220"", ""headline"": ""US STOCKS-Wall Street ends lower after US jobs report; Apple weighs"", ""summary"": ""Wall Street closed lower on Friday after a report of slowing U.S. labor market growth, and all three major indexes posted weekly losses as investors braced for more possible downside surprises a day after disappointing earnings from Apple.  Apple's shares fell 4.8%, its biggest daily percentage decline since Sept. 29, 2022 that dented the S&P 500 by about 16 points the day after the iPhone maker forecast a continued slide in sales.  A partial counterweight to Apple for the S&P 500 and Nasdaq was Amazon.com.""}, {""date"": ""20230805120533"", ""headline"": ""Amgen's (NASDAQ:AMGN) Dividend Will Be Increased To $2.13"", ""summary"": ""Amgen Inc. ( NASDAQ:AMGN ) will increase its dividend from last year's comparable payment on the 8th of September to...""}, {""date"": ""20230805124500"", ""headline"": ""1 Top Dividend Growth Stock to Buy on the Dip"", ""summary"": ""Its shares are down by 12% since 2023 started, and the company has faced several issues recently that have harmed its financial results, leading many investors to abandon the stock.  Let's find out why income seekers should strongly consider adding shares of Amgen to their portfolios now.  Amgen is one of the largest biotechnology companies in the world, with a presence in dozens of countries and a portfolio that boasts more than 20 products.""}, {""date"": ""20230806024100"", ""headline"": ""2023 shaping up to be biggest year for biopharma M&A since pandemic"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806053200"", ""headline"": ""Is Amgen (AMGN) Stock Fairly Valued? A Comprehensive Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806093100"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Cigna (CI) and Ultragenyx Pharmaceutical (RARE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806110100"", ""headline"": ""Nearly half of U.S. adults want weight-loss drugs \u2013 KFF poll"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806180211"", ""headline"": ""Stock futures rise as Wall Street comes off a losing week: Live updates"", ""summary"": ""Last week was the worst for the S&P 500 and Nasdaq Composite since March.""}]",{}
9,2023-08-06,239.4420623779297,2023-08-13,258.36871337890625,0.07904480446339957,U5+,"[{""date"": ""20230806024100"", ""headline"": ""2023 shaping up to be biggest year for biopharma M&A since pandemic"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806053200"", ""headline"": ""Is Amgen (AMGN) Stock Fairly Valued? A Comprehensive Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806093100"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Cigna (CI) and Ultragenyx Pharmaceutical (RARE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806110100"", ""headline"": ""Nearly half of U.S. adults want weight-loss drugs \u2013 KFF poll"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230806180211"", ""headline"": ""Stock futures rise as Wall Street comes off a losing week: Live updates"", ""summary"": ""Last week was the worst for the S&P 500 and Nasdaq Composite since March.""}, {""date"": ""20230807010200"", ""headline"": ""Dow up 425 points on gains in shares of Amgen, Boeing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807034000"", ""headline"": ""Amgen Inc. stock rises Monday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807070600"", ""headline"": ""Longeveron Announces Key Additions To Its Leadership Team And Board As It Gears Up For Phase 2 Trials For Its Lead Drug Candidate For Several Conditions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807082000"", ""headline"": ""Amgen Gives You Growth, Dividend Growth, And Value"", ""summary"": ""Amgen appears to remain undervalued for value and income investors. Read more to see a detailed analysis of AMGN stock.""}, {""date"": ""20230807082500"", ""headline"": ""Monday\u2019s Top Wall Street Analyst Upgrades and Downgrades: Amazon, Apple, Block, Coinbase, Datadog, Fortinet, Gilead Sciences, Moderna, Nvidia, PayPal, Petrobras and More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807095000"", ""headline"": ""Boeing, Amgen share gains lead Dow's 337-point jump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807102600"", ""headline"": ""Amgen (AMGN) Shares Cross Above 200 DMA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807111100"", ""headline"": ""Amgen Inc: A Strong Contender in the Drug Manufacturers Industry with a High GF Score"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807114056"", ""headline"": ""Amgen Is Back!"", ""summary"": ""Amgen's stock has rebounded by 10% and is showing improving fundamentals, with strong volume and revenue growth in core drugs. Find out why AMGN stock is a Buy.""}, {""date"": ""20230807123700"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230807134721"", ""headline"": ""August MDA Breakout Stocks Week 32 - 2023: High-Frequency Gainers To Give You An Edge"", ""summary"": ""Two new Breakout Stocks for Week 32 curated by the MDA model for 10% short-term upside and additional model selections. Click here to read more.""}, {""date"": ""20230807192303"", ""headline"": ""CNBC Daily Open: Playing the T-bill game"", ""summary"": ""The U.S. economy has remained resilient and seemingly largely impervious to the Fed's highest rates in more than two decades.""}, {""date"": ""20230807204251"", ""headline"": ""Dow Jones Today: Index Rebounds with 400-Point Gain"", ""summary"": ""Following last week\u2019s downward turn, the Dow Jones Industrial Average bounced back, rising 407 points, or 1.2%, as investors readied for new inflation data to close out the week.""}, {""date"": ""20230808023001"", ""headline"": ""CNBC Daily Open: Treasury bets"", ""summary"": ""The U.S. economy has remained resilient and seemingly largely impervious to the Fed's highest rates in more than two decades.""}, {""date"": ""20230808034100"", ""headline"": ""Amgen Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808041600"", ""headline"": ""Amgen (AMGN) Receives a Sell from Robert W. Baird"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808095300"", ""headline"": ""Watch weight loss stocks after cardiovascular data for Wegovy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808095900"", ""headline"": ""Amgen a Top 25 Dividend Giant With 3.37% Yield (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808100000"", ""headline"": ""Amgen a Top Socially Responsible Dividend Stock With 3.4% Yield (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230808163340"", ""headline"": ""Is Amgen Inc (AMGN) Stock Fairly Valued?"", ""summary"": ""An In-depth Analysis of Amgen's Current Valuation""}, {""date"": ""20230808175804"", ""headline"": ""Amgen Inc: A Strong Contender in the Drug Manufacturers Industry with a GF Score of 85"", ""summary"": ""Amgen Inc (NASDAQ:AMGN), a leading player in the Drug Manufacturers industry, is currently trading at $262.57 with a market cap of $140.87 billion.  According to the GF Score, a stock performance ranking system developed by GuruFocus, Amgen Inc has a score of 85 out of 100, indicating good outperformance potential.  This rank measures the robustness of a company's financial situation, taking into account factors such as its debt burden, debt to revenue ratio, and Altman Z-Score.""}, {""date"": ""20230808192318"", ""headline"": ""Buy 2 August Dogs Of The Dow, Watch 5"", ""summary"": ""Discover the criteria for stocks to be added to the Dow, the highest-yield stocks in August, and analyst predictions for stocks' performance. Read more here.""}, {""date"": ""20230809022800"", ""headline"": ""Barclays Sticks to Its Sell Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809033739"", ""headline"": ""3 Biotech Stocks You\u2019ll Regret Not Buying Soon"", ""summary"": ""The biotech industry proved itself resilient in the face of the COVID-19 pandemic. With research from Mckinsey, venture capitalist (VC) companies increased investments from 2,200 in 2016 to 3,100 in 2021 in biotechnology (biotech) startups. These startups have advanced medicine overall, improving cell therapy, tissue regeneration, genetic medicine, and more. With increasing innovation, we see an ongoing cycle. VC companies will continue to invest by providing resources and funding for these comp""}, {""date"": ""20230809034000"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809102200"", ""headline"": ""Amgen Reaches Analyst Target Price"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809123500"", ""headline"": ""Looking At Amgen's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230809200001"", ""headline"": ""The 3 Best Biotech Stocks to Buy in August"", ""summary"": ""Many healthcare stocks suffer from COVID fatigue as profits fall amid a global decline in the virus\u2019 spread. But medical innovations and technological breakthroughs are rapidly transforming the healthcare landscape, and biotech stocks are garnering unprecedented attention in the investment community. These companies, operating at the intersection of biology and technology, promise groundbreaking treatments, therapies and solutions to some of the world\u2019s most persistent medical challenges. As the""}, {""date"": ""20230810015700"", ""headline"": ""Dow up 181 points on gains in shares of Walt Disney, Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810033800"", ""headline"": ""Here's How Much You Would Have Made Owning Amgen Stock In The Last 15 Years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810062100"", ""headline"": ""Ideaya Biosciences price target raised to $35 from $30 at Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810095900"", ""headline"": ""Want Rising Dividend Income? Buy Amgen Stock"", ""summary"": ""Pharmaceutical company Amgen (NASDAQ: AMGN)\u00a0is a favorite among income investors.  Here are four reasons that the stock could have a special place in a portfolio centered around dividend growth.  In the second quarter ended June 30, Amgen's total revenue increased by 5.9% year over year to $7 billion.""}, {""date"": ""20230810105900"", ""headline"": ""Walt Disney, Amgen share gains contribute to Dow's 200-point climb"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230810110103"", ""headline"": ""Amgen (NASDAQ:AMGN) jumps 13% this week, though earnings growth is still tracking behind five-year shareholder returns"", ""summary"": ""When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than...""}, {""date"": ""20230810130006"", ""headline"": ""Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""20230810132152"", ""headline"": ""These 10 medications are likely targets for Medicare price negotiations this fall"", ""summary"": ""It's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their medications are targets.""}, {""date"": ""20230810152637"", ""headline"": ""3 Dow Jones Stocks To Watch In August 2023"", ""summary"": ""Dow Jones Industrial Average stocks to check out in the stock market today.""}, {""date"": ""20230811030800"", ""headline"": ""Nasdaq Suffers Second Straight Week of Losses, Breaks Key Support Level As Tech Bears Return: Is This Time Different?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230811034000"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230811035700"", ""headline"": ""Uber Crowded, Battleground and Sweet 16 stock portfolios from Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230812090000"", ""headline"": ""How To Invest $100,000 Today: 5 Strategies Including The Near-Perfect Portfolio Strategy"", ""summary"": ""Discover five investment strategies, including the Near-Perfect Portfolio, aimed at capital preservation, sustainable income, and long-term growth. Click for more.""}, {""date"": ""20230812120344"", ""headline"": ""Amgen (NASDAQ:AMGN) Could Be A Buy For Its Upcoming Dividend"", ""summary"": ""Amgen Inc. ( NASDAQ:AMGN ) is about to trade ex-dividend in the next four days. The ex-dividend date is one business...""}, {""date"": ""20230813010300"", ""headline"": ""Pharma under threat from bill to expand drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230813083100"", ""headline"": ""Horizon Therapeutics, Activision among best bets for M&A deals to close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230813092322"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of August 13"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the full August 13 weekly update.""}]",{}
10,2023-08-13,258.36871337890625,2023-08-20,259.7774658203125,0.005452488511410003,U1,"[{""date"": ""20230813010300"", ""headline"": ""Pharma under threat from bill to expand drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230813083100"", ""headline"": ""Horizon Therapeutics, Activision among best bets for M&A deals to close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230813092322"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of August 13"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the full August 13 weekly update.""}, {""date"": ""20230814030700"", ""headline"": ""The Latest Analyst Ratings for Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814034000"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814055300"", ""headline"": ""Amgen price target raised to $223 from $214 at Mizuho"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814063500"", ""headline"": ""Amgen price target raised to $310 from $275 at Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814070900"", ""headline"": ""QUALCOMM, AIG And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230814075503"", ""headline"": ""Tracking George Soros's Portfolio - Q2 2023 Update"", ""summary"": ""George Soros's 13F portfolio value decreased slightly from $6.49B to $6.41B, with 172 positions. Click here to read the portfolio's Q2 2023 update.""}, {""date"": ""20230814145331"", ""headline"": ""Jefferies Maintains AMGEN (AMGN) Buy Recommendation"", ""summary"": """"}, {""date"": ""20230814145336"", ""headline"": ""Mizuho Maintains AMGEN (AMGN) Neutral Recommendation"", ""summary"": """"}, {""date"": ""20230814152200"", ""headline"": ""August MDA Breakout Stocks Week 33 - 2023: Facing The Largest Negative Signal Since February"", ""summary"": ""The Momentum Gauges and S&P 500 Gauges have turned negative. Read why this indicates a shift in market momentum and the need for caution in stock selection.""}, {""date"": ""20230815034000"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815080500"", ""headline"": ""Tuesday\u2019s Top Wall Street Analyst Upgrades and Downgrades: Amgen, Coterra Energy, Eaton, Marriott, Monster Beverage, Mosaic, Urban Outfitters, Wayfair and More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815085800"", ""headline"": ""Tudor Investment boosts stakes in Big Tech, exits VMware, BAH, HRL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815103300"", ""headline"": ""Is Amgen (AMGN) Stock Fairly Valued?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230815113530"", ""headline"": ""15 Worst Performing Blue Chip Stocks in 2023"", ""summary"": ""In this piece, we will take a look at the 15 worst performing blue chip stocks in 2023. If you want to skip a background of what\u2019s been going on in this lucrative sector this year, then head on over to 5 Worst Performing Blue Chip Stocks in 2023. In traditional poker, a blue chip [\u2026]""}, {""date"": ""20230815114024"", ""headline"": ""I Got 99 Problems But A High Yield Ain't One (151 Trade Ideas)"", ""summary"": ""Discover how our Advanced cash covered put selling strategy can help you generate high yields while minimizing market risk. Click for our exclusive picks.""}, {""date"": ""20230816034000"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816051700"", ""headline"": ""Horizon Therapeutics: Can Investors Profit From Amgen Deal Confusion?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816101500"", ""headline"": ""February 2024 Options Now Available For Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230816140028"", ""headline"": ""Is Now The Time To Put Amgen (NASDAQ:AMGN) On Your Watchlist?"", ""summary"": ""For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...""}, {""date"": ""20230816140753"", ""headline"": ""Could Amgen Stock Help You Become a Millionaire?"", ""summary"": ""Healthcare company Amgen (NASDAQ: AMGN) has been a reliable investment to own over what has been a turbulent year for the broader market.  A particularly promising drug involved in the deal is Tepezza, a treatment for thyroid eye disease which could bring in up to $4 billion in peak annual sales.""}, {""date"": ""20230816143130"", ""headline"": ""Improved Outlook For Horizon Therapeutics And Amgen"", ""summary"": ""Horizon Therapeutics' better-than-expected Q2 eases concerns about Amgen acquisition failing to close due to Horizon's business underperformance. Read more here.""}, {""date"": ""20230816180202"", ""headline"": ""Horizon Therapeutics - Can Investors Profit From Amgen Deal Confusion?"", ""summary"": ""Exploring the uncertain fate of the $28.5bn acquisition deal between Horizon Therapeutics and Amgen, and its potential impact on their share prices.""}, {""date"": ""20230816182500"", ""headline"": ""Amgen Stock Scores Relative Strength Rating Upgrade; Hits Key Benchmark"", ""summary"": ""Amgen shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 68 to 80.""}, {""date"": ""20230816221941"", ""headline"": ""Unusual Call Option Trade in AMGEN (AMGN)  Worth $4,395.60K"", ""summary"": """"}, {""date"": ""20230817033900"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817041300"", ""headline"": ""Jefferies starts BeiGene at buy, cites deep pipeline, Novartis partnership"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817041800"", ""headline"": ""The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230817113700"", ""headline"": ""Looking At Amgen's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818033900"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230818121700"", ""headline"": ""AARP, Public Citizen file briefs in Medicare drug price negotiations case"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230820130029"", ""headline"": ""With 78% ownership of the shares, Amgen Inc. (NASDAQ:AMGN) is heavily dominated by institutional owners"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Amgen's stock price might be vulnerable to their...""}]",{}
11,2023-08-20,259.7774658203125,2023-08-27,254.37989807128906,-0.020777659570968776,D3,"[{""date"": ""20230820130029"", ""headline"": ""With 78% ownership of the shares, Amgen Inc. (NASDAQ:AMGN) is heavily dominated by institutional owners"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Amgen's stock price might be vulnerable to their...""}, {""date"": ""20230821030200"", ""headline"": ""Horizon Therapeutics gains amid speculation on potential FTC settlement on Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821033900"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821093200"", ""headline"": ""Amgen's Lumakras facing FDA advisory panel for full approval"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821114200"", ""headline"": ""First Week of September 15th Options Trading For Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821121500"", ""headline"": ""Is Amgen Stock a Top Buy and Hold?"", ""summary"": ""One way to increase your odds of success is to buy shares of high-quality companies that sport strong competitive advantages, solid growth prospects, and attractive valuations.  Biotech giant Amgen (NASDAQ: AMGN) ticks many of these boxes.  Read on to find out more about this top dividend-paying biotech stock.""}, {""date"": ""20230821125200"", ""headline"": ""Peering Into Amgen's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821130005"", ""headline"": ""Is Trending Stock Amgen Inc. (AMGN) a Buy Now?"", ""summary"": ""Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""20230821144940"", ""headline"": ""11 Most Profitable Biotech Stocks Today"", ""summary"": ""In this piece, we will take a look at the 11 most profitable biotechnology stocks to buy today. If you want to skip our introduction to the biotechnology industry and want to take a look at the top five stocks in this list, then head on over to 5 Most Profitable Biotech Stocks Today. Biotechnology [\u2026]""}, {""date"": ""20230821165500"", ""headline"": ""IN BRIEF: US FDA to review Amgen's Lumakras for lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230821165832"", ""headline"": ""Medicare drug price negotiations unlikely to be derailed by lawsuits: UBS"", ""summary"": ""UBS believes there is little chance the lawsuits brought on by pharma companies will delay Medicare pricing negotiations.""}, {""date"": ""20230821200000"", ""headline"": ""AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS\u00ae (SOTORASIB) FOR THE TREATMENT OF KRAS G12C-POSITIVE NSCLC AT FDA ADVISORY COMMITTEE MEETING"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data supporting the supplemental New Drug Application (sNDA) for the full approval of LUMAKRAS\u00ae (sotorasib) for adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at a meeting on Oct. 5, 2023.""}, {""date"": ""20230821202038"", ""headline"": ""These Are the ONLY 3 Biotech Stocks to Consider in August 2023"", ""summary"": ""The world may be on the mend from the grip of the global pandemic, but the consistent drumbeat for medical innovation remains as unyielding as ever. Amid this backdrop, Biotech stocks present a beacon of hope for humanity and a compelling avenue for savvy investors. Delving into the best biotech stocks offers a chance to back businesses spearheading these life-altering breakthroughs and potentially reap massive dividends. American pharmaceutical giants, often overshadowed in global conversations""}, {""date"": ""20230822085500"", ""headline"": ""Amgen (AMGN) Gets a Buy from Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230822093433"", ""headline"": ""AMGEN TO DISCUSS APPLICATION FOR LUMAKRAS FOR THE TREATMENT OF KRAS G12C-POSITIVE NSCLC AT FDA ADVISORY COMMITTEE MEETING"", ""summary"": ""THOUSAND OAKS - Amgen today announced the U.S. Food and Drug Administration Oncologic Drugs Advisory Committee will review data supporting the supplemental New Drug Application for the full...""}, {""date"": ""20230822104700"", ""headline"": ""See How Amgen Ranks Among Analysts' Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230822104700"", ""headline"": ""Video: Dow Analyst Moves: AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230822163800"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slid 1.18% to $257.62 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230822172458"", ""headline"": ""Health care stocks: What the market technicals show"", ""summary"": ""Why are UnitedHealth (UNH), Merck & Company (MRK), Johnson & Johnson (JNJ), and Amgen (AMGN), this strategist's top health care stock picks? Freedom Capital Markets Chief Global Strategist Jay Woods joins Yahoo Finance Live to discuss and break down the market technicals of health care stocks.\u00a0 Woods says he focuses on those four health care stocks, \""because they're in Dow Jones Industrial Average. If you're looking for reasons why the Dow can rally, I give you health care.\""\u00a0 The Health Care Select Sector (XLV) \""continues to make higher lows, as it goes along,\"" Woods notes. \""If you're a little skittish on the overall market, health care is a safety sector,\"" Woods says.""}, {""date"": ""20230822195055"", ""headline"": ""12 Best Cheap Dividend Stocks To Buy Now"", ""summary"": ""In this article, we discuss 12 best cheap dividend stocks to buy now. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Cheap Dividend Stocks To Buy Now. Investing in cheap stocks is like finding a great deal at a store \u2013 it\u2019s about picking [\u2026]""}, {""date"": ""20230823030400"", ""headline"": ""This Is What Whales Are Betting On Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823103200"", ""headline"": ""Amgen says FTC case to block Horizon Therapeutics deal `defies logic'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230823104503"", ""headline"": ""Amgen : Joins Forces with American Heart Association on Lower Your LDL Cholesterol Now\u2122"", ""summary"": ""A 2023 survey from the American Heart Association with The Harris Poll shows more than half of Americans who have had a heart attack or stroke don't prioritize lowering LDL or bad...""}, {""date"": ""20230823163800"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slumped 0.10% to $257.36 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230824022026"", ""headline"": ""Bristol-Myers Squibb: Top Defensive Pick During Recessions With A Value Proposition"", ""summary"": ""Discover why Bristol-Myers is a strong investment, undervalued with a promising dividend yield. After a slow start, expect a bullish turnaround.""}, {""date"": ""20230824024855"", ""headline"": ""Tracking David Abrams' Abrams Capital Management Portfolio - Q2 2023 Update"", ""summary"": ""Abrams' 13F portfolio value increased from $3.16B to $3.48B this quarter. Click here for a detailed analysis.""}, {""date"": ""20230824045900"", ""headline"": ""Stock buybacks spur wealth inequality and stifle innovation. But should they be banned?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824072800"", ""headline"": ""GRI Bio Is Bringing Hope To Patients With Idiopathic Pulmonary Fibrosis And Lupus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824074104"", ""headline"": ""Akero Therapeutics: An Assessment"", ""summary"": ""Akero's lead candidate, EFX, has shown promising results in clinical trials for both compensated cirrhotic NASH and pre-cirrhotic NASH. Read more here.""}, {""date"": ""20230824074700"", ""headline"": ""Thursday\u2019s Top Analyst Upgrades and Downgrades: Amazon, Amgen, Duke Energy, General Mills, KeyCorp, Lowe\u2019s, Macy\u2019s, Marvell Technology, Netflix, Walmart and More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824084600"", ""headline"": ""Drugs picked for Medicare price negotiations to be announced on Tuesday \u2013 Politico"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824111800"", ""headline"": ""FTC likely to lose its challenge to the Horizon/Amgen deal, legal experts say - analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824112741"", ""headline"": ""Eli Lilly And Novo Nordisk: Are Weight Loss Drugs A Global Revolution Or Short-Lived Fad?"", ""summary"": ""Eli Lilly (LLY) and Novo Nordisk's (NVO) current valuations are not sustainable and there exist numerous adverse factors. Learn what are those adverse factors.""}, {""date"": ""20230824120000"", ""headline"": ""October 6th Options Now Available For Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230824140000"", ""headline"": ""4 Surefire Stocks to Buy in the Next Bear Market"", ""summary"": ""Are stocks slipping back toward a new bear market?  The economic news is sending mixed messages.  Given the prospect of a return to bear market conditions, though, it wouldn't hurt to at least make some plans for the possibility.""}, {""date"": ""20230824150310"", ""headline"": ""CVS Health launches new brand Cordavis to target $100 billion biosimilar market"", ""summary"": ""CVS is launching a new business segment that will negotiate with drugmakers to produce private label products for it to sell, the healthcare giant said Wednesday.""}, {""date"": ""20230824163800"", ""headline"": ""Amgen Inc. stock falls Thursday, still outperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.29% to $256.62 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230824173259"", ""headline"": ""Top Merger Stocks Held By Fund Managers, Mid-Q3 2023"", ""summary"": ""Horizon Therapeutics remains top stock held by merger-focused funds for the third consecutive quarter. Read more about top merger stocks held by fund managers.""}, {""date"": ""20230824175600"", ""headline"": ""Stock buybacks spur wealth inequality and stifle innovation. Should they be banned?"", ""summary"": ""Stock buybacks have become a major source of wealth inequality and have stifled innovation in the U.S., according to this academic.""}, {""date"": ""20230825033000"", ""headline"": ""Horizon Therapeutics gains as FTC seeks delay of in-house trial on Amgen deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825033700"", ""headline"": ""Horizon Therapeutics gains as FTC granted delay in-house trial on Amgen deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825034800"", ""headline"": ""Horizon Therapeutics gains as FTC withdraws in-house trial on Amgen deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825035900"", ""headline"": ""Horizon Therapeutics jumps as FTC withdraws in-house trial on $28B Amgen deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825041100"", ""headline"": ""Horizon Therapeutics jumps as FTC withdraws in-house trial on $28B Amgen deal (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825094700"", ""headline"": ""Merck starts phase 3 program for oral PCSK9 inhibitor to lower cholesterol"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825100200"", ""headline"": ""As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit \u2014 even if their drugs aren\u2019t on the list"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230825112318"", ""headline"": ""11 Most Undervalued Dow Stocks To Buy According To Hedge Funds"", ""summary"": ""In this piece, we will take a look at the 11 most undervalued Dow stocks to buy according to hedge funds. If you want to skip our introduction to one of the most historic stock indexes in America, then head on over to 5 Most Undervalued Dow Stocks To Buy According To Hedge Funds. The [\u2026]""}, {""date"": ""20230825163800"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 0.09% to $256.38 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230825213224"", ""headline"": ""Horizon Therapeutics Jumps On A New FTC Development In The Amgen Takeover Battle"", ""summary"": ""The FTC pulled back one of its efforts to block Amgen's Horizon buyout, according to a document released Friday that sent HZNP stock flying.""}, {""date"": ""20230825213943"", ""headline"": ""UPDATE 2-SoftBank-backed Neumora Therapeutics files paperwork for U.S. IPO"", ""summary"": ""The filing comes at a time of renewed investor interest in IPOs following a flurry of deals in the United States and European markets, which have over the last year seen many high-profile startups shelve their listing plans due to market volatility.  Neumora's lead drug candidate navacaprant is a potential oral treatment of major depressive disorder.  Neumora did not disclose the size, timetable or other details of the offering in its filing with the U.S. securities regulator.""}, {""date"": ""20230826010400"", ""headline"": ""Crohn's disease drugmakers set to benefit from expected rise in cases"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230826104500"", ""headline"": ""Amgen Presents Phase 2 OLPASIRan Data at ESC 2023"", ""summary"": ""Amgen announced data from the final analysis of the Phase 2 OCEAN-DOSE study of olpasiran, a small interfering RNA during the Late-Breaking Science Session at the European Society of Cardiology ...""}, {""date"": ""20230826113300"", ""headline"": ""FTC Takes A Rare Step Back, Pauses Legal Battle With Amgen Over $28B Horizon Deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230826114006"", ""headline"": ""US FTC suspends challenge to block Amgen's $27.8 bln deal for Horizon Therapeutics"", ""summary"": ""The U.S. Federal Trade Commission has suspended its challenge of Amgen's $27.8billion purchase of Horizon Therapeutics, allowing theFTC to consider whether the agency should settle the case,...""}, {""date"": ""20230826144500"", ""headline"": ""AMGEN PRESENTS LATE-BREAKING PHASE 2 OLPASIRAN DATA AT ESC 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced data from the final analysis of the Phase 2 OCEAN(a)-DOSE study of olpasiran, a small interfering RNA (siRNA) during the Late-Breaking Science Session at the European Society of Cardiology (ESC) Annual Meeting being held in Amsterdam. In the off-treatment extension period, olpasiran showed a lasting effect on Lp(a) reduction nearly a year after the last dose.""}, {""date"": ""20230826150900"", ""headline"": ""FTC Pauses Challenge to Amgen\u2019s $27.8 Billion Deal for Horizon Therapeutics"", ""summary"": ""The move gives the agency time to weigh a settlement that would allow the deal to close with conditions.""}, {""date"": ""20230826154006"", ""headline"": ""UPDATE 2-US FTC suspends challenge to block Amgen's $27.8 bln deal for Horizon Therapeutics"", ""summary"": ""The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen's $27.8 billion purchase of Horizon Therapeutics, allowing the FTC to consider whether the agency should settle the case, a filing late on Friday showed.  Amgen said the company was aware of the move and is prepared to demonstrate that there is no legal or factual reason to prohibit the acquisition to the courts.  The agency had said it opposed the deal because of concern that Amgen would leverage its big selling drugs to pressure insurance companies and pharmacy benefit managers to give favorable terms for Horizon's two key products - the fast-growing thyroid eye disease treatment Tepezza and gout drug Krystexxa.""}, {""date"": ""20230826154316"", ""headline"": ""US FTC suspends challenge to block Amgen's $27.8 billion deal for Horizon Therapeutics"", ""summary"": ""Amgen said the company was aware of the move and is prepared to demonstrate that there is no legal or factual reason to prohibit the acquisition to the courts.  The agency had said it opposed the deal because of concern that Amgen would leverage its big selling drugs to pressure insurance companies and pharmacy benefit managers to give favorable terms for Horizon's two key products - the fast-growing thyroid eye disease treatment Tepezza and gout drug Krystexxa.  The Thousand Oaks, California-based company announced plans to buy Horizon in December last year, saying that its rare disease drugs would offer it some protection from the drug pricing provisions of the Inflation Reduction Act, which are aimed at drugs most widely used by the government's Medicare health plan.""}, {""date"": ""20230827070700"", ""headline"": ""Fly Intel: Top five weekend stock stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827085100"", ""headline"": ""FTC pauses challenge to Amgen deal for Horizon Therapeutics, WSJ reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827110100"", ""headline"": ""Wall Street lists potential targets for Medicare drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
12,2023-08-27,254.37989807128906,2023-09-03,254.70730590820312,0.0012870821924078069,U1,"[{""date"": ""20230827070700"", ""headline"": ""Fly Intel: Top five weekend stock stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827085100"", ""headline"": ""FTC pauses challenge to Amgen deal for Horizon Therapeutics, WSJ reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230827110100"", ""headline"": ""Wall Street lists potential targets for Medicare drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828032400"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828044700"", ""headline"": ""Biggest stock movers today: XPeng, VinFast and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828060545"", ""headline"": ""August MDA Breakout Stocks Week 35 - 2023: High-Frequency Gainers To Give You An Edge"", ""summary"": ""Two new sample Breakout Stocks for Week 35 curated by the MDA model for a 10% short-term upside along with a Dow pick. Click here for a detailed analysis.""}, {""date"": ""20230828062600"", ""headline"": ""US Stocks Seen Opening Firmer In New Week's 1st Session As Traders Look To Week's Key Data; Analyst Constructive Despite Bearish Signals"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828071800"", ""headline"": ""Horizon Therapeutics jumps after FTC pauses Amgen challenge for settlement talks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828080300"", ""headline"": ""Horizon Therapeutics shares climb after FTC pauses challenge of deal with Amgen"", ""summary"": ""Shares of Horizon Therapeutics PLC gained more than 5% premarket on Monday after the Federal Trade Commission last week paused its legal challenge to Amgen...""}, {""date"": ""20230828083300"", ""headline"": ""Amgen could reach settlement with FTC over Horizon in next few weeks - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828084500"", ""headline"": ""BMO Capital Issues a Hold Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828093800"", ""headline"": ""Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828095600"", ""headline"": ""Biggest stock movers today: Hawaiian Electric, RPT Realty, VinFast Auto and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828110913"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""Horizon Therapeutics shares jumped after the Federal Trade Commission paused a challenge to its acquisition by Amgen and Chinese EV maker XPeng announced a partnership with ride-hailing provider Didi. Here\u2019s what investors need to know today.""}, {""date"": ""20230828123700"", ""headline"": ""US Stocks Grind Higher As China Cuts Taxes On Trading, Eyes Further Stimulus: What's Driving Markets Monday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828124300"", ""headline"": ""Amgen-Horizon Deal: FTC Pauses Proceedings to Block the Acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230828125905"", ""headline"": ""Dow 30 Stocks List: Ranked By Hedge Fund Bullishness Index"", ""summary"": ""In this article, we discuss Dow 30 stocks ranked in accordance with the hedge fund bullishness index. If you want to skip our detailed discussion about the stock market performance, head directly to Top 10 Dow Stocks: Ranked By Hedge Fund Bullishness Index. Dow 30 is a stock index that takes into consideration the performance [\u2026]""}, {""date"": ""20230828134004"", ""headline"": ""Why Amgen (AMGN) is a Top Value Stock for the Long-Term"", ""summary"": ""The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.""}, {""date"": ""20230828144628"", ""headline"": ""Horizon Therapeutics Shares Surge As FTC Postpones Challenge to Merger"", ""summary"": ""Horizon Therapeutics shares jumped more than 5% early trading Monday after the FTC said it would suspend its challenge to Amgen's acquisition of the drug maker.""}, {""date"": ""20230828151100"", ""headline"": ""Horizon (HZNP) Up as FTC Pauses Acquisition by Amgen Lawsuit"", ""summary"": ""The Federal Trade Commission suspends its ongoing lawsuit to block Horizon's (HZNP) acquisition by Amgen until Sep 18, 2023. The company's stock rises 5.8% in response.""}, {""date"": ""20230828154255"", ""headline"": ""FTC suspends challenge to Amgen-Horizon Therapeutics deal"", ""summary"": ""The Federal Trade Commission is suspending its challenge to Amgen's (AMGN) $27.8 billion bid to acquire Horizon Therapeutics (HZNP). The FTC is concerned Amgen will be able to bundle its products to a couple of Horizon's, giving it an advantage over rivals. It's a notion Amgen rejects. The FTC is pausing its challenge in hopes of reaching a settlement that would allow the deal to close. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks the story down.""}, {""date"": ""20230828163900"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.07% higher to $256.55 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230828202041"", ""headline"": ""Amgen-Horizon Takeover Seen Close to a Lock After FTC Pauses Challenge"", ""summary"": ""(Bloomberg) -- Traders are almost 100% certain that Amgen Inc. will complete its $28 billion takeover of Horizon Therapeutics Plc after the Federal Trade Commission paused its in-house case to block the deal.Most Read from BloombergChina\u2019s Worsening Economic Slowdown Is Rippling Across the Globe3M Agrees to Pay More Than $5.5 Billion Over Combat EarplugsTraders Have S&P 500 Comebacks Fading at Historic PaceAuto Union Boss Wants 46% Raise, 32-Hour Work Week in \u2018War\u2019 Against Detroit CarmakersTrump""}, {""date"": ""20230829000400"", ""headline"": ""10 drugs targeted for Medicare price negotiations as Biden pitches cost reductions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829033500"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829035200"", ""headline"": ""Amgen Now #52 Largest Company, Surpassing NextEra Energy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829052100"", ""headline"": ""Nasdaq, S&P 500 Futures Flatline Ahead Of JOLTS, House Price Data; Why This Analyst Recommends 'Buying Weakness Than Selling Rallies'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829065000"", ""headline"": ""Medicare lists first ten drugs selected for pricing negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829065100"", ""headline"": ""Biden unveils first 10 drugs subject to Medicare price negotiation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829075000"", ""headline"": ""Merck, Amgen, AbbVie products among first 10 drugs selected for Medicare price negotiations"", ""summary"": ""Medicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implications...""}, {""date"": ""20230829083500"", ""headline"": ""Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829095600"", ""headline"": ""Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829102900"", ""headline"": ""White House names first 10 drugs eligible for Medicare price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230829114618"", ""headline"": ""Biden Administration targets drugs from J&J, Merck for controversial Medicare price negotiations"", ""summary"": ""The Biden administration revealed the first 10 drugs that will face the Medicare negotiation process under the Inflation Reduction Act.""}, {""date"": ""20230829132412"", ""headline"": ""Best Buy results, Medicare negotiations list, Hurricane Idalia: Top stories"", ""summary"": ""Best Buy (BBY) lowers its full-year sales outlook despite topping earnings estimates. The Biden administration has shared its list of ten prescription drugs that will be subject to pricing negotiations between manufacturers and Medicare. Tropical Storm Idalia has officially been upgraded to a hurricane. It's expected to make landfall on Florida's west coast on Wednesday.Yahoo Finance Live's Brad Smith highlights three of this morning's biggest stories.""}, {""date"": ""20230829144735"", ""headline"": ""Biden admin unveils ten drugs picked for Medicare price negotiations"", ""summary"": ""The Biden administration has released the list of the first ten drugs that will be subject to Medicare price negotiations. The Center for Medicare Director Dr. Meena Seshamani tells Yahoo Finance Live that they are looking at \""the benefits that a drug brings to populations. Does it address an unmet need? Does it address different populations that have needs?\"" When it comes to why some drugs were chosen Dr. Seshamani says the organization followed the criteria written in the Inflation Reduction Act, adding that the list will not change. These are the ten drugs Medicare will be negotiating the prices of:Eliquis- Bristol-Myers Squibb (BMY), Pfizer (PFE) Jardiance- Boehringer Ingelheim, Eli Lilly (LLY) Xarelto- Bayer (BAYRY), Johnson & Johnson (JNJ) Januvia- Merck (MRK) Farxiga- AstraZeneca (AZN) Entresto- Novartis (NVS) Enbrel- Amgen (AMGN) Imbruvica- Johnson & Johnson (JNJ), AbbVie (ABBV) Stelara- Johnson & Johnson (JNJ) Fiasp, NovoLog- Novo Nordisk (NVO)""}, {""date"": ""20230829153700"", ""headline"": ""Expensive Drugs Targeted for First U.S. Price Negotiations"", ""summary"": ""Lower prices would take effect in 2026 depending on the talks between the U.S. and drugmakers and the outcome of industry lawsuits.""}, {""date"": ""20230829163900"", ""headline"": ""Amgen Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. rose 1.20% to $259.64 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230830034900"", ""headline"": ""NuVasive/Globus Medical spread widens amid notice of FTC meeting (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830051700"", ""headline"": ""Court hearing on FTC's challenge to Horizon/Amgen rescheduled until next week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830110600"", ""headline"": ""NuVasive/Globus Medical spread widens amid notice of FTC closed door meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230830153330"", ""headline"": ""Medicare price negotiation list: What it means for pharma companies"", ""summary"": ""On Tuesday, the Biden administration listed ten drugs subject to Medicare price negotiations. Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the list and how this may impact the pharmaceutical companies who profit from these drugs.\u00a0\u00a0 The ten drugs and pharma companies impacted are:\u00a0 Eliquis - Bristol-Myers Squibb (BMY), Pfizer (PFE) Jardiance - Boehringer Ingelheim, Eli Lilly (LLY) Xarelto- Bayer (BAYRY), Johnson & Johnson (JNJ) Januvia - Merck (MRK) Farxiga - AstraZeneca (AZN) Entresto - Novartis (NVS) Enbrel - Amgen (AMGN) Imbruvica - Johnson & Johnson (JNJ), AbbVie (ABBV) Stelara - Johnson & Johnson (JNJ) Fiasp, NovoLog - Novo Nordisk (NVO)""}, {""date"": ""20230830163900"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. sank 0.68% to $257.88 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230830172549"", ""headline"": ""Medicare's drug pricing list didn't impact company stocks \u2014 here's why"", ""summary"": ""Company stocks were unaffected by the Biden Administration's historic announcement Tuesday of Medicare's first list of drugs for negotiating prices.""}, {""date"": ""20230831101700"", ""headline"": ""Rising High: Exclusive talk with psychotropics company Lucy Scientific Discovery"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230831113300"", ""headline"": ""$1000 Invested In This Stock 15 Years Ago Would Be Worth $4,200 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230831115300"", ""headline"": ""Is This the Green Light Biotech Stocks Have Been Waiting For?"", ""summary"": ""It looks like the Federal Trade Commission will give up on its attempt to block Amgen's acquisition of Horizon Therapeutics.""}, {""date"": ""20230831152212"", ""headline"": ""Big Pharma's biggest ally gets trolled on X for attacking Medicare drug pricing list"", ""summary"": ""Drug lobbying firm PhRMA faced backlash on social media for its attempt to call Medicare pricing negotiations unfair.""}, {""date"": ""20230831163900"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.60% to $256.34 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230831233000"", ""headline"": ""AMGEN TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCE AND THE CITI GLOBAL HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the 2023 Wells Fargo Healthcare Conference at 9:30 a.m. ET on Wednesday, Sept. 6, 2023. Amgen will also present at the Citi Global Healthcare Conference at 1:00 p.m. ET on Thursday, Sept. 7, 2023. Peter H. Griffith, executive vice president and chief financial officer at Amgen, and Murdo Gordon, executive vice president of global commercial operations at Amgen will present at both conferences. The webcasts from these events will be broadcast over the internet""}, {""date"": ""20230901031500"", ""headline"": ""What You Missed On Wall Street On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901075200"", ""headline"": ""Amgen reaches settlement with FTC on Horizon Therapeutics takeover"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901075900"", ""headline"": ""Horizon Therapeutics gains amid reports FTC settled with Amgen over $28B deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901081100"", ""headline"": ""Amgen to settle FTC and state challenges to Horizon Therapeutics takeover"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901082200"", ""headline"": ""Horizon Therapeutics gains after FTC settles with Amgen over $28B deal  (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901082400"", ""headline"": ""Amgen, Horizon Therapeutics confirm resolution of FTC lawsuit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901082600"", ""headline"": ""Amgen, Horizon enter consent order agreement with FTC to close acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901082800"", ""headline"": ""Horizon Therapeutics gains afer FTC settles with Amgen over $28B deal  (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901092000"", ""headline"": ""FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics"", ""summary"": ""The Federal Trade Commission reached a deal with Amgen to approve its $27.8 billion acquisition of Horizon Therapeutics plc the agency announced Friday.""}, {""date"": ""20230901095300"", ""headline"": ""Amgen-Horizon Therapeutics $28B Acquisition: Federal Trade Commission Gives Green Signal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901103300"", ""headline"": ""As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901110900"", ""headline"": ""TOP NEWS: Amgen buy of Horizon closer as FTC lawsuit resolved"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901111900"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901113000"", ""headline"": ""As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs\u00a0"", ""summary"": ""States like Colorado are looking to set upper payment limits on certain drugs as soon as next year.""}, {""date"": ""20230901120200"", ""headline"": ""Horizon Therapeutics (NASDAQ:HZNP) Gains After FTC Settlement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901130006"", ""headline"": ""Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock"", ""summary"": ""Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20230901130440"", ""headline"": ""Amgen gets US FTC's go-ahead for $27.8 billion Horizon deal"", ""summary"": ""The U.S. Federal Trade Commission (FTC) has allowed Amgen to continue its $27.8 billion acquisition of Horizon Therapeutics, while preventing the drugmaker from using anticompetitive tactics to extend the market dominance of two Horizon drugs.  The agreement, announced on Friday, ends months of uncertainty over the deal since the FTC in May filed a lawsuit over concerns that Amgen would leverage its drugs to secure favorable insurance coverage terms for Horizon's thyroid eye disease treatment Tepezza and gout drug Krystexxa.  Under the FTC settlement, Amgen is prohibited from bundling any of its products with Tepezza or Krystexxa, and from using any product rebate or contract term to exclude or disadvantage products that would compete with those drugs.""}, {""date"": ""20230901132000"", ""headline"": ""AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION"", ""summary"": ""Amgen (NASDAQ:AMGN) and Horizon Therapeutics plc (NASDAQ:HZNP) today announced the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's acquisition of Horizon.""}, {""date"": ""20230901132940"", ""headline"": ""Amgen\u2019s $27.8 Billion Horizon Takeover Allowed in FTC Accord"", ""summary"": ""(Bloomberg) -- Amgen Inc. can move forward with its $27.8 billion takeover of Horizon Therapeutics Plc after the US Federal Trade Commission said Friday that it accepted a binding settlement that the combined company won\u2019t bundle together two of Horizon\u2019s blockbuster drugs.Most Read from BloombergHuawei Teardown Shows Chip Breakthrough in Blow to US SanctionsMercedes Bets on Range Boost in Swipe at Tesla\u2019s EV LeadWhy China Is Avoiding Using \u2018Bazooka\u2019 to Spur EconomyDiamond Prices Are in Free Fal""}, {""date"": ""20230901134800"", ""headline"": ""Horizon Therapeutics Stock Rises After Settlement Clears Way for Amgen Deal"", ""summary"": ""Shares of Horizon Therapeutics rose Friday morning after the FTC said [it reached a settlement](https://www.wsj.com/us-news/law/ftc-settles-with-amgen-over-27-8-billion-deal-for-horizon-therapeutics-b96a2d69) with Amgen that would let it acquire the company.""}, {""date"": ""20230901140512"", ""headline"": ""Amgen resolves US regulator\u2019s challenge to $28bn Horizon deal"", ""summary"": ""Federal Trade Commission said it secured concessions from pharma company to resolve its competition concerns""}, {""date"": ""20230901141100"", ""headline"": ""Amgen and Horizon Therapeutics Stocks Rise After FTC Settlement Over $27.8 Billion Merger"", ""summary"": ""The Federal Trade Commission makes provision that prohibits \u201cbundling\u201d discounts for some medications.""}, {""date"": ""20230901143202"", ""headline"": ""Trending : FTC Ends Challenge of Amgen/Horizon Deal"", ""summary"": ""14:16 ET -- Amgen and Horizon Therapeutics are among the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The Federal Trade Commission...""}, {""date"": ""20230901144852"", ""headline"": ""CDC: Dividend ETF With Unconventional Market Timing"", ""summary"": ""VictoryShares US EQ Income Enhanced Volatility Wtd is a defensive ETF with unconventional market timing and lower risk in drawdowns. Learn more about CDC here.""}, {""date"": ""20230901154438"", ""headline"": ""Why Amgen's $28 Billion Merger News Also Bodes Well For Pfizer, Biogen"", ""summary"": ""Amgen stock rose Friday after the FTC dropped its lawsuit, clearing the way for the biotech to buy Horizon Therapeutics for $28 billion.""}, {""date"": ""20230901161100"", ""headline"": ""NEW YORK MARKET CLOSE: Dow and dollar rise after mixed payrolls report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230901161100"", ""headline"": ""Amgen\u2019s $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle"", ""summary"": ""The Federal Trade Commission said it had agreed to end its legal challenge of the deal. The pact also dismisses the antitrust claims of six states that joined the FTC in May seeking to block the transaction.""}, {""date"": ""20230901163900"", ""headline"": ""Amgen Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.14% higher to $256.71 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230901180418"", ""headline"": ""Amgen gets green light from FTC for $27.8B Horizon Therapeutics deal"", ""summary"": ""The Federal Trade Commission will allow Amgen to continue a $27.8 billion purchase of Horizon Therapeutics. The companies anticipate closing the deal in the fourth quarter.""}, {""date"": ""20230901185400"", ""headline"": ""Amgen, FTC Settle Over $27.8 Billion Horizon Deal. Stocks Rise."", ""summary"": ""The Federal Trade Commission prohibited the merged company from \u201cbundling\u201d discounts for some medications.""}, {""date"": ""20230901211332"", ""headline"": ""Dow Jones Today: Index Moves Up on Jobs Report"", ""summary"": ""The Dow Jones finished higher by about 115 points, or 0.3%, on investors optimism that the latest employment report will help prompt the Fed to end its interest rate hikes.""}, {""date"": ""20230902010500"", ""headline"": ""Lilly, Novo Nordisk top pharma performers in August; AstraZeneca, Roche lag"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230902130000"", ""headline"": ""SCHD: The First Acquisition For The Dividend Income Accelerator Portfolio Is A Strategic Buy"", ""summary"": ""SCHD is highly attractive for investors due to its combination of dividend income and sustainable dividend growth. Read more about SCHD stock.""}, {""date"": ""20230903074900"", ""headline"": ""The 3 Most Promising Dow Stocks to Own Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230903081922"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of September 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the full September 3 weekly update.""}, {""date"": ""20230903110000"", ""headline"": ""Why is big pharma unmoved despite Medicare pricing threat?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
13,2023-09-03,254.70730590820312,2023-09-10,257.4060974121094,0.010595658001576469,U2,"[{""date"": ""20230903074900"", ""headline"": ""The 3 Most Promising Dow Stocks to Own Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230903081922"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of September 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the full September 3 weekly update.""}, {""date"": ""20230903110000"", ""headline"": ""Why is big pharma unmoved despite Medicare pricing threat?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230904093820"", ""headline"": ""AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION"", ""summary"": ""THOUSAND OAKS - Amgen and Horizon Therapeutics plc today announced the entry into a consent order agreement with the Federal Trade Commission that resolves the pending FTC administrative...""}, {""date"": ""20230904135006"", ""headline"": ""Amgen (AMGN) is a Top-Ranked Momentum Stock: Should You Buy?"", ""summary"": ""Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.""}, {""date"": ""20230904161400"", ""headline"": ""FTC Allows Amgen (AMGN) to Proceed With $28B Horizon Buyout"", ""summary"": ""Per the settlement terms, Amgen (AMGN) is prohibited from bundling its products with Horizon's Tepezza or Krystexxa. Amgen expects to complete the Horizon acquisition before 2023-end.""}, {""date"": ""20230905034000"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905060000"", ""headline"": ""FTC settlement could shelter Amgen from US price cuts, taxes"", ""summary"": ""The U.S. Federal Trade Commission'sdecision on Friday to allow Amgen's takeover of HorizonTherapeutics was the latest setback to its stated goal ofstricter antitrust enforcement, and instead paved...""}, {""date"": ""20230905072051"", ""headline"": ""September Dogs Of The Dow: Walgreens Now Tops All By Yield"", ""summary"": ""There were two Dow Index stocks showing dividends exceeding single share price this month. Click here for a detailed analysis.""}, {""date"": ""20230905084200"", ""headline"": ""Irish High Court hearing for Horizon's $28B sale to Amgen set for Oct. 5"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905100517"", ""headline"": ""Analysis-FTC settlement could shelter Amgen from US price cuts, taxes"", ""summary"": ""The U.S. Federal Trade Commission's decision on Friday to allow Amgen's takeover of Horizon Therapeutics was the latest setback to its stated goal of stricter antitrust enforcement, and instead paved the way for Amgen to gain drugs not subject to new price negotiations and possibly lower the company's tax burden.  The move signals the FTC's uncertainty that a court would support its novel theory of future competition being disadvantaged by Amgen's \""bundling\"" of drugs in negotiations with insurers.  \""I think there is some skittishness on whether to pursue this and develop new case law,\"" said Abiel Garcia, a partner at Kesselman, Brantly & Stockinger and a former deputy attorney general in California's antitrust department.""}, {""date"": ""20230905125700"", ""headline"": ""Amgen's Horizon Acquisition Offers Multiple Advantages: Tax Breaks, Shield From Drug Pricing Negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230905131300"", ""headline"": ""Should You Still Buy the Dow Jones' Best-Performing August Stocks?"", ""summary"": ""They're rolling now, but this market has been too hot-and-cold of late to ignore any company's -- or company's stock's -- underlying bigger picture.""}, {""date"": ""20230905195533"", ""headline"": ""Truist Securities Reiterates AMGEN (AMGN) Hold Recommendation"", ""summary"": """"}, {""date"": ""20230906034000"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906034400"", ""headline"": ""Amgen initiated with a Buy at HSBC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906070800"", ""headline"": ""GLOBAL BROKER RATINGS: Shore Capital raises B&M; HSBC likes Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906081108"", ""headline"": ""The FTC \""Settles\"" For A Conduct Consent Decree To Resolve Its Challenge To The Amgen-Horizon Merger"", ""summary"": ""For years, the antitrust enforcement agencies have indicated their antipathy toward resolving competition issues in proposed mergers by entering into consent decrees that prohibit certain conduct,...""}, {""date"": ""20230906113200"", ""headline"": ""Apple, Boeing share losses lead Dow's 265-point fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230906120000"", ""headline"": ""Biden FTC\u2019s Antitrust Bark Proves Worse Than Its Bite"", ""summary"": ""Federal Trade Commission Chair  Lina Khan  has been open about her willingness to take on hard cases and lose.  \u201cI\u2019m certainly not someone who thinks success is marked by a 100% court record,\u201d Khan has said.  Frequent defeats, including last week\u2019s settlement with  Amgen  are weakening the agency\u2019s hand, though.""}, {""date"": ""20230906134000"", ""headline"": ""Amgen (AMGN) Stock Outperforms Industry YTD: Here's Why"", ""summary"": ""Amgen (AMGN) expects strong sales growth of products like Tezspire, Evenity and Repatha to be offset by lower revenues from oncology biosimilars and Enbrel.""}, {""date"": ""20230906144051"", ""headline"": ""Is Amgen A Worthy Investment Despite President Biden's Inflation Reduction Act?"", ""summary"": ""Amgen discovers, develops, manufactures, and delivers human therapeutics worldwide. Find out why we initiate our coverage of AMGN stock with a hold rating.""}, {""date"": ""20230906144906"", ""headline"": ""Amgen Inc. (AMGN) Wells Fargo Securities Healthcare Conference (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Wells Fargo Securities Healthcare Conference September 6, 2023 9:30 AM ETCompany ParticipantsArvind Sood - VP of IRPeter Griffith - EVP and CFOConference...""}, {""date"": ""20230906151403"", ""headline"": ""12 Best Healthcare ETFs To Buy"", ""summary"": ""In this article, we discuss 12 best healthcare ETFs. If you want to skip our discussion on the healthcare market, head directly to 5 Best Healthcare ETFs To Buy. In December 2022, BlackRock highlighted concerns about the performance for the healthcare sector in 2023. The previous year was rather challenging for equity and fixed income [\u2026]""}, {""date"": ""20230907011000"", ""headline"": ""Meet Bullfrog AI: Fly exclusive interview with CEO Vin Singh"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230907034000"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230907034838"", ""headline"": ""HSBC Initiates Coverage of AMGEN (AMGN) with Buy Recommendation"", ""summary"": """"}, {""date"": ""20230907074600"", ""headline"": ""Thursday\u2019s Top Analyst Upgrades and Downgrades: American Airlines, Amgen, Block, Chewy, First Solar, Nvidia, Southwest Airlines and More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230907113548"", ""headline"": ""Amgen: Not An Investment Mistake, But It Was Better Before"", ""summary"": ""Amgen's solid quarterly results and potential as a good investment are overshadowed by concerns over the Horizon acquisition and high debt levels. Learn more on AMGN stock here.""}, {""date"": ""20230907131616"", ""headline"": ""High Times Ties Up with Lucy Scientific in Going-Public Transaction on Nasdaq"", ""summary"": ""-High Times Holdings Corp. to exchange core IP assets for 19.9% stake in Lucy Scientific Discovery (NASDAQ: LSDI) plus milestone payments -Transaction creates liquidity opportunity for High Times shareholders who [\u2026]""}, {""date"": ""20230907154308"", ""headline"": ""Amgen Inc. (AMGN) Citi Global Healthcare Conference (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Citi Global Healthcare Conference September 7, 2023 1:00 PM ETCompany ParticipantsPeter Griffith - Executive Vice President and Chief Financial OfficerJustin...""}, {""date"": ""20230907170647"", ""headline"": ""Healthcare Stocks Push the Dow Higher"", ""summary"": ""Healthcare stocks were gaining Thursday, helping to raise the Dow, while the Nasdaq and S&P 500 dropped. Shares of Amgen (ticker: AMGN) gained 1.7% as the biotechnology stock was the second-best performer in the Dow Jones Industrial Average.""}, {""date"": ""20230907200000"", ""headline"": ""AMGEN TO PRESENT AT THE MORGAN STANLEY GLOBAL HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the Morgan Stanley Global Healthcare Conference at 8:50 a.m. ET on Tuesday, Sept. 12, 2023. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20230908034000"", ""headline"": ""Amgen Inc. stock rises Friday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908093400"", ""headline"": ""How Is The Market Feeling About Amgen?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230908135800"", ""headline"": ""Biotech Stock Roundup: MRNA's Vaccine Update, AMGN & HZNP Clear FTC Lawsuit & More"", ""summary"": ""Pipeline and regulatory updates from (MRNA) and Amgen (AMGN) are in focus in the biotech sector.""}, {""date"": ""20230908215017"", ""headline"": ""Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $259.43, marking a +1.98% move from the previous day.""}, {""date"": ""20230909040052"", ""headline"": ""Banker glee does not tell the whole story on Lina Khan setbacks"", ""summary"": ""Settlement over Amgen $28bn acquisition shows the antitrust chief still won concessions to protect consumers""}, {""date"": ""20230909072000"", ""headline"": ""Charting The Moat Index's Long-Term Track Record"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230909120000"", ""headline"": ""Big Pharma\u2019s Battle With the Biden Administration Could Have Legs"", ""summary"": ""Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the Inflation Reduction Act.""}, {""date"": ""20230910012600"", ""headline"": ""Oppenheimer Keeps Their Buy Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910022400"", ""headline"": ""HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910081500"", ""headline"": ""Amgen presents new LUMAKRAS plus chemotherapy data in first-line KRAS G12C NSCLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910110000"", ""headline"": ""Eli Lilly, Novo to lead $100B weight loss drug market in 2030: JPMorgan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910130000"", ""headline"": ""AMGEN PRESENTS NEW LUMAKRAS\u00ae (SOTORASIB) PLUS CHEMOTHERAPY DATA IN FIRST-LINE KRAS G12C NSCLC AT WCLC"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced exciting data from a study arm of the CodeBreaK 101 clinical trial, a Phase 1b study evaluating LUMAKRAS\u00ae (sotorasib) with carboplatin and pemetrexed in adult patients with KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC). These results were featured in an oral presentation at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer (WCLC) in Singapore on Sunday, September 10.""}]",{}
14,2023-09-10,257.4060974121094,2023-09-17,258.68603515625,0.004972445318929042,U1,"[{""date"": ""20230910012600"", ""headline"": ""Oppenheimer Keeps Their Buy Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910022400"", ""headline"": ""HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910081500"", ""headline"": ""Amgen presents new LUMAKRAS plus chemotherapy data in first-line KRAS G12C NSCLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910110000"", ""headline"": ""Eli Lilly, Novo to lead $100B weight loss drug market in 2030: JPMorgan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230910130000"", ""headline"": ""AMGEN PRESENTS NEW LUMAKRAS\u00ae (SOTORASIB) PLUS CHEMOTHERAPY DATA IN FIRST-LINE KRAS G12C NSCLC AT WCLC"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced exciting data from a study arm of the CodeBreaK 101 clinical trial, a Phase 1b study evaluating LUMAKRAS\u00ae (sotorasib) with carboplatin and pemetrexed in adult patients with KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC). These results were featured in an oral presentation at the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer (WCLC) in Singapore on Sunday, September 10.""}, {""date"": ""20230911022119"", ""headline"": ""September Self-Indexing Strategies For A Possible Blue October"", ""summary"": ""Magic Formula is still one of my favorite broad-based indexing strategies. Find out the top 30 dividend paying Magic Formula stocks scored for September 2023.""}, {""date"": ""20230911031200"", ""headline"": ""Amgen's sotorasib cancer therapy shows positive data in phase 1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911034000"", ""headline"": ""Amgen Inc. stock rises Monday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911063300"", ""headline"": ""Big Institutions Grab \u2018Strong Buy\u2019 Dividend Stocks in a Sector Not Totally Driven by AI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911070303"", ""headline"": ""Neumora Therapeutics to Sell 14.7 Million Shares at $16-$18 Each in IPO"", ""summary"": ""By Colin Kellaher Neumora Therapeutics, a clinical-stage biopharmaceutical company backed by Amgen, on Monday said it plans to sell 14.7 million shares at between $16 and $18 apiece in its...""}, {""date"": ""20230911070800"", ""headline"": ""Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911083700"", ""headline"": ""Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230911100623"", ""headline"": ""AMGEN PRESENTS NEW LUMAKRAS PLUS CHEMOTHERAPY DATA IN FIRST-LINE KRAS G12C NSCLC AT WCLC"", ""summary"": ""THOUSAND OAKS - Amgen today announced exciting data from a study arm of the CodeBreaK 101 clinical trial, a Phase 1b study evaluating LUMAKRAS with carboplatin and pemetrexed in adult patients with...""}, {""date"": ""20230911101309"", ""headline"": ""FTC, States Agree On Path Forward For Amgen's Horizon Therapeutics Deal"", ""summary"": ""Settlement said to resolve anticompetitive concerns over critical drugs. The Federal Trade Commission and attorneys general from six states - California, Illinois, Minnesota, New York, Washington,...""}, {""date"": ""20230911120100"", ""headline"": ""Take the Zacks Approach to Beat the Market: Shopify, Novo Nordisk, Amgen in Focus"", ""summary"": ""Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.""}, {""date"": ""20230911183700"", ""headline"": ""Amgen Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold"", ""summary"": ""The Relative Strength (RS) Rating for Amgen stock entered a new percentile Monday, with a rise from 75 to 81.  When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.  Is Amgen Stock A Buy?""}, {""date"": ""20230911200000"", ""headline"": ""AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 11:40 a.m. BST on Thursday, Sept. 14, 2023. Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20230912034000"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912065000"", ""headline"": ""Horizon Therapeutics ticks higher as Amgen end date extended until December"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912080600"", ""headline"": ""Horizon Therapeutics ticks higher as Amgen end date extended until December (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912091000"", ""headline"": ""Dow's nearly 100-point drop led by losses for shares of Amgen, Procter & Gamble"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230912130006"", ""headline"": ""Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know"", ""summary"": ""Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""20230912135804"", ""headline"": ""Amgen Inc. (AMGN) Morgan Stanley 21st Annual Global Healthcare Conference 2023 (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Morgan Stanley 21st Annual Global Healthcare Conference 2023 September 12, 2023 8:50 AM ETCompany ParticipantsRobert Bradway - Chairman and Chief Executive...""}, {""date"": ""20230913012252"", ""headline"": ""The 3 Most Undervalued Biotech Stocks to Buy in September 2023"", ""summary"": ""It\u2019s been a difficult time for biotechnology stocks. After a boom during the Covid-19 pandemic, the entire sector appears to have been abandoned by investors. The Standards and Practices (S&P) 500 Biotechnology Select Industry Index has declined 11% throughout the past 12 months and is down 18% throughout the last five years. Companies large and small have seen their stock prices slump as investor confidence in the industry wanes. Of course, hurdles surrounding prescription drug makers and medic""}, {""date"": ""20230913013600"", ""headline"": ""$1000 Invested In This Stock 15 Years Ago Would Be Worth $4,200 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230913030835"", ""headline"": ""BBH: Our Favorite Biotech ETF Can Keep Outperforming"", ""summary"": ""VanEck Biotech ETF outperforms other industry ETFs due to its focus on large-cap leaders and the potential of AI in R&D programs. Read more on BBH ETF here.""}, {""date"": ""20230913034000"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230913143000"", ""headline"": ""2 Top Dividend Stocks to Buy in September"", ""summary"": ""If you're looking for dividend stocks that can provide steady income and growth potential, you might want to consider adding Amgen (NASDAQ: AMGN) and American Express (NYSE: AXP) to your portfolio.  Read on to find out more about these top-shelf dividend stocks.  Amgen is one of biotech's original pioneers, with a diversified portfolio of drugs and biosimilars that treat various diseases, such as cancer, cardiovascular, inflammation, and bone health.""}, {""date"": ""20230914022100"", ""headline"": ""FTC warns pharma industry on improperly listed patents"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914034000"", ""headline"": ""Amgen Inc. stock rises Thursday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914044400"", ""headline"": ""3 Quality Dividend Stocks For A Bear Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914050200"", ""headline"": ""Primecap Odyssey Funds' 2023 Semiannual Letter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914101832"", ""headline"": ""Amgen-partnered AI biotech startup brings in $273M"", ""summary"": ""A biotech startup using generative AI to create new, protein-based medicines has closed on a $273 million round as it looks to expand its reach.""}, {""date"": ""20230914110000"", ""headline"": ""Variants in the genome interact with each other and with the environment to affect risk of cardiovascular disease"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914111700"", ""headline"": ""Dow's 320-point rally led by gains in shares of JPMorgan Chase, Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230914123316"", ""headline"": ""Nvidia, Amgen back AI-driven drug firm Generate:Biomedicines' $273 mln fundraise"", ""summary"": ""Drug developer Generate:Biomedicines, which uses artificial intelligence (AI) to find new treatments, said on Thursday it has raised $273 million from investors including Nvidia's venture capital arm and Amgen.  Generate \u2014 founded by venture firm Flagship Pioneering, which has incubated biotech companies, most famously Moderna Inc \u2014 uses AI to replace trial-and-error drug discovery methods and create novel protein-based therapeutics.  Generate is testing a monoclonal antibody therapy for COVID-19, its first therapy to reach human testing.""}, {""date"": ""20230914124929"", ""headline"": ""Should You Consider Selling Amgen (AMGN)?"", ""summary"": ""ClearBridge Investments, an investment management company, released its \u201cClearBridge Large Cap Value Strategy\u201d second quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy outperformed its Russell 1000 Value Index benchmark in the second quarter. The strategy benefited from nine of the 11 sectors in which it was invested for [\u2026]""}, {""date"": ""20230914215017"", ""headline"": ""Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $262.30, marking a +1.97% move from the previous day.""}, {""date"": ""20230915034000"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230915115100"", ""headline"": ""Amgen Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
15,2023-09-17,258.68603515625,2023-09-24,265.6116027832031,0.026772097004656548,U3,"[{""date"": ""20230918064900"", ""headline"": ""Amgen price target raised to $280 from $260 at Argus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230918124659"", ""headline"": ""SCHD: Stop The Madness"", ""summary"": ""Schwab U.S. Dividend Equity ETF offers a combination of slow growth blue chip names with consistent dividend hikes. Click here for a detailed analysis on SCHD.""}, {""date"": ""20230919002438"", ""headline"": ""Argus Research Maintains AMGEN (AMGN) Buy Recommendation"", ""summary"": """"}, {""date"": ""20230919034000"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230919043707"", ""headline"": ""Tracking John Paulson's Paulson & Company Portfolio - Q2 2023 Update"", ""summary"": ""John Paulson's 13F portfolio value decreased by 15% to $1.02B this quarter. Click here to read the portfolio's full Q2 2023 update.""}, {""date"": ""20230919054800"", ""headline"": ""Amgen Reaches Analyst Target Price"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230919141104"", ""headline"": ""Healthcare: FTC Chair Lina Khan to crack down on 'below radar' deals"", ""summary"": ""FTC Chair Lina Khan wants to help create more competition in the market and avoid monopolies.""}, {""date"": ""20230919215201"", ""headline"": ""FTC chair targets deals that have fallen in agency's 'blind spots'"", ""summary"": ""FTC chair Lina Khan has her sights focused on challenging mergers & acquisitions in the healthcare and tech sectors, specifically those valued under $100 million. Khan argues that these mergers can snowball into larger monopolies when left unchecked. Senior Reporter for Yahoo Finance Anjalee Khemlani joins to breakdown Lina Khan's recent statement at the Oliver Wyman Health Innovation Summit in Chicago.""}, {""date"": ""20230920035500"", ""headline"": ""Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230920111300"", ""headline"": ""IBM, Amgen share gains contribute to Dow's nearly 200-point jump"", ""summary"": ""The Dow Jones Industrial Average is climbing Wednesday morning with shares of IBM and Amgen delivering strong returns for the price-weighted average. The Dow...""}, {""date"": ""20230920112000"", ""headline"": ""Check Out What Whales Are Doing With AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230920140100"", ""headline"": ""Dow's nearly 100-point rally led by gains for shares of Amgen, IBM"", ""summary"": ""Shares of Amgen and IBM are trading higher Wednesday afternoon, propelling the Dow Jones Industrial Average into positive territory. Shares of Amgen and IBM...""}, {""date"": ""20230920163800"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. rallied 2.71% to $271.46 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500...""}, {""date"": ""20230920175744"", ""headline"": ""Best Dividend Stocks: Amgen Hits Buy Point, Offers Solid Dividend Growth"", ""summary"": ""Shares of Amgen have broken out of a cup-with-handle base, another reason why income investors should consider the dividend stock.  The biotech company \u2014 headquartered in Thousand Oaks, Calif. \u2014 has an assortment of drugs used to treat cancer and autoimmune disorders.  Amgen is best known for it its rheumatoid arthritis drug Enbrel, which contributed 17% of sales last year.""}, {""date"": ""20230920200000"", ""headline"": ""AMGEN LAUNCHES PARTNERS OF CHOICE NETWORK OF EIGHT LEADING ONCOLOGY ACADEMIC CENTERS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the launch of Amgen Partners of Choice, a new network that brings together Amgen's oncology research and development experts and world-class clinical leaders at eight research centers across the globe. As part of Amgen's mission to improve care through partnerships across the healthcare ecosystem, the network fosters academic collaboration to advance new treatment options for patients with the greatest unmet needs. The member institutions are:""}, {""date"": ""20230920233255"", ""headline"": ""Amgen (AMGN)'s True Worth: A Complete Analysis of Its Market Value"", ""summary"": ""Is Amgen (AMGN) fairly valued? Let's delve into its financials and growth prospects to find out.""}, {""date"": ""20230921081644"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: September 2023 Fair Value Update"", ""summary"": ""I've been building my cash position in preparation for a market crash and taking advantage of high interest rates. Read more here.""}, {""date"": ""20230921133700"", ""headline"": ""2 Dividend Growth Stocks to Buy Right Now"", ""summary"": ""Dividends are great. They're a reliable source of passive income for retirees (and others) or can help boost long-term returns for investors who choose to reinvest them. But what happens when a company decreases or suspends its payouts? No investor wants to run into this problem.""}, {""date"": ""20230921215020"", ""headline"": ""Amgen (AMGN) Stock Moves -0.76%: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $269.41, marking a -0.76% move from the previous day.""}, {""date"": ""20230921220604"", ""headline"": ""Why Shares of Neumora Therapeutics Slumped This Week"", ""summary"": ""Shares of Neumora Therapeutics (NASDAQ: NMRA) were down more than 32% for the week as of Thursday's market close, according to data provided by\u00a0S&P Global Market Intelligence.  The clinical-stage biotech just went public last Friday via an initial public offering (IPO).  The company priced its IPO shares at $17 a share, but it opened last Friday at $16.50 and only rose to as high as $17.74.""}, {""date"": ""20230922014300"", ""headline"": ""BCBSM modifying weight loss drug coverage to require 'lifestyle modifications'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922050000"", ""headline"": ""INSIGHT-Big Pharma bets on AI to speed up clinical trials"", ""summary"": ""Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test medicines, both accelerating drug development and potentially saving millions of dollars.  Human studies are the most expensive and time-consuming part of drug development as it can take years to recruit patients and trial new medicines in a process that can cost over a billion dollars from the discovery of a drug to the finishing line.  Pharmaceutical companies have been experimenting with AI for years, hoping machines can discover the next blockbuster drug.""}, {""date"": ""20230922050402"", ""headline"": ""Big Pharma bets on AI to speed up clinical trials"", ""summary"": ""Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test medicines, both accelerating drug development and potentially saving millions of dollars.  Human studies are the most expensive and time-consuming part of drug development as it can take years to recruit patients and trial new medicines in a process that can cost over a billion dollars from the discovery of a drug to the finishing line.  Pharmaceutical companies have been experimenting with AI for years, hoping machines can discover the next blockbuster drug.""}, {""date"": ""20230922065400"", ""headline"": ""From Years to Months: How AI is Shaping the Landscape of Clinical Trials"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922115600"", ""headline"": ""AI To Revolutionize Clinical Trials And Diagnostics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230922163800"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slumped 0.63% to $267.70 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230924033210"", ""headline"": ""Patience Is The Name Of This (Market) Game"", ""summary"": ""Market weakness continues due to concerns about the Fed and interest rates. Read why market weakness during earnings quiet periods may present buying opportunities.""}, {""date"": ""20230924040500"", ""headline"": ""The Hedge Fund That Made a Killing Betting Against Lina Khan"", ""summary"": ""The efforts by Federal Trade Commission Chair Lina Khan to protect Main Street are inadvertently enriching some on Wall Street, generating outsize profits for Pentwater Capital Management and other large hedge funds that bet on merger deals.  In both cases, the FTC\u2019s intervention spooked investors and sent shares of the target companies swinging.""}, {""date"": ""20230924120600"", ""headline"": ""GLP-1 drugs may already be impacting aesthetics sectors, survey finds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230924233331"", ""headline"": ""Kyowa Kirin: High-Risk High-Return Call Reiterating Our Buy Rating"", ""summary"": ""Kyowa Kirin's recent track record for new drug trial success has been poor, but the partnership with Amgen provides reassurance. Read why KYKOF stock is a Buy.""}]",{}
16,2023-09-24,265.6116027832031,2023-10-01,266.663330078125,0.003959643644710464,U1,"[{""date"": ""20230924033210"", ""headline"": ""Patience Is The Name Of This (Market) Game"", ""summary"": ""Market weakness continues due to concerns about the Fed and interest rates. Read why market weakness during earnings quiet periods may present buying opportunities.""}, {""date"": ""20230924040500"", ""headline"": ""The Hedge Fund That Made a Killing Betting Against Lina Khan"", ""summary"": ""The efforts by Federal Trade Commission Chair Lina Khan to protect Main Street are inadvertently enriching some on Wall Street, generating outsize profits for Pentwater Capital Management and other large hedge funds that bet on merger deals.  In both cases, the FTC\u2019s intervention spooked investors and sent shares of the target companies swinging.""}, {""date"": ""20230924120600"", ""headline"": ""GLP-1 drugs may already be impacting aesthetics sectors, survey finds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230924233331"", ""headline"": ""Kyowa Kirin: High-Risk High-Return Call Reiterating Our Buy Rating"", ""summary"": ""Kyowa Kirin's recent track record for new drug trial success has been poor, but the partnership with Amgen provides reassurance. Read why KYKOF stock is a Buy.""}, {""date"": ""20230925024000"", ""headline"": ""FDA Strikes Off Coherus BioSciences' New Injector Biosimilar Treatment For Cancer Patients"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230925060100"", ""headline"": ""Analysts\u2019 Top Healthcare Picks: Cytokinetics (CYTK), Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230925115000"", ""headline"": ""Beat the Market Like Zacks: Elementis, Novo Nordisk, Amgen in Focus"", ""summary"": ""Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.""}, {""date"": ""20230925130007"", ""headline"": ""Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""20230925163800"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 0.31% to $266.86 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230925170206"", ""headline"": ""Dow Jones Biotech Giant Amgen, Meta Stock, Eye Buy Points In Stock Market Correction"", ""summary"": ""Dow Jones biotech leader Amgen and Meta stock are among the best stocks to watch in today's stock market action.""}, {""date"": ""20230926083800"", ""headline"": ""Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks."", ""summary"": ""Outside of a handful of highflying technology stocks, U.S. stocks have been practically flat in 2023, but on Wall Street, some analysts remain as bullish as...""}, {""date"": ""20230926121800"", ""headline"": ""Akebia gains as Australia clears kidney disease therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230926122020"", ""headline"": ""Big Pharma R&D Spending: The Secret Ingredient To Outperformance?"", ""summary"": ""High R&D spending by pharma companies does not necessarily lead to sales growth, let alone shareholder returns. See why bold M&A deals may be a different story.""}, {""date"": ""20230926163800"", ""headline"": ""Amgen Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.82% higher to $269.04 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20230927010800"", ""headline"": ""Are We in a New Golden Age of Merger Arbitrage?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927083600"", ""headline"": ""Amgen discloses more than $400 million stake in recent IPO Neumora Therapeutics"", ""summary"": ""An Amgen disclosure of a large stake in Neumora Therapeutics indicated the value of its investment in the biotech, which recently went public, has tripled.""}, {""date"": ""20230927100000"", ""headline"": ""Amgen Could Get a Piece of the Obesity Market"", ""summary"": ""Amgen has a couple of shots on goal to break into one of the biggest markets the pharmaceutical industry has ever seen.""}, {""date"": ""20230927111000"", ""headline"": ""September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230927163700"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 0.02% to $268.98 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230927220020"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $268.98, marking a -0.02% move from the previous day.""}, {""date"": ""20230928011400"", ""headline"": ""FDA Oncologic Drugs Advisory Committee holds virtual meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928032300"", ""headline"": ""Mirati stock climbs 10% ahead of data presentation, FDA meeting on rival drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928033300"", ""headline"": ""Teva names Novartis exec to lead US commercial business"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928090000"", ""headline"": ""Earn Double-Digit Income With Options (October 2023)"", ""summary"": ""Earning a decent income from investments higher than the inflation rate is challenging. Check out how we formulate a sustainable and repeatable options income strategy.""}, {""date"": ""20230928124504"", ""headline"": ""3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals"", ""summary"": ""The companies that already have obesity drugs can\u2019t keep up with the demand for their treatments, and the demand for the drugs is only likely to become more intense. That\u2019s because over 42% of the U.S. population was obese as of 2020, while the pervasive publicity around these drugs will make them more popular, and the social and political pressure for insurers to cover the treatments will become more intense. This has led to the rise of biotech stocks to buy. More specifically on the last point""}, {""date"": ""20230928125500"", ""headline"": ""DBS Remains a Buy on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230928150015"", ""headline"": ""The Anti-obesity Drug Market Is About to Get More Crowded"", ""summary"": ""Obesity is an epidemic that affects more than 40% of all American adults, and it's creating a feeding frenzy for investors. With the rise of...""}, {""date"": ""20230928163700"", ""headline"": ""Amgen Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.68% higher to $270.82 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230928215017"", ""headline"": ""Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $270.82, marking a +0.68% move from the previous day.""}, {""date"": ""20230929010900"", ""headline"": ""Check Out What Whales Are Doing With AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929020400"", ""headline"": ""Catalyst Watch: Tesla deliveries, Google event, Kellogg spinoff, Amgen drama and Ether ETFs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929061200"", ""headline"": ""GLP-1 drug developer Carmot Therapeutics reportedly mulling IPO or buyout"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929092100"", ""headline"": ""As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929102000"", ""headline"": ""As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment\u00a0"", ""summary"": ""A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.""}, {""date"": ""20230929115100"", ""headline"": ""AskSlim Market Week - Friday, Sep. 29"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230929133400"", ""headline"": ""Amgen Stock Was a Winner in the Third Quarter. These Solar Shares Weren\u2019t."", ""summary"": ""Amgen was the best-performing stock in the Dow Jones Industrial Average in the third quarter, while Zions Bancorp, up 30%, was the top stock in the S&P 500.""}, {""date"": ""20230929163800"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.76% to $268.76 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230929173400"", ""headline"": ""Amgen Stock Was a Winner in the Third Quarter. These Solar Shares Were Not."", ""summary"": ""Amgen was the best-performing stock in both the Dow Jones Industrial Average and Nasdaq 100 in the third quarter, while Zions Bancorp, up 32%, was the top stock in the S&P 500.""}]","{""assetTurnoverTTM"": 0.3207, ""bookValue"": 7656, ""cashRatio"": 2.0491329479768785, ""currentRatio"": 2.8593, ""ebitPerShare"": 3.8848, ""eps"": 3.2156, ""ev"": 168202.84, ""fcfMargin"": 0.3639, ""fcfPerShareTTM"": 17.5308, ""grossMargin"": 0.7385, ""inventoryTurnoverTTM"": 1.4407, ""longtermDebtTotalAsset"": 0.6521, ""longtermDebtTotalCapital"": 0.8667, ""longtermDebtTotalEquity"": 7.7116, ""netDebtToTotalCapital"": 0.3776, ""netDebtToTotalEquity"": 3.3604, ""netMargin"": 0.2506, ""operatingMargin"": 0.3028, ""payoutRatioTTM"": 0.589, ""pb"": 18.6097, ""peTTM"": 18.8311, ""pfcfTTM"": 15.1909, ""pretaxMargin"": 0.2821, ""psTTM"": 5.3097, ""quickRatio"": 2.5629, ""receivablesTurnoverTTM"": 4.6784, ""roaTTM"": 0.0904, ""roeTTM"": 1.2908, ""roicTTM"": 0.123, ""rotcTTM"": 0.147, ""salesPerShare"": 12.8309, ""sgaToSale"": 0.2615, ""totalDebtToEquity"": 7.8981, ""totalDebtToTotalAsset"": 0.6679, ""totalDebtToTotalCapital"": 0.8876, ""totalRatio"": 1.0924, ""period"": ""2023-09-30""}"
17,2023-10-01,266.663330078125,2023-10-08,265.38336181640625,-0.00479994103930137,D1,"[{""date"": ""20231002020100"", ""headline"": ""Drugmakers comply with Medicare pricing talks despite lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002034500"", ""headline"": ""Horizon Therapeutics ticks higher amid Nasdaq delisting notice for sale to Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002105500"", ""headline"": ""Amgen price target raised to $230 from $210 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231002163800"", ""headline"": ""Amgen Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slid 0.91% to $266.31 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231002164952"", ""headline"": ""Drugmakers sign on to negotiate Medicare prices under protest"", ""summary"": ""All the drugmakers that make the 10 prescription medicines  subject to the first-ever price negotiations for the U.S. Medicare health program, including Amgen and Novartis, said they signed on to participate in the talks by the Oct. 1 deadline.  The penalties for not doing so would have been steep: drugmakers would have to pay 65% to 95% taxes on their drug's Medicare sales or withdraw all of their products from the Medicare and Medicaid programs, which together provide health benefits to 158 million Americans.  \""Merck will sign the initial agreement with CMS under protest,\"" the U.S. company said in a statement.""}, {""date"": ""20231003023500"", ""headline"": ""Is Amgen's Lung Cancer Drug Lumakras Up to the Mark? FDA Briefing Raises Concerns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003034200"", ""headline"": ""Jones Research sees Amgen FDA issues reading through to Mirati"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003050000"", ""headline"": ""Dive Into Dividends: 14 Must-Have Stocks When Markets Dip"", ""summary"": ""Investors want income-producing investments amid rising interest and costs. Click here to learn about 14 Dividend Stocks with yield and strong dividend growth rates.""}, {""date"": ""20231003083600"", ""headline"": ""FDA staff voice concerns about whether Amgen's CodeBreaK 200 trial 'adequate'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003114400"", ""headline"": ""Bad news for Amgen could be 'good' for Mirati Therapeutics, says Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003120000"", ""headline"": ""Drugmakers agree to US government price talks amid pushback"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003120700"", ""headline"": ""Amgen stock dips after FDA reveals concerns about Lumakras study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003123900"", ""headline"": ""Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231003134830"", ""headline"": ""UPDATE 3-Amgen's late-stage data for lung cancer drug 'not adequate' - FDA staff"", ""summary"": ""The U.S. Food and Drug Administration staff reviewers said on Tuesday Amgen's late-stage study might not be sufficient to confirm the effectiveness for its lung cancer drug, as the firm pursues a traditional nod for the treatment.  Lumakras, which bought in sales of $285 million last year, targets a mutated form of a gene known as KRAS that occurs in about 13% of non-small cell lung cancers - the most common form of the disease.  Amgen's drug was granted accelerated approval by the U.S. FDA in 2021 for advanced lung cancer patients with KRAS mutations whose disease has worsened after treatment with chemotherapy or other medicines.""}, {""date"": ""20231003140806"", ""headline"": ""The 10 pharma companies participating in Medicare price negotiations"", ""summary"": ""Ten pharmaceutical manufacturers are signing the Inflation Reduction Act's Medicare drug price negotiation program. These companies are Bristol Myers Squibb (BMY), AstraZeneca (AZN), Boehringer Ingelheim, Immunex, Janssen Pharmaceuticals, Pharmacyclics, Merck & Company (MRK), Janssen Biotech, Novartis (NVS), and Novo Nordisk (NVO), according to the Biden administration. Yahoo Finance Health Care Reporter Anjalee Khemlani discusses the news. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231003161614"", ""headline"": ""October Dogs Of The Dow: 3 Buyable, 7 Watchable"", ""summary"": ""Discover how the Dow Jones adds and selects stocks, the highest-yielding stocks in October, and the leading performers in the Dow Industrial Index. Click for more.""}, {""date"": ""20231003163800"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 1.99% to $261.01 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231004022700"", ""headline"": ""Dow rallies nearly 100 points on gains in shares of Microsoft, Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004033900"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004061100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Intellia Therapeutics (NTLA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231004090011"", ""headline"": ""Gilead Sciences: A Healthy Buy With Solid Dividend"", ""summary"": ""Gilead Sciences has outperformed the S&P 500 with a 19% total return since my last Buy rating in August last year. Learn why GILD stock is a buy.""}, {""date"": ""20231004091000"", ""headline"": ""Should You Still Buy the Dow Jones' Best-Performing September Stocks?"", ""summary"": ""A handful of blue-chip tickers defied the bigger bearish tide last month, but that doesn't necessarily make these stocks a buy.""}, {""date"": ""20231004150000"", ""headline"": ""Large-scale proteomics in population-based studies from UK and Iceland"", ""summary"": ""In a paper released today, deCODE Genetics' scientists shared their findings from a plasma proteomics study performed using affinity-based methods. They analyzed the proteins in the context of diseases and diversity in the sequence of the genome and compared measurements made using two platforms of thousands of proteins in samples from large groups from the UK Biobank and Iceland.""}, {""date"": ""20231004195500"", ""headline"": ""Top Research Reports for Amgen, ServiceNow & RTX"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AMGN), ServiceNow, Inc. (NOW) and RTX Corporation (RTX).""}, {""date"": ""20231004220019"", ""headline"": ""Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing"", ""summary"": ""Amgen (AMGN) reachead $265.44 at the closing of the latest trading day, reflecting a +1.7% change compared to its last close.""}, {""date"": ""20231004230011"", ""headline"": ""Pharma Giants Combine Forces to Fight New M&A Rules"", ""summary"": ""Meet the anti-antitrust coalition. With a looming overhaul of US merger-and-acquisition law set to reshape the economics of the M&A-heavy...""}, {""date"": ""20231005021800"", ""headline"": ""FDA panel finds results from key Amgen Lumakras study unreliable"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005024100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA), Veralto Corporation (VLTO) and Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005033900"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005064600"", ""headline"": ""Horizon Therapeutics announces acquisition by Amgen approved in Ireland"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005065000"", ""headline"": ""Amgen wins Irish approval for planned Horizon Therapeutics purchase"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005075500"", ""headline"": ""FDA Oncologic Drugs Advisory Committee holds virtual meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005085100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Regeneron (REGN) and Alnylam Pharma (ALNY)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005111600"", ""headline"": ""The Zacks Analyst Blog Highlights Amgen, ServiceNow, RTX, Automatic Data Processing and Canadian Pacific Kansas City"", ""summary"": ""Amgen, ServiceNow, RTX, Automatic Data Processing and Canadian Pacific Kansas City are included in this Analyst Blog.""}, {""date"": ""20231005115300"", ""headline"": ""Mirati stock up 9% amid FDA meeting on rival Amgen drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231005185708"", ""headline"": ""UPDATE 2-US FDA panel says Amgen lung cancer drug data cannot be relied on"", ""summary"": ""Advisers to the U.S. Food and Drug Administration on Thursday found that data from a late-stage trial of Amgen's Lumakras could not be relied on, raising questions about the agency's upcoming decision on whether to grant traditional approval of the drug for a type of advanced lung cancer.  The drug was approved by the FDA in 2021 under an accelerated pathway, with confirmatory data a condition for gaining traditional approval.  The main goal of the confirmatory study was progression-free survival (PFS), or how long before the disease begins to worsen, but the FDA questioned some methods used in conducting the trial.""}, {""date"": ""20231006013800"", ""headline"": ""Biotech Sector: On The Verge Of Triumph Or Turmoil?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006022800"", ""headline"": ""Here\u2019s Why Mirati Therapeutics Stock (NASDAQ:MRTX) Soared Yesterday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006033000"", ""headline"": ""Confirmatory Trial Trouble In KRAS"", ""summary"": ""I wrote last year about KRAS-targeting drugs as cancer therapies, and that pretty much means G12C-KRAS targeting ones.""}, {""date"": ""20231006033900"", ""headline"": ""Amgen Inc. stock rises Friday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006062200"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Amgen (AMGN) and Neurocrine (NBIX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006065200"", ""headline"": ""Mirati Therapeutics price target raised to $72 from $31 at BMO Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006070800"", ""headline"": ""Negative Amgen AdCom a positive for Mirati, says Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006073300"", ""headline"": ""Amgen completes acquisition of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006080100"", ""headline"": ""FDA Adcomm Gives Thumbs Down To Amgen's Lumakras For Advanced Form Of Lung Cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006081100"", ""headline"": ""Analysts Are Bullish on These Healthcare Stocks: United Therapeutics (UTHR), Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006081200"", ""headline"": ""Amgen completes $27.8B acquisition of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006083600"", ""headline"": ""Amgen to continue to seek full approval of Lumakras cancer drug after FDA panel criticizes trial"", ""summary"": ""Amgen will continue to seek full approval for its Lumakras cancer drug as a treatment for a form of lung cancer.""}, {""date"": ""20231006092300"", ""headline"": ""Amgen completes USD28 billion acquisition of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006112400"", ""headline"": ""FDA AdCom Gives Thumbs Down To Late-Stage Data For Amgen's Lumakras In Advanced Form Of Lung Cancer (UPDATED)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006114700"", ""headline"": ""Amgen's Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics' Lung Cancer Drug: Analysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231006123000"", ""headline"": ""AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC"", ""summary"": ""Amgen (NASDAQ: AMGN) today announced that it has completed its acquisition of Horizon Therapeutics plc for $116.50 per share in cash, representing a transaction equity value of approximately $27.8 billion.""}, {""date"": ""20231006130006"", ""headline"": ""Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""20231006131100"", ""headline"": ""UPDATE 2-Amgen completes $27.8 bln Horizon Therapeutics deal"", ""summary"": ""Amgen said on Friday it had completed the $27.8 billion acquisition of Horizon Therapeutics after it received the go-ahead from the U.S. Federal Trade Commission (FTC) last month on certain conditions.  Under the settlement terms with the FTC following its lawsuit to block the deal, Amgen is prevented from using anti-competitive tactics to extend the market dominance of Horizon's fast-growing thyroid eye disease treatment Tepezza and gout drug Krystexxa.  The FTC's antitrust lawsuit had raised concerns over increased oversight on mergers and acquisitions in a sector that often turns to consolidation to power future growth as patents on older treatments expire.""}, {""date"": ""20231006131816"", ""headline"": ""Amgen completes $27.8 billion Horizon Therapeutics deal"", ""summary"": ""Under the settlement terms with the FTC following its lawsuit to block the deal, Amgen is prevented from using anti-competitive tactics to extend the market dominance of Horizon's fast-growing thyroid eye disease treatment Tepezza and gout drug Krystexxa.  The FTC's antitrust lawsuit had raised concerns over increased oversight on mergers and acquisitions in a sector that often turns to consolidation to power future growth as patents on older treatments expire.  The deal closure was within the fourth-quarter timeline set by the two companies, and is expected to add to Amgen's adjusted earnings from next year.""}, {""date"": ""20231006153400"", ""headline"": ""Mirati (MRTX) Surges 45% as Sanofi Reportedly Eyes Buyout"", ""summary"": ""A Bloomberg article suggests that pharma giant Sanofi (SNY) is exploring a potential acquisition deal for small cancer drugmaker Mirati Therapeutics (MRTX).""}, {""date"": ""20231006180647"", ""headline"": ""Hedge Funds Won Big on Bets Amgen-Horizon Deal Would Go Through"", ""summary"": ""(Bloomberg) -- Hedge funds Pentwater Capital Management, HBK Investments and Farallon Capital Management are reaping a windfall from bets that US regulators wouldn\u2019t be able to stop Amgen Inc. from completing its $28 billion takeover of Horizon Therapeutics Plc. Most Read from BloombergThe 5% Bond Market Means Pain Is Heading Everyone\u2019s WayThe Moral Case for No Longer Engaging With Elon Musk\u2019s XFake Mansions and Rent-Stabilized Units Emerge in Trump TrialCorporate America Is Ignoring Jay Powell""}, {""date"": ""20231006180948"", ""headline"": ""Biotech-Pharma Trade: Buying Opportunities On The Horizon"", ""summary"": ""Concerns over interest rates, pricing erosion, and Medicare's drug price negotiation plan weigh on biotech and pharma sectors. Learn what investors need to know.""}, {""date"": ""20231006215021"", ""headline"": ""Amgen (AMGN) Increases Yet Falls Behind Market: What Investors Need to Know"", ""summary"": ""Amgen (AMGN) closed at $267.47 in the latest trading session, marking a +0.9% move from the prior day.""}, {""date"": ""20231008022300"", ""headline"": ""As FDA mulls fate of Amgen drug, Sanofi could snap up rival Mirati"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231008115801"", ""headline"": ""SCHD: A Magnificent Buy At This Time"", ""summary"": ""The Schwab U.S. Dividend Equity ETF holds well-diversified, high-quality stocks with economies of scale. Explore more details here.""}]","{""assetTurnoverTTM"": 0.3207, ""bookValue"": 7656, ""cashRatio"": 2.0491329479768785, ""currentRatio"": 2.8593, ""ebitPerShare"": 3.8848, ""eps"": 3.2156, ""ev"": 168202.84, ""fcfMargin"": 0.3639, ""fcfPerShareTTM"": 17.5308, ""grossMargin"": 0.7385, ""inventoryTurnoverTTM"": 1.4407, ""longtermDebtTotalAsset"": 0.6521, ""longtermDebtTotalCapital"": 0.8667, ""longtermDebtTotalEquity"": 7.7116, ""netDebtToTotalCapital"": 0.3776, ""netDebtToTotalEquity"": 3.3604, ""netMargin"": 0.2506, ""operatingMargin"": 0.3028, ""payoutRatioTTM"": 0.589, ""pb"": 18.6097, ""peTTM"": 18.8311, ""pfcfTTM"": 15.1909, ""pretaxMargin"": 0.2821, ""psTTM"": 5.3097, ""quickRatio"": 2.5629, ""receivablesTurnoverTTM"": 4.6784, ""roaTTM"": 0.0904, ""roeTTM"": 1.2908, ""roicTTM"": 0.123, ""rotcTTM"": 0.147, ""salesPerShare"": 12.8309, ""sgaToSale"": 0.2615, ""totalDebtToEquity"": 7.8981, ""totalDebtToTotalAsset"": 0.6679, ""totalDebtToTotalCapital"": 0.8876, ""totalRatio"": 1.0924, ""period"": ""2023-09-30""}"
18,2023-10-08,265.38336181640625,2023-10-15,281.8836364746094,0.06217524167780386,U5+,"[{""date"": ""20231008022300"", ""headline"": ""As FDA mulls fate of Amgen drug, Sanofi could snap up rival Mirati"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231008115801"", ""headline"": ""SCHD: A Magnificent Buy At This Time"", ""summary"": ""The Schwab U.S. Dividend Equity ETF holds well-diversified, high-quality stocks with economies of scale. Explore more details here.""}, {""date"": ""20231009060315"", ""headline"": ""14 Best Cancer Stocks To Buy Now"", ""summary"": ""In this article, we discuss 14 best cancer stocks to buy. If you want to skip our detailed discussion on the oncology industry, head directly to 5 Best Cancer Stocks To Buy Now. The global oncology landscape continues to evolve, with ongoing efforts to discover, develop, and provide innovative treatments aimed at improving outcomes for [\u2026]""}, {""date"": ""20231009061500"", ""headline"": ""GCOW: An ETF for Dividend and Free Cash Flow Lovers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009065202"", ""headline"": ""TPHD: A Dividend ETF With Biblical Aspirations"", ""summary"": ""Timothy Plan High Dividend Stock ETF holds mostly mid-cap stocks with industrials, utilities, and energy appearing as top sectors. Find out why TPHD is a Buy.""}, {""date"": ""20231009110600"", ""headline"": ""$100 Invested In This Stock 15 Years Ago Would Be Worth $500 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009121300"", ""headline"": ""Will more bidders emerge or CVR ever be paid in Mirati takeover deal?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231009134900"", ""headline"": ""Coherus (CHRS) Stock Rises on BLA Re-Filing for Udenyca Onbody"", ""summary"": ""Coherus (CHRS) resubmits biologics license application for Udenyca Onbody, an on-body injector presentation of Udenyca to the FDA. Stock rises.""}, {""date"": ""20231009140100"", ""headline"": ""Mirati (MRTX) Gets Buyout Offer From Bristol Myers for $4.8B"", ""summary"": ""Sanofi (SNY) is set to acquire Mirati (MRTX) for $58 per share in cash along with a contingent value right of $12 per share, tied to a regulatory milestone.""}, {""date"": ""20231009141500"", ""headline"": ""2 Magnificent Dividend Stocks to Buy Hand Over Fist in October"", ""summary"": ""Investing in stocks may not look particularly appealing at the moment, given that the 10-year U.S. Treasury bond is offering a near 5% annualized yield.  The drugmaker also sports a moderate cash payout ratio of 42%, implying that it can comfortably support additional increases to the dividend in the years ahead.""}, {""date"": ""20231010004113"", ""headline"": ""Oppenheimer Maintains AMGEN (AMGN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20231010060700"", ""headline"": ""Neumora Therapeutics appoints Lenz as EVP, Head of Research, Development"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010090000"", ""headline"": ""SCHD: Still My Favorite Stagflation Hedge"", ""summary"": ""Schwab U.S. Dividend Equity ETF is an excellent hedge against possible stagflation due to its focus on dividends. Read why SCHD ETF is my stagflation hedge.""}, {""date"": ""20231010091400"", ""headline"": ""Video: Dow Movers: AMGN, KO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231010105300"", ""headline"": ""Should You Still Buy the Nasdaq's Best-Performing September Stocks?"", ""summary"": ""Stocks pulled back in September, primarily due to the Federal Reserve forecast that rates would stay higher for longer.  Unsurprisingly, the Nasdaq Composite took the news worse than the other two major indexes, as shown in the chart below.  Let's take a look at the three top performers on the Nasdaq to see whether any are worth buying.""}, {""date"": ""20231010122738"", ""headline"": ""High Yield Stock Watchlist - October 2023"", ""summary"": ""The majority of the stocks on my watchlist are undervalued based on dividend yield theory. Read more here.""}, {""date"": ""20231010153614"", ""headline"": ""Amgen (AMGN) Valuation: A Comprehensive Analysis of Its Market Value"", ""summary"": ""A deep dive into the intrinsic value and financial performance of Amgen Inc (AMGN)""}, {""date"": ""20231010163800"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.11% to $271.25 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231011032900"", ""headline"": ""What You Missed On Wall Street on Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011044500"", ""headline"": ""These Stocks Are Moving the Most Today: Exxon, Pioneer Natural, Silk Road Medical, DaVita, Amgen, Lilly, and More"", ""summary"": ""Exxon Mobil to purchase shale-drilling company Pioneer Natural Resources for $59.5 billion in stock, Silk Road Medical reduces full-year revenue guidance,...""}, {""date"": ""20231011053500"", ""headline"": ""Amgen upgraded to Outperform from Market Perform at Leerink"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011054600"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Baxter International (BAX), Amgen (AMGN) and Alnylam Pharma (ALNY)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011055000"", ""headline"": ""Amgen resumed with a Neutral at BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011061100"", ""headline"": ""Axsome Therapeutics appoints Mahony to board of directors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011074800"", ""headline"": ""Amgen\u2019s cancer-drug pipeline looks promising despite FDA setback, analysts say"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011084700"", ""headline"": ""Amgen's cancer-drug pipeline looks promising despite FDA setback, analysts say "", ""summary"": ""Strong oncology, obesity, and cardiovascular drug candidates behind rating upgrade""}, {""date"": ""20231011092500"", ""headline"": ""Amgen gains as Leerink upgrades on earnings upside and catalysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011110500"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011110500"", ""headline"": ""Expert Ratings for Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011113940"", ""headline"": ""Amgen's Acquisition Of Horizon Means The Stock Is A Buy"", ""summary"": ""Amgen strengthens its inflammation portfolio and expands globally with the $27.8 billion acquisition of Horizon. Find out if AMGN stock is a buy.""}, {""date"": ""20231011124000"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231011133738"", ""headline"": ""Amgen upgraded, Texas Instruments downgraded: Wall Street's top analyst calls"", ""summary"": ""Today's top research calls for upgrade, downgrade and initiate on stocks, as compiled by The Fly.""}, {""date"": ""20231011163800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 4.55% to $283.60 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231011170656"", ""headline"": ""Markets Rise at Midday as Bond Yields Fall Ahead of Fed Meeting Minutes"", ""summary"": ""U.S. equites rose at midday on Wednesday, Oct. 11, 2023, as bond yields extended their decline and ahead of the release of minutes from the latest Fed meeting.""}, {""date"": ""20231011172700"", ""headline"": ""Exxon\u2019s Deal for Pioneer Is No Big Payday for Arbitragers"", ""summary"": ""The arbitrage spread appears to be about 2.5% in the transaction but pros say they can enhance the return with dividends""}, {""date"": ""20231011195252"", ""headline"": ""Dow Jones Rises After Fed Minutes As House Vote On New Speaker Looms; Meta Breaks Out"", ""summary"": ""Dow Jones rose after the Fed meeting minutes for September were released and the House planned to vote on a new speaker. Meta broke out.""}, {""date"": ""20231011200856"", ""headline"": ""Amgen Stock Surges To 10-Month High, Up 5% On An Unexpected Upgrade"", ""summary"": ""Amgen stock snagged an upgrade Wednesday and surged to a 10-month high as one analyst examined the biotech behemoth's post-Horizon future.""}, {""date"": ""20231011202756"", ""headline"": ""Plug Power, ChargePoint, Amgen: Top Stocks"", ""summary"": ""Plug Power (PLUG) shares close Wednesday higher after raising its forward revenue outlook through 2027. EV infrastructure company ChargePoint's (CHPT) stock tumbles while raising $232 million in its path to profitability. Lastly, Leerink Partners upgrade Amgen (AMGN) to \""Outperform.\"" Yahoo Finance's Julie Hyman and Josh Lipton monitor several of the day's top trending stocks in the after-hours trading session. For more expert insight and the latest market action,\u00a0click here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231011203303"", ""headline"": ""B of A Securities Reiterates AMGEN (AMGN) Neutral Recommendation"", ""summary"": """"}, {""date"": ""20231011203303"", ""headline"": ""Leerink Partners Upgrades AMGEN (AMGN)"", ""summary"": """"}, {""date"": ""20231012052700"", ""headline"": ""Amgen price target raised to $320 from $265 at Wells Fargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012080000"", ""headline"": ""Better Passive Income Snowball: SCHD Or DIVO?"", ""summary"": ""We compare two potential core ETFs for building a passive income snowball. Click here to learn which one is a better fit for the investing strategy.""}, {""date"": ""20231012083200"", ""headline"": ""Jefferies 'optimistic' about Amgen PRMT5 data following embargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012095000"", ""headline"": ""Here\u2019s Why Amgen (AMGN) Outperformed in Q3"", ""summary"": ""Aristotle Capital Management, LLC, an investment management company, released its \u201cValue Equity Strategy\u201d third quarter 2023 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund returned \u20102.99% gross of fees (\u20103.05% net of fees), outperforming the Russell 1000 Value Index\u2019s \u20103.16% return and the S&P 500 Index\u2019s \u20103.27% return. [\u2026]""}, {""date"": ""20231012103200"", ""headline"": ""Stocks to watch out in the Health Care sector as earnings close in"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012103600"", ""headline"": ""Interesting AMGN Put And Call Options For December 1st"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012104900"", ""headline"": ""Stocks to watch in the Health Care sector as earnings close in"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012110300"", ""headline"": ""Check Out What Whales Are Doing With AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231012130000"", ""headline"": ""Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032"", ""summary"": ""PALM BEACH, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- FinancialNewsMedia.com News Commentary - Significant influences driving the CAR T-cell therapy market is a rising demand for model therapeutics for treatment of cancer, increase in prevalence of cancer and an escalating awareness of CAR T-cell therapy medicines. The CAR T-cell therapy market is currently going through a rapid expansion, owing to rapidly expanding clinical trial activities and recent commercialization of CAR-T cell therapy, whic""}, {""date"": ""20231012134000"", ""headline"": ""Amgen: Is There More Upside to Come?"", ""summary"": ""Shares of the biopharmaceutical firm Amgen have been climbing higher. Let's check and see if there is more upside to come.    In this daily bar chart of Amgen, below, I can see that prices have charged higher from a low in early June.""}, {""date"": ""20231012155500"", ""headline"": ""Amgen's (AMGN) Stock Rallies Almost 5% on Broker Upgrade"", ""summary"": ""A Leerink Partner analyst expects accelerating pipeline news flow for Amgen (AMGN).""}, {""date"": ""20231012163800"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.51% higher to $285.04 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20231012215020"", ""headline"": ""(AMGN) Rises As Market Takes a Dip: Key Facts"", ""summary"": ""In the closing of the recent trading day, Amgen (AMGN) stood at $285.04, denoting a +0.51% change from the preceding trading day.""}, {""date"": ""20231013020600"", ""headline"": ""AMGN Crosses Above 3% Yield Territory"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013074535"", ""headline"": ""Jefferies Reiterates AMGEN (AMGN) Buy Recommendation"", ""summary"": """"}, {""date"": ""20231013090100"", ""headline"": ""Amgen's PRMT5 drug shows 5 partial respons from 31 patients, STATnews reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013090300"", ""headline"": ""Amgen's PRMT5 drug shows 5 partial responses from 31 patients, STATnews reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013092500"", ""headline"": ""Is Amgen Stock a Buy Now?"", ""summary"": ""The U.S. Federal Trade Commission (FTC) allowed Amgen's (NASDAQ: AMGN) purchase of Horizon Therapeutics to go through last month and the company announced the closing of the deal in a press release last week.  Now that the deal is complete investors can expect some enhanced growth potential on the horizon for Amgen.  The acquisition of Horizon Therapeutics gives Amgen access to an incredibly promising drug called Tepezza, which patients use for thyroid eye disease.""}, {""date"": ""20231013100000"", ""headline"": ""Sanofi reaps rewards of immunology investment with eczema results"", ""summary"": ""Pharmaceutical giant set to take on Amgen with atopic dermatitis treatment.""}, {""date"": ""20231013100300"", ""headline"": ""Ideaya has positive read from Amgen PRMT5 data, says Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013102400"", ""headline"": ""Tango Therapeutics stock plunges amid data release for Amgen PRMT5 drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013104100"", ""headline"": ""Tango Therapeutics stock plunges amid Amgen PRMT5 drug data (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013123000"", ""headline"": ""Is This Dividend Stock a Screaming Buy After Its Latest Acquisition?"", ""summary"": ""Large companies often turn to acquisitions to jump-start revenue and earnings growth or to speed up research and development, among other reasons.  With that said, let's look at the case of biotech giant Amgen (NASDAQ: AMGN), which just closed a blockbuster acquisition of Horizon Therapeutics.  What does Horizon Therapeutics bring?""}, {""date"": ""20231013125400"", ""headline"": ""Stifel disagrees with negative reaction in Ideaya shares after Amgen data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231013140000"", ""headline"": ""Amgen: Horizon's Pipeline May Be Too Expensive"", ""summary"": ""We believe that Amgen overpaid for Horizon's pipeline, since most of its upside potential is attributed to price increases instead of the expanding TAM. Read more here.""}, {""date"": ""20231013163800"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Amgen Inc. sank 0.33% to $284.10 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20231014080600"", ""headline"": ""Johnson & Johnson Stock: Is Now the Time to Sell?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3207, ""bookValue"": 7656, ""cashRatio"": 2.0491329479768785, ""currentRatio"": 2.8593, ""ebitPerShare"": 3.8848, ""eps"": 3.2156, ""ev"": 168202.84, ""fcfMargin"": 0.3639, ""fcfPerShareTTM"": 17.5308, ""grossMargin"": 0.7385, ""inventoryTurnoverTTM"": 1.4407, ""longtermDebtTotalAsset"": 0.6521, ""longtermDebtTotalCapital"": 0.8667, ""longtermDebtTotalEquity"": 7.7116, ""netDebtToTotalCapital"": 0.3776, ""netDebtToTotalEquity"": 3.3604, ""netMargin"": 0.2506, ""operatingMargin"": 0.3028, ""payoutRatioTTM"": 0.589, ""pb"": 18.6097, ""peTTM"": 18.8311, ""pfcfTTM"": 15.1909, ""pretaxMargin"": 0.2821, ""psTTM"": 5.3097, ""quickRatio"": 2.5629, ""receivablesTurnoverTTM"": 4.6784, ""roaTTM"": 0.0904, ""roeTTM"": 1.2908, ""roicTTM"": 0.123, ""rotcTTM"": 0.147, ""salesPerShare"": 12.8309, ""sgaToSale"": 0.2615, ""totalDebtToEquity"": 7.8981, ""totalDebtToTotalAsset"": 0.6679, ""totalDebtToTotalCapital"": 0.8876, ""totalRatio"": 1.0924, ""period"": ""2023-09-30""}"
19,2023-10-15,281.8836364746094,2023-10-22,276.6348876953125,-0.018620267727990858,D2,"[{""date"": ""20231016033800"", ""headline"": ""Amgen resumed with an Equal Weight at Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016040700"", ""headline"": ""Amgen\u2019s Future: Evaluating Growth, Pipeline Progress and Risks Post-Horizon Acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016061200"", ""headline"": ""Xeris Biopharma  tightens FY23 revenue view to $155M-$165M from $145M-$165M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016104428"", ""headline"": ""AbbVie: Successfully Navigating Humira's Patent Cliff With 4% Yield And 270% DGR Since 2014"", ""summary"": ""Despite declining Humira sales, AbbVie remains resilient, focusing on new therapies, M&A, and R&D for sustained growth. Find out why ABBV stock is a Hold.""}, {""date"": ""20231016110200"", ""headline"": ""$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231016130000"", ""headline"": ""AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the presentation of new data across its broad oncology portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress 2023, taking place from October 20-24 in Madrid. Results from Amgen-sponsored and collaborative studies, including two late-breaking oral presentations, will feature data in a range of tough-to-treat cancers.""}, {""date"": ""20231016130005"", ""headline"": ""Why Investors Need to Take Advantage of These 2 Medical Stocks Now"", ""summary"": ""The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.""}, {""date"": ""20231016161010"", ""headline"": ""Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?"", ""summary"": ""Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.""}, {""date"": ""20231016163700"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.98% higher to $286.88 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20231016192500"", ""headline"": ""Investors Shun Dividend-Paying Stocks"", ""summary"": ""One aspect of the equity market advance this year is investors' heightened focus on a handful of stocks some are referring to as Magnificent Seven. Read more here.""}, {""date"": ""20231017023700"", ""headline"": ""Amgen Unusual Options Activity For October 17"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017035500"", ""headline"": ""William Blair healthcare/biotech analysts hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017081600"", ""headline"": ""Amgen price target raised to $310 from $280 at Argus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231017105527"", ""headline"": ""Morgan Stanley Reiterates AMGEN (AMGN) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""20231017130006"", ""headline"": ""Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know"", ""summary"": ""Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""20231017154011"", ""headline"": ""PBYI vs. AMGN: Which Stock Is the Better Value Option?"", ""summary"": ""PBYI vs. AMGN: Which Stock Is the Better Value Option?""}, {""date"": ""20231017203000"", ""headline"": ""Dividend Income Update September 2023"", ""summary"": ""With the start of the final quarter of 2023, it\u2019s time to take a look back at my previous month of dividend income.""}, {""date"": ""20231018005541"", ""headline"": ""Argus Research Maintains AMGEN (AMGN) Buy Recommendation"", ""summary"": """"}, {""date"": ""20231018084500"", ""headline"": ""Seagen abstract hits best case scenario, says RBC Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018123900"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231018152000"", ""headline"": ""5 Biotech Stocks Set to Outpace Q3 Earnings Estimates"", ""summary"": ""Let us look at some biotech stocks, AMGN, BIIB, GSK, PRTA and VRTX, which are poised to beat on third-quarter earnings.""}, {""date"": ""20231018163700"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slid 0.30% to $283.58 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231018215017"", ""headline"": ""Amgen (AMGN) Stock Moves -0.3%: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $283.58, moving -0.3% from the previous trading session.""}, {""date"": ""20231019060100"", ""headline"": ""Invest with Confidence: Intrinsic Value Unveiled of Amgen Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019075700"", ""headline"": ""Amgen\u2019s Growth Potential: A Comprehensive Analysis of Stock Rally, EPS Expectations, and Emerging Catalysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019101800"", ""headline"": ""Dow drops nearly 100 points on losses in shares of Merck, Amgen"", ""summary"": ""Shares of Merck and Amgen are posting losses Thursday morning, dragging the Dow Jones Industrial Average into negative territory. The Dow was most recently...""}, {""date"": ""20231019112400"", ""headline"": ""See Which Of The Latest 13F Filers Holds Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019122500"", ""headline"": ""Baron Health Care Fund Q3 2023 Shareholder Letter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231019163800"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. shed 1.05% to $280.60 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231019200000"", ""headline"": ""AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that it will host a webcasted call for the investment community at 8:00 a.m. ET on Tuesday, Oct. 24, 2023 following the presentation of new data from Amgen's innovative oncology portfolio including AMG 193 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 and data from tarlatamab, xaluritamig, and LUMAKRAS\u00ae (sotorasib) that will be presented at the European Society for Medical Oncology (ESMO) Congress 2023. David""}, {""date"": ""20231020020200"", ""headline"": ""Catalyst Watch: Tech earnings blitz, Qualcomm event and Stellantis reveals"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020030000"", ""headline"": ""Bond Prices Are Slumping Again. Consider These Dividend ETFs Instead."", ""summary"": ""Morningstar has identified four dividend funds that hold quality companies and have a proven record.""}, {""date"": ""20231020052200"", ""headline"": ""Amgen price target raised to $300 from $290 at Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020060600"", ""headline"": ""Amgen reinstated with a Neutral at JPMorgan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020070400"", ""headline"": ""Amgen presents data from global Phase 2 DeLLphi-301 study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020083700"", ""headline"": ""SolarEdge downgraded, Crocs upgraded: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020085600"", ""headline"": ""Amgen hails new tarlatamab data in small cell lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020120000"", ""headline"": ""AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced results from the global Phase 2 DeLLphi-301 study, evaluating tarlatamab, an investigational delta-like ligand 3 (DLL3) targeting BiTE\u00ae (bispecific T-cell engager) molecule, in patients with advanced stage small cell lung cancer (SCLC) who had failed two or more prior lines of treatment. The data are being presented today at 3:20 PM CEST at a Proffered Paper session as a late-breaking oral presentation (LBA92) during the European Society for Medical Oncology (""}, {""date"": ""20231020123000"", ""headline"": ""Amgen posts Phase 2 data for targeted immunotherapy in lung cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231020163700"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Amgen Inc. dropped 0.64% to $278.81 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231020184100"", ""headline"": ""Top Stock Reports for Apple, Amgen & Becton, Dickinson"", ""summary"": ""Today's Research Daily features new research reports on 12 major stocks, including Apple Inc. (AAPL), Amgen Inc. (AMGN) and Becton, Dickinson and Company (BDX).""}, {""date"": ""20231021014342"", ""headline"": ""Oppenheimer Maintains AMGEN (AMGN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20231021014342"", ""headline"": ""JP Morgan Reiterates AMGEN (AMGN) Neutral Recommendation"", ""summary"": """"}, {""date"": ""20231022031300"", ""headline"": ""Ambrx Biopharma 'the real winner in prostate' at ESMO, says Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022034500"", ""headline"": ""Amgen presents data from the global Phase 3 CodeBreaK 300 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022143000"", ""headline"": ""AMGEN PRESENTS NEW LUMAKRAS\u00ae (SOTORASIB) PLUS VECTIBIX\u00ae (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced data from the global Phase 3 CodeBreaK 300 trial evaluating two doses of LUMAKRAS\u00ae (sotorasib) (960 mg or 240 mg) in combination with Vectibix\u00ae (panitumumab). Both doses demonstrated a statistically significant superiority in progression-free survival (PFS) over the investigator's choice of therapy in patients with chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC). The results are being presented today at the Presidential Symposium 2 sessio""}]",{}
20,2023-10-22,276.6348876953125,2023-10-29,259.5294189453125,-0.06183409797841577,D5+,"[{""date"": ""20231022031300"", ""headline"": ""Ambrx Biopharma 'the real winner in prostate' at ESMO, says Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022034500"", ""headline"": ""Amgen presents data from the global Phase 3 CodeBreaK 300 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231022143000"", ""headline"": ""AMGEN PRESENTS NEW LUMAKRAS\u00ae (SOTORASIB) PLUS VECTIBIX\u00ae (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced data from the global Phase 3 CodeBreaK 300 trial evaluating two doses of LUMAKRAS\u00ae (sotorasib) (960 mg or 240 mg) in combination with Vectibix\u00ae (panitumumab). Both doses demonstrated a statistically significant superiority in progression-free survival (PFS) over the investigator's choice of therapy in patients with chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC). The results are being presented today at the Presidential Symposium 2 sessio""}, {""date"": ""20231023033200"", ""headline"": ""Looking At Amgen's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023061200"", ""headline"": ""Amgen's Lumakras shows progression-free survival improvement in trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231023083200"", ""headline"": ""AbbVie (ABBV) to Report Q3 Earnings: What's in the Cards?"", ""summary"": ""AbbVie's (ABBV) Q3 performance will likely reflect its newer immunotherapy drugs trying to compensate for declining Humira sales following the loss of U.S. exclusivity.""}, {""date"": ""20231023103200"", ""headline"": ""The Zacks Analyst Blog Highlights Apple, Amgen, Becton, Dickinson, UnitedHealth and Verisk"", ""summary"": ""Apple, Amgen, Becton, Dickinson, UnitedHealth and Verisk are included in this Analyst Blog.""}, {""date"": ""20231023163700"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 2.06% to $273.06 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231023182600"", ""headline"": ""Circling Bank On Tango Therapeutics"", ""summary"": ""We are circling back on clinical stage developmental concern Tango Therapeutics, Inc. for the first time since November 2022. Read more about TNGX stock here.""}, {""date"": ""20231024011000"", ""headline"": ""Video: Dow Movers: AMGN, VZ"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024021300"", ""headline"": ""Amgen Layoffs 2023: What to Know About the Latest AMGN Job Cuts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024030600"", ""headline"": ""Amgen declares $2.13 dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024120600"", ""headline"": ""Amgen reportedly to cut 350 Horizon employees in wake of merger"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231024125000"", ""headline"": ""Amgen to Lay Off 350 U.S. Employees of Horizon Therapeutics"", ""summary"": ""By Joseph Walker Amgen is laying off about 350 U.S. employees of Horizon Therapeutics, the drugmaker that Amgen bought in a $27.8 billion deal that closed...""}, {""date"": ""20231024130347"", ""headline"": ""Hematology/Oncology Update ESMO 2023"", ""summary"": ""The following slide deck was published by Amgen Inc.""}, {""date"": ""20231024131500"", ""headline"": ""3 Biotech Stocks With Decent Dividend for a Steady Return"", ""summary"": ""Here we pick three medical device stocks, AbbVie (ABBV), Amgen (AMGN) and Gilead Sciences (GILD), which have a solid five-year dividend growth history.""}, {""date"": ""20231024140052"", ""headline"": ""Amgen (AMGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release"", ""summary"": ""Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""20231024150259"", ""headline"": ""12 Defensive Healthcare Dividend Stocks To Invest In"", ""summary"": ""In this article, we discuss 12 defensive healthcare dividend stocks to invest in. You can skip our detailed analysis of the healthcare sector and dividend stocks, and go directly to read 5 Defensive Healthcare Dividend Stocks To Invest In. The healthcare sector has undergone significant evolution over the years, especially after the pandemic. Advances in [\u2026]""}, {""date"": ""20231024151908"", ""headline"": ""Amgen Inc. (AMGN) Amgen Conference Call Following European Society for Medical Oncology Congress 2023 Transcript"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Amgen Conference Call Following European Society for Medical Oncology Congress 2023 October 24, 2023 8:00 AM ETCompany...""}, {""date"": ""20231024163800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 1.12% to $276.12 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20231024200000"", ""headline"": ""AMGEN ANNOUNCES 2023 FOURTH QUARTER DIVIDEND"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.13 per share dividend for the fourth quarter of 2023. The dividend will be paid on December 8, 2023, to all stockholders of record as of the close of business on November 17, 2023.""}, {""date"": ""20231024215018"", ""headline"": ""Amgen (AMGN) Outperforms Broader Market: What You Need to Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $276.12, marking a +1.12% move from the previous day.""}, {""date"": ""20231025014500"", ""headline"": ""These Gene-Editing Stocks Are Survivors. Take Another Look."", ""summary"": ""The market has nearly abandoned many of the biotech start-ups it funded in the excitement of the first Covid-19 vaccines in 2021.""}, {""date"": ""20231025034800"", ""headline"": ""Amgen\u2019s Promising Oncology Pipeline Progress and Favorable Clinical Trials Fuel Analyst\u2019s Buy Rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025053600"", ""headline"": ""Amgen price target raised to $310 from $300 at Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025062100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Danaher (DHR) and Sanofi (OtherSNYNF)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025063300"", ""headline"": ""Amgen price target raised to $336 from $293 at TD Cowen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025082809"", ""headline"": ""20 Countries with Lowest Rates of Cancer"", ""summary"": ""In this article, we will be taking a look at the 20 countries with lowest rates of cancer. If you want to skip our analysis of the oncology industry, then head straight to 5 Countries with Lowest Rates of Cancer. Cancer\u2014 a disease in which some of the body\u2019s cells grow uncontrollably and spread to [\u2026]""}, {""date"": ""20231025084900"", ""headline"": ""USA Compression and Disney have been highlighted as Zacks Bull and Bear of the Day"", ""summary"": ""USA Compression and Disney have been highlighted as Zacks Bull and Bear of the Day.""}, {""date"": ""20231025110100"", ""headline"": ""Video: Daily Dividend Report: AMGN,ROL,APH,WFC,SWK"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025112600"", ""headline"": ""Amgen (AMGN) to Report Q3 Earnings: Will It Beat Estimates?"", ""summary"": ""Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.""}, {""date"": ""20231025124200"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231025140219"", ""headline"": ""UniQure (QURE) Expected to Beat Earnings Estimates: Should You Buy?"", ""summary"": ""UniQure (QURE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""20231025152040"", ""headline"": ""Oppenheimer Maintains AMGEN (AMGN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20231025163700"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slid 1.43% to $272.16 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231025200000"", ""headline"": ""AMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL RESULTS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that it will report its third quarter financial results on Tuesday, October 31, 2023, before the opening of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 5:00 a.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.""}, {""date"": ""20231026054800"", ""headline"": ""ImmunoGen 'should rank high on list' of possible M&A targets, says Guggenheim"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026110000"", ""headline"": ""A large international study of migraine reveals new biological pathways for treatment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231026113000"", ""headline"": ""3 Pharma Stocks That Are Screaming Buys in October"", ""summary"": ""It hasn't been the easiest of years for Johnson & Johnson (NYSE: JNJ), Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD).  Continued uncertainty regarding talc lawsuits is weighing on Johnson & Johnson.  Amgen's huge pipeline hasn't been fully appreciated by the market, and Gilead's settlement of an antitrust lawsuit resulted in lowering yearly earnings per share guidance.""}, {""date"": ""20231026163700"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Amgen Inc. dropped 0.90% to $269.71 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231027015600"", ""headline"": ""Amgen\u2019s Promising Oncology Pipeline: A Buy Rating Driven by T-Cell Engagers\u2019 Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027020300"", ""headline"": ""Catalyst Watch: Apple earnings, Fed policy meeting, jobs report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027024100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Immutep (IMMP) and Bristol-Myers Squibb (BMY)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027033600"", ""headline"": ""Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231027114650"", ""headline"": ""UPDATE 4-AbbVie takes $2.1 bln charge on cancer drug ahead of US price negotiation"", ""summary"": ""AbbVie, girding for government price negotiations on its big-selling cancer drug Imbruvica, on Friday disclosed a $2.1 billion charge related to an expected drop in revenue once the new price for U.S. Medicare patients goes into effect.  The Illinois-based drugmaker's leukemia pill in August was selected as one of the 10 drugs subject to the first-ever price negotiations by U.S. Medicare insurance plans with a stated government goal of saving $25 billion per year on drug costs by 2031.  While new prices for the first 10 drugs have yet to be negotiated and will not go into effect until 2026, AbbVie said it had used an undisclosed placeholder price that led it to estimate \""a significant decrease in the estimated future cash flows\"" from the drug.""}, {""date"": ""20231027115653"", ""headline"": ""Xencor: Data In Early 2024 Could Bring Shareholder Value"", ""summary"": ""Xencor is expected to release data from a phase 2 study in early 2024 targeting patients with mCRPC and gynecological cancers. Read more about XNCR stock here.""}, {""date"": ""20231027163700"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 3.02% to $261.57 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231027185250"", ""headline"": ""Apple Headlines Earnings Calendar With Chip Titan AMD, Amgen Also Set To Report"", ""summary"": ""Apple stock is below its 200-day line with earnings due. Advanced Micro Devices and Amgen also report next week.""}, {""date"": ""20231028154350"", ""headline"": ""Microsoft Leads These 5 Dow Jones Stocks Near Buy Points"", ""summary"": ""Microsoft, one of just two Magnificent Seven stocks to move higher last week, leads this watchlist of five Dow Jones stocks. near buy points.""}, {""date"": ""20231029073000"", ""headline"": ""Earnings week ahead: Apple, AMD, Pfizer, McDonald's, Starbucks and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231029103000"", ""headline"": ""2 Dow Jones Dividend Stocks to Buy Hand Over Fist Right Now"", ""summary"": ""Dividend stocks have not performed particularly well in 2023, and for good reason.  With many financial institutions offering safer alternatives, such as money market accounts and certificates of deposit, with annualized rates above 5%, there's been little reason for investors to stomach the volatility associated with equities.  Dividend stocks have a long history of outperforming most other asset classes over holding periods of 20 years or longer.""}, {""date"": ""20231029110500"", ""headline"": ""Pharma, PBMs spar over rising drug costs amid public scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
21,2023-10-29,259.5294189453125,2023-11-05,267.75469970703125,0.031693057361839916,U4,"[{""date"": ""20231029073000"", ""headline"": ""Earnings week ahead: Apple, AMD, Pfizer, McDonald's, Starbucks and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231029103000"", ""headline"": ""2 Dow Jones Dividend Stocks to Buy Hand Over Fist Right Now"", ""summary"": ""Dividend stocks have not performed particularly well in 2023, and for good reason.  With many financial institutions offering safer alternatives, such as money market accounts and certificates of deposit, with annualized rates above 5%, there's been little reason for investors to stomach the volatility associated with equities.  Dividend stocks have a long history of outperforming most other asset classes over holding periods of 20 years or longer.""}, {""date"": ""20231029110500"", ""headline"": ""Pharma, PBMs spar over rising drug costs amid public scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030024600"", ""headline"": ""Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030031300"", ""headline"": ""Amgen slated to release first earnings report since Horizon merger on Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030090400"", ""headline"": ""Earnings Outlook For Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030092541"", ""headline"": ""11 Best Immunotherapy Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 of the best immunotherapy stocks to buy now. If you want to skip our detailed discussion on the cancer and oncology industry, head directly to the 5 Best Immunotherapy Stocks To Buy Now. The global oncology landscape is continually transforming, driven by persistent efforts to explore, create, and deliver [\u2026]""}, {""date"": ""20231030094635"", ""headline"": ""11 Best Pharma Stocks To Buy Now"", ""summary"": ""In this article, we discuss the 12 best pharma stocks to buy now. You can skip our detailed analysis of the pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Pharma Stocks To Buy Now. Shortly following the onset of the COVID-19 pandemic, it became evident that the world [\u2026]""}, {""date"": ""20231030100300"", ""headline"": ""Notable earnings before Tuesday's open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030110000"", ""headline"": ""SCHD Just Fell Off A Cliff: An Inside Look"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030113927"", ""headline"": ""Schwab Dividend ETF (SCHD) Just Fell Off A Cliff: An Inside Look"", ""summary"": ""SCHD ETF faced a drop in value due to selling pressure in top holdings. Look for the trend to reverse over time due to the high quality nature of the holdings.""}, {""date"": ""20231030122600"", ""headline"": ""Notable companies reporting before tomorrow's open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231030153700"", ""headline"": ""Drug, Biotech Stocks' Q3 Earnings Due on Oct 31: AMGN, PFE, INCY"", ""summary"": ""Let's take a look at three biotech/drug companies, AMGN, PFE and INCY, slated to release quarterly results on Oct 31.""}, {""date"": ""20231030163800"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.62% higher to $263.19 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20231031011600"", ""headline"": ""Noteworthy Tuesday Option Activity: AMGN, CE, REGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031034000"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031044100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Qiagen (QGEN) and HCA Healthcare (HCA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031060100"", ""headline"": ""Amgen reports Q3 adjusted EPS $4.96, consensus $4.39"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031060300"", ""headline"": ""Amgen narrows FY23 adjusted EPS view to $18.20-$18.80 from $17.80-$18.80"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031061100"", ""headline"": ""Amgen sees FY23 CapEx about $950M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031062000"", ""headline"": ""Amgen\u2019s stock jumps premarket after earnings beat and company again raises guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031062500"", ""headline"": ""Amgen reports Q3 total product sales up 5% y/y"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031064100"", ""headline"": ""Amgen Non-GAAP EPS of $4.96 beats by $0.28, revenue of $6.9B misses by $50M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031064700"", ""headline"": ""U.S. Stocks Poised To Extend Gains As Fed Meeting Gets Underway; Why This Analyst Expects 'Young Bull Market' To Remain Alive"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031065800"", ""headline"": ""Amgen stock gains after lifting annual outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031070000"", ""headline"": ""Amgen 3Q Profit Sinks On Discontinued Development Charge"", ""summary"": ""By Ben Glickman Amgen's third-quarter profit sank on an impairment charge related to discontinued development of one of its drug candidates. The Thousand...""}, {""date"": ""20231031070200"", ""headline"": ""Charlie Munger says there\u2019s not much \u2018low-hanging fruit left\u2019 as he discusses Apple, Costco vs. Walmart, and EVs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031070800"", ""headline"": ""Amgen Lifts FY23 Guidance After 3Q Adjusted Profit Tops Estimates"", ""summary"": ""By Ben Glickman Amgen narrowed its full-year guidance for adjusted profit and raised its revenue guidance after third-quarter adjusted profit topped Wall...""}, {""date"": ""20231031071700"", ""headline"": ""Amgen: Q3 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031071900"", ""headline"": ""Amgen's stock hit by expectations its obesity pipeline is facing a longer wait"", ""summary"": ""Amgen Inc.'s stock fell 3.3% Tuesday despite an earnings beat and raised guidance. Obesity drugs were to blame.""}, {""date"": ""20231031073700"", ""headline"": ""Amgen\u2019s Stock Rated as Buy: Promising Earnings, HZNP Acquisition Impact, and Product Pipeline Strengths"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031075000"", ""headline"": ""Amgen in charts: Sales of Prolia, XGEVA surge on higher prices; Enbrel, Otezla fall Y/Y"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031075000"", ""headline"": ""5 stocks to watch on Tuesday: Sarepta Therapeutics, Pfizer, AMD and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031080400"", ""headline"": ""Amgen Boosts Revenue Guidance, but the Stock Is Falling"", ""summary"": ""The biotechnology company beat third-quarter adjusted earnings estimates but fell a bit short on sales.""}, {""date"": ""20231031081700"", ""headline"": ""Amgen (NASDAQ:AMGN) Delivers Better-than-Expected Q3 Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031082900"", ""headline"": ""Amgen ups annual revenue guidance despite quarterly income dip"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031085800"", ""headline"": ""Amgen stock erases gains despite outlook boost (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031093100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), AbbVie (ABBV) and Crispr Therapeutics AG (CRSP)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031094500"", ""headline"": ""Dow drops 85 points on losses for Caterpillar, Amgen shares"", ""summary"": ""Behind negative returns for shares of Caterpillar and Amgen, the Dow Jones Industrial Average is falling Tuesday morning. The Dow was most recently trading...""}, {""date"": ""20231031102600"", ""headline"": ""Amgen says study of AMG 340 in mCRPC will be discontinued"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031110000"", ""headline"": ""AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 20231.""}, {""date"": ""20231031110500"", ""headline"": ""Treasury Announcement More Important Than Fed's, Japan Abandons Yield Control, Tesla Under $200"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031111017"", ""headline"": ""Amgen third-quarter sales rise 5%; profit up before charge"", ""summary"": ""Amgen, which earlier this month acquired Horizon Therapeutics for $27.8 billion, on Tuesday said its third-quarter product sales rose 5% as double-digit volume growth was offset by lower prices.  Amgen said it would discuss sales of Horizon's drugs on a conference call with analysts and investors, but raised its post-acquisition forecast for full-year sales to between $28 billion and $28.4 billion from a previous estimate of $26.6 billion to $27.4 billion.  Wall Street analysts, on average, have forecast 2023 earnings of $18.47 per share on revenue of $28 billion, according to LSEG data.""}, {""date"": ""20231031115841"", ""headline"": ""UPDATE 1-Amgen third-quarter sales rise 5%; profit up before charge"", ""summary"": ""Amgen, which earlier this month acquired Horizon Therapeutics for $27.8 billion, on Tuesday said its third-quarter product sales rose 5% as double-digit volume growth was offset by lower prices.  Amgen said it would discuss sales of Horizon's drugs on a conference call with analysts and investors, but raised its post-acquisition forecast for full-year sales to between $28 billion and $28.4 billion from a previous estimate of $26.6 billion to $27.4 billion.  Wall Street analysts, on average, have forecast 2023 earnings of $18.47 per share on revenue of $28 billion, according to LSEG data.""}, {""date"": ""20231031120000"", ""headline"": ""Amgen\u2019s stock hit by expectations its obesity pipeline is facing a longer wait"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031120400"", ""headline"": ""Amgen Boosts Revenue Guidance. But the Stock Trades Lower."", ""summary"": ""The biotechnology company beat third-quarter adjusted earnings estimates but fell a bit short on sales.""}, {""date"": ""20231031121500"", ""headline"": ""Stocks Lack Direction As Traders Remain Cautious Ahead Of Fed Meeting, Nvidia Falls On Export Controls: What's Driving Markets Tuesday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031122506"", ""headline"": ""Amgen (AMGN) Q3 Earnings Top Estimates"", ""summary"": ""Amgen (AMGN) delivered earnings and revenue surprises of 6.67% and 0.80%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""20231031123254"", ""headline"": ""Amgen Inc (AMGN) Q3 2023 Earnings: Revenue Up 4% to $6.9 Billion, GAAP EPS Down 19% to $3.22"", ""summary"": ""Amgen Inc (AMGN) reports Q3 2023 financial results, highlighting growth in product sales and pipeline progress""}, {""date"": ""20231031123800"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031131504"", ""headline"": ""Amgen Inc. (AMGN) Q3 2023 Earnings Call Transcript"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Q3 2023 Earnings Conference Call October 31, 2023 8:00 AM ETCompany ParticipantsJustin Claeys - VP, IRRobert Bradway -...""}, {""date"": ""20231031131616"", ""headline"": ""Amgen Inc. 2023 Q3 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Amgen Inc.""}, {""date"": ""20231031133028"", ""headline"": ""Here's What Key Metrics Tell Us About Amgen (AMGN) Q3 Earnings"", ""summary"": ""Although the revenue and EPS for Amgen (AMGN) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.""}, {""date"": ""20231031153000"", ""headline"": ""Amgen (AMGN) Beats on Q3 Earnings Beat, Lags Sales, Ups View"", ""summary"": ""Amgen (AMGN) beats Q3 estimates for earnings but misses on sales. Following the acquisition of Horizon Therapeutics, it raises earnings and sales guidance for 2023.""}, {""date"": ""20231031161800"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks up with Fed likely to extend rate pause"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231031163500"", ""headline"": ""Never Mind Covid, Investors Want a Pfizer Obesity Pill"", ""summary"": ""It is little wonder, then, that investors were hoping Pfizer could jump to the winning camp with an obesity pill.  \u201cNot one mention [of danuglipron] in the prepared remarks from Pfizer,\u201d noted  Will Sevush,  a healthcare strategist for Jefferies.  Before today\u2019s earnings,  David Risinger,  a Leerink Partners analyst, had written that Pfizer might even release data from its mid-stage study alongside the earnings results as soon as Tuesday.""}, {""date"": ""20231031163800"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 2.85% to $255.70 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231031165601"", ""headline"": ""Amgen's obesity drug plans, outlook for 2024"", ""summary"": ""Amgen (AMGN) reported third-quarter earnings that beat expectations and raised its full-year revenue guidance. The company recently completed its acquisition of Horizon Therapeutics, which brings its drug Tepezza to Amgen. Amgen is also looking to move into the obesity drug space which has garnered much attention from Wall Street. Yahoo Finance Senior Reporter Anjalee Khemlani interviewed Amgen CFO Peter Griffith to get his take on the company's performance. When it comes to the obesity space, Griffith says, \""what I am delighted to announce is that we've completed enrollment in Maridebart Cafraglutide, or we call it 'Mari', formerly AMG 133, for the treatment of obesity, in phase 2. We've got over 570 patients in the cohort, with and without diabetes, and so that's the center of the platform that we want to build on with obesity.\"" For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231031170000"", ""headline"": ""GSK Reports Earnings Wednesday. Here\u2019s What to Expect."", ""summary"": ""The company will for the first time report sales of Arexvy, its new RSV vaccine that launched this fall.""}, {""date"": ""20231031171851"", ""headline"": ""Markets Edge Higher at Midday Ahead of Wednesday's Fed Decision"", ""summary"": ""U.S. equities edged higher at midday on Tuesday, Oct. 31, 2023 ahead of Wednesday's decision by the Federal Reserve, with policymakers widely expected to keep interest rates steady.""}, {""date"": ""20231031173628"", ""headline"": ""Amgen Tumbles After Scrapping A $900 Million Prostate Cancer Drug"", ""summary"": ""Amgen handily beat earnings forecasts Tuesday, but Amgen stock tumbled after the company scrapped an experimental prostate cancer treatment.""}, {""date"": ""20231031190500"", ""headline"": ""Amgen gets FDA approval for its inflammatory diseases treatment Wezlana"", ""summary"": ""Amgen has received approval from the U.S. Food and Drug Administration for Wezlana, its treatment for multiple inflammatory diseases.""}, {""date"": ""20231031210020"", ""headline"": ""S&P 500 Gains and Losses Today: Arista Networks Results and Guidance Beat Estimates"", ""summary"": ""The S&P 500 gained 0.65% on Tuesday, Oct. 31, 2023, ahead of Wednesday's Federal Reserve decision, more key earnings news, and Friday's jobs report.""}, {""date"": ""20231101011300"", ""headline"": ""Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101012200"", ""headline"": ""These Analysts Revise Their Forecasts On Amgen After Q3 Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101041237"", ""headline"": ""Q3 2023 Amgen Inc Earnings Call"", ""summary"": ""Q3 2023 Amgen Inc Earnings Call""}, {""date"": ""20231101053900"", ""headline"": ""Amgen cleared in U.S. to market biosimilar to J&J\u2019s Stelara"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101054100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Biogen (BIIB) and Vertex Pharmaceuticals (VRTX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101060000"", ""headline"": ""Amgen price target lowered to $268 from $272 at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101060200"", ""headline"": ""Beyond Market Price: Uncovering Amgen Inc's Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101062700"", ""headline"": ""Hold Rating on Amgen: Balancing Expectations with Underperformance and Future Prospects"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101075900"", ""headline"": ""GLOBAL BROKER RATINGS: JPMorgan cuts BP to 'underweight'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101083700"", ""headline"": ""Positive Prospects for Amgen: A Comprehensive Analysis of Q3 Performance and Future Catalysts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231101120500"", ""headline"": ""Company News for Nov 01, 2023"", ""summary"": ""Companies In The Article Are: AMGN, NVDA, RGEN, COCO""}, {""date"": ""20231101130000"", ""headline"": ""AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the presentation of new scientific and clinical research across its expanded rheumatology pipeline and portfolio, following the recent acquisition of Horizon Therapeutics. More than 20 abstracts will be presented during the American College of Rheumatology (ACR) Convergence 2023, taking place Nov. 10-15, in San Diego.""}, {""date"": ""20231101143148"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Q3 2023 Earnings Call Transcript"", ""summary"": ""Amgen Inc. (NASDAQ:AMGN) Q3 2023 Earnings Call Transcript October 31, 2023 Operator: My name is Julianne, and I\u2019ll be your conference facilitator today for Amgen\u2019s Third Quarter 2023 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the conclusion of the [\u2026]""}, {""date"": ""20231101170000"", ""headline"": ""Novo Nordisk Reports Earnings Soon. Wegovy and Ozempic Will Be in Focus."", ""summary"": ""The report comes amid what has been a surprisingly grim two weeks for the pharmaceutical stocks.""}, {""date"": ""20231102012100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102020300"", ""headline"": ""Amgen Wins Big With FDA, Analyst Sees Soaring Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102040900"", ""headline"": ""What You Missed On Wall Street On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102050600"", ""headline"": ""Amgen upgraded to Buy from Hold at Truist"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102050808"", ""headline"": ""The Amgen Inc (AMGN) Company: A Short SWOT Analysis"", ""summary"": ""Unveiling the Strengths and Challenges: A Deep Dive into Amgen Inc (AMGN) SWOT Analysis""}, {""date"": ""20231102051700"", ""headline"": ""Amgen upgraded to Buy on pipeline execution at Truist"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102055948"", ""headline"": ""Amazon headed for rosy period, says HSBC; Roku flying: 6 big analyst picks"", ""summary"": ""Truist upgraded Amgen (NASDAQ:AMGN) to Buy from Hold with a price target of $320.00 (from $260.00), citing the biotech's commercial execution and \""ability to grow mid-cycle assets\"" to achieve record sales, \""despite underwhelming initial launches.\""""}, {""date"": ""20231102072500"", ""headline"": ""Amgen presents new data on KRYSTEXXA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102085700"", ""headline"": ""Roku upgraded, Amazon initiated: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102093100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), IQVIA Holdings (IQV) and Argenx Se (ARGX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102094500"", ""headline"": ""Dow up 200 points on gains in Amgen, Walgreens Boots shares"", ""summary"": ""Buoyed by strong returns for shares of Amgen and Walgreens Boots, the Dow Jones Industrial Average is up Thursday morning. The Dow is trading 200 points...""}, {""date"": ""20231102110000"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102120000"", ""headline"": ""AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA\u00ae (PEGLOTICASE)"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced new data for KRYSTEXXA\u00ae (pegloticase) showing a decrease in blood pressure during treatment of adults living with chronic gout refractory to oral urate-lowering treatment \u2212 uncontrolled gout \u2212 both with and without chronic kidney disease (CKD). The data will be presented at the American Society of Nephrology Kidney Week, taking place Nov. 2-5, in Philadelphia.""}, {""date"": ""20231102122100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Beam Therapeutics (BEAM) and Argenx Se (ARGX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102123200"", ""headline"": ""Concerns Over Amgen\u2019s Performance and Future Prospects: An In-Depth Sell Rating Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102123200"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Eli Lilly & Co (LLY) and Repligen (RGEN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231102131835"", ""headline"": ""Truist Securities Upgrades AMGEN (AMGN)"", ""summary"": """"}, {""date"": ""20231103031600"", ""headline"": ""Morgan Stanley Sticks to Its Hold Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231103163800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. rallied 1.23% to $269.86 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}]",{}
22,2023-11-05,267.75469970703125,2023-11-12,265.224609375,-0.009449284493604049,D1,"[{""date"": ""20231106030200"", ""headline"": ""The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman \u2013 and Martin Shkreli"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231106140006"", ""headline"": ""Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""20231106160000"", ""headline"": ""Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition"", ""summary"": ""A comprehensive new study from deCODE genetics, a subsidiary of Amgen, published today in Nature Genetics, provides insights into the epidemiology and somatic and germline genetics of clonal hematopoiesis. Whole genome sequence data from Iceland and the UK Biobank, combined with a unique somatic mutation Barcoding strategy, was used to investigate clonal hematopoiesis at the population scale.""}, {""date"": ""20231106162812"", ""headline"": ""November Dogs Of The Dow: 3 Buyable, 4 Watchable"", ""summary"": ""Learn about the Dow Jones Industrial Average and the top-performing stocks in November. Click to see our exclusive list of dividend stocks we consider buyable now.""}, {""date"": ""20231106163800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. rallied 1.10% to $272.83 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231107030400"", ""headline"": ""Amgen reports data from Phase 2 study evaluating dazodalibep"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231107105300"", ""headline"": ""See How Amgen Ranks Among Analysts' Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231107105500"", ""headline"": ""Video: Dow Analyst Moves: AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231107132823"", ""headline"": ""High Yield Stock Watchlist - November 2023"", ""summary"": ""The majority of the 22 stocks on my high yield watchlist for November 2023 are undervalued based on dividend yield theory. Click here for the complete list.""}, {""date"": ""20231107145008"", ""headline"": ""Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio"", ""summary"": ""Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.""}, {""date"": ""20231107163800"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.63% to $271.11 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231107210000"", ""headline"": ""AMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN SJ\u00d6GREN'S SYNDROME AT ACR 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced new data from its Phase 2 study evaluating dazodalibep, an investigational medicine, for the treatment of Sj\u00f6gren's. These results will be featured in presentations at the American College of Rheumatology (ACR) Convergence 2023, Nov. 10-15, in San Diego. Findings from the study demonstrate that dazodalibep may improve both the systemic and symptomatic disease burden of two different patient populations.""}, {""date"": ""20231107210500"", ""headline"": ""AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced results from the global Phase 4 FOREMOST study evaluating Otezla\u00ae (apremilast) in patients with early oligoarticular psoriatic arthritis. FOREMOST is the first placebo-controlled study designed to specifically assess people with oligoarticular psoriatic arthritis with early disease duration of five or fewer years. Results will be presented at the American College of Rheumatology (ACR) Convergence 2023, Nov. 10-15 in San Diego.""}, {""date"": ""20231108032600"", ""headline"": ""Amgen initiated with a Hold at Deutsche Bank"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108104700"", ""headline"": ""Amgen's Rare Autoimmune Disease Candidate Shows Improvement In Disease Burden In Treating Sj\u00f6gren's Syndrome"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108125700"", ""headline"": ""CytomX Therapeutics price target raised to $3 from $2 at Wedbush"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108160100"", ""headline"": ""Ligand Reports Third Quarter 2023 Financial Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231108163800"", ""headline"": ""Amgen Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.79% higher to $273.26 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...""}, {""date"": ""20231109010900"", ""headline"": ""Sen. Elizabeth Warren tells FTC she remains concerned about Amgen's Horizon deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109065700"", ""headline"": ""GLOBAL BROKER RATINGS: Wells Fargo raises Adyen; HSBC likes AB InBev"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109084940"", ""headline"": ""Top 20 Drug Companies in the US by Revenue"", ""summary"": ""In this article, we will be taking a look at the top 20 drug companies in the US by revenue. To skip our detailed analysis, you can go directly to see the Top 5 Drug Companies in the US by Revenue. Following the Covid-19 pandemic, which drastically altered the way of living, the top pharmaceutical [\u2026]""}, {""date"": ""20231109122200"", ""headline"": ""Eli Lilly declines a day after FDA nod for weight loss therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109125200"", ""headline"": ""Fortunes Can Be Made With Bristol-Myers Squibb"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231109130000"", ""headline"": ""US Senator Elizabeth Warren expresses 'disappointment' in FTC's Amgen decision"", ""summary"": ""Senator Elizabeth Warren, an antitrust hawk, expressed disappointment with the U.S. Federal Trade Commission's decision to allow pharmaceutical firm Amgen to move forward with its acquisition of Horizon Therapeutics.  Warren, a Democrat, has staunchly supported the FTC and Justice Department's tougher stance on mergers under President Joe Biden.  In a rare break with the Biden administration's antitrust enforcers, she urged them to get even tougher.""}, {""date"": ""20231109130800"", ""headline"": ""Amgen, Home Depot share losses contribute to Dow's 150-point drop"", ""summary"": ""Shares of Amgen and Home Depot are trading lower Thursday afternoon, sending the Dow Jones Industrial Average into negative territory. The Dow was most...""}, {""date"": ""20231109133606"", ""headline"": ""Deutsche Bank Initiates Coverage of AMGEN (AMGN) with Hold Recommendation"", ""summary"": """"}, {""date"": ""20231109144200"", ""headline"": ""Dow's nearly 250-point fall led by losses in shares of Amgen, Home Depot"", ""summary"": ""Shares of Amgen and Home Depot are posting losses Thursday afternoon, sending the Dow Jones Industrial Average into negative territory. Shares of Amgen and...""}, {""date"": ""20231109163800"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. shed 3.37% to $264.06 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231110065300"", ""headline"": ""Mirati lung cancer therapy endorsed in EU"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231110123800"", ""headline"": ""12 Dogs of the Dow Dividend Stocks to Buy"", ""summary"": ""In this article, we discuss 12 Dogs of the Dow dividend stocks to buy. You can skip our detailed analysis of the dogs of the Dow strategy and its returns over the years, and go directly to read 5 Dogs of the Dow Dividend Stocks to Buy. Many investors who prioritize dividends find dividend yields [\u2026]""}, {""date"": ""20231110140000"", ""headline"": ""AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced new data reinforcing the safety and efficacy of Repatha\u00ae (evolocumab) from the FOURIER Open Label Extension (OLE) [FOURIER-OLE] trial at the American Heart Association (AHA) Scientific Sessions 2023 in Philadelphia. These presentations will focus on the reduction of a known cardiovascular disease (CVD) risk factor, LDL \""bad\"" cholesterol (LDL-C). Amgen will also present new research from the Phase 2 OCEAN(a)-DOSE study of its investigational small interfering R""}, {""date"": ""20231110151500"", ""headline"": ""2 Top Biotech Stocks to Buy Right Now"", ""summary"": ""It's been a rough year for the biotech industry, which as a whole has substantially lagged the broader market.  Two worth a closer look today are Amgen (NASDAQ: AMGN) and Moderna (NASDAQ: MRNA) whose prospects really don't look as bad as their year-to-date performances suggest.  At current levels, both Amgen and Moderna are worth investing in now.""}, {""date"": ""20231110163800"", ""headline"": ""Amgen Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. rose 1.23% to $267.31 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231111090000"", ""headline"": ""Why You Should Aim For $2 Million For Retirement"", ""summary"": ""Retirement goals should be set based on individual situations and factors like your pre-retirement earnings. Explore more details here.""}, {""date"": ""20231111120535"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Looks Like A Good Stock, And It's Going Ex-Dividend Soon"", ""summary"": ""Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Amgen Inc...""}, {""date"": ""20231111194055"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of November 12"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the November 12 weekly update.""}, {""date"": ""20231111221424"", ""headline"": ""3.2%-Yielding Amgen's Realistic Path To >11% Annual Returns"", ""summary"": ""Amgen completes acquisition of Horizon Therapeutics, boosting long-term growth potential. Read why we have a buy rating on AMGN stock.""}, {""date"": ""20231112110500"", ""headline"": ""Eli Lilly expected to add $4.1B U.S. sales from new weight loss drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
23,2023-11-12,265.224609375,2023-11-19,265.3900146484375,0.0006236422548695497,U1,"[{""date"": ""20231112110500"", ""headline"": ""Eli Lilly expected to add $4.1B U.S. sales from new weight loss drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231113040400"", ""headline"": ""PRIMECAP Management Adjusts Portfolio, Notably Trims Eli Lilly Stake"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231113041955"", ""headline"": ""OUSA: Attractive Quality, Average Performance"", ""summary"": ""OUSA ETF holds 100 dividend stocks selected and weighted based on profitability, dividend quality, leverage and volatility. Read why I'm neutral on the fund.""}, {""date"": ""20231113163800"", ""headline"": ""Amgen Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 0.23% to $266.69 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20231113180601"", ""headline"": ""6 intriguing stocks investors should consider: Piper Sandler"", ""summary"": ""The market has slightly rebounded, with some investors excited for a possible Santa Claus rally to close out the year. Piper Sandler's technical research team announced six stocks that are currently looking attractive for investor portfolios: Amazon (AMZN), Amgen Inc. (AMGN), Coterra Energy (CTRA), Lululemon (LULU), Assurant (AIZ), and Palo Alto Networks (PANW). Jason Glazer, Piper Sandler & Co. Managing Director and Head of Product Management, joins Yahoo Finance to break down the company's picks, how they arrived there, and give insight into the chosen stocks. \""[Lululemon] stands out because it has both high earnings growth and earnings expectations and if you go into the business they have pretty high margins with about 45% of sales coming from company-owned sales and 45% of sales coming through the e-commerce channel,\"" Glazer explains. \""They're tremendous at product innovation, they keep full-price selling, unlike a lot of the discounting you see in the retail industry, and they also have some tremendous growth opportunities in China.\"" For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""20231113192229"", ""headline"": ""13 Dividend Giants with Lowest Short Interest"", ""summary"": ""In this article, we discuss 13 dividend giants with the lowest short interest. You can skip our detailed analysis of dividend stocks and their previous performance, and go directly to read 5 Dividend Giants with Lowest Short Interest. While the financial world is typically viewed as serious and analytical, the art of short selling adds [\u2026]""}, {""date"": ""20231114000505"", ""headline"": ""13 Cheap Blue Chip Stocks To Buy"", ""summary"": ""In this piece, we will take a look at the 13 cheap blue chip stocks to buy. To skip our overview of the blue chip sector and the latest news about the stock market, take a look at the 5 Cheap Blue Chip Stocks To Buy. Within the American stock market, the Dow Jones Industrial [\u2026]""}, {""date"": ""20231114064650"", ""headline"": ""Amgen Is Still A Hold, But Should Be On Your Watchlist"", ""summary"": ""Amgen is a resilient healthcare company that tends to perform well in challenging business environments. See why I think AMGN stock is still a hold.""}, {""date"": ""20231114092100"", ""headline"": ""Ex-Dividend Reminder: Amgen, Royalty Pharma and Phillips Edison"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114113100"", ""headline"": ""Eli Lilly (NYSE:LLY) Slips despite Good News on Heart Drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231114163800"", ""headline"": ""Amgen Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. rose 1.25% to $270.02 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231114210734"", ""headline"": ""Amgen: Buy In Stable Fundamental And Technical Price Growth"", ""summary"": ""Amgen's Q3 2023 financial performance showed increased total revenues and product sales, driven by volume growth and strong international markets. Click here to read my analysis.""}, {""date"": ""20231115050300"", ""headline"": ""Invest with Confidence: Intrinsic Value Unveiled of Amgen Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115084500"", ""headline"": ""O'Keefe Stevens Advisory Q3 2023 Update"", ""summary"": ""At the end of Q3 2023, O'Keefe Stevens Advisory's top 5 holdings represented ~27% of assets, down from 35% at the end of Q2. Click here to read the full fund letter. ""}, {""date"": ""20231115094900"", ""headline"": ""1 in 25 carries a genotype that is associated with a shortened lifespan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115100611"", ""headline"": ""Amgen Inc's Dividend Analysis"", ""summary"": ""Amgen Inc(NASDAQ:AMGN) recently announced a dividend of $2.13 per share, payable on 2023-12-08, with the ex-dividend date set for 2023-11-16.  As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates.  Using the data from GuruFocus, let's look into Amgen Inc's dividend performance and assess its sustainability.""}, {""date"": ""20231115113900"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231115163800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. rose 1.11% to $273.03 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231116061200"", ""headline"": ""Homology Medicines, Q32 Bio enter all-stock merger agreement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116080000"", ""headline"": ""Big Pharma scrambles to feed demand for weight-loss treatments amid rising US obesity rates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116112200"", ""headline"": ""Amgen Inc(AMGN) 2022 CEO Robert A. Bradway's shareholder letter: A Year of Strong Performance ..."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116113200"", ""headline"": ""Homology Medicines slumps after merger deal with Q32 Bio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231116163800"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.70% to $269.00 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231116193601"", ""headline"": ""Amgen : LUMAKRAS\u00ae (sotorasib) Dose Comparison Study Results"", ""summary"": ""LUMAKRAS\u00ae Dose Comparison Study Results Today, during an ESMO Plenary Virtual Session, Amgen presented data from the LUMAKRAS\u00ae 960 mg versus 240 mg dose comparison study in...""}, {""date"": ""20231117140005"", ""headline"": ""Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""20231117163800"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 1.34% to $265.39 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231119103901"", ""headline"": ""18 Best-Performing Dow Stocks in 2023"", ""summary"": ""In this article, we will take a look at the 18 best-performing Dow stocks in 2023. To see more such companies, go directly to 5 Best-Performing Dow Stocks in 2023. The economy and stock markets have defied almost every prediction and estimate in 2023. When the year started there was almost a consensus among notable [\u2026]""}, {""date"": ""20231119110200"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119213759"", ""headline"": ""Tracking George Soros' 13F Portfolio - Q3 2023 Update"", ""summary"": ""George Soros' 13F portfolio value increased by 10% to $7.05B. Click here to read more about Soros Fund Management's holdings and trades for Q3 2023.""}]",{}
24,2023-11-19,265.3900146484375,2023-11-26,265.4599914550781,0.00026367535618598836,U1,"[{""date"": ""20231119103901"", ""headline"": ""18 Best-Performing Dow Stocks in 2023"", ""summary"": ""In this article, we will take a look at the 18 best-performing Dow stocks in 2023. To see more such companies, go directly to 5 Best-Performing Dow Stocks in 2023. The economy and stock markets have defied almost every prediction and estimate in 2023. When the year started there was almost a consensus among notable [\u2026]""}, {""date"": ""20231119110200"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231119213759"", ""headline"": ""Tracking George Soros' 13F Portfolio - Q3 2023 Update"", ""summary"": ""George Soros' 13F portfolio value increased by 10% to $7.05B. Click here to read more about Soros Fund Management's holdings and trades for Q3 2023.""}, {""date"": ""20231120014500"", ""headline"": ""Fly Insider: Air Products, Amgen among  this week's notable insider trades"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120022600"", ""headline"": ""Bernard Horn's Polaris Global Value Fund 3rd-Quarter Letter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120042800"", ""headline"": ""Rep. James Comer probes FTC conduct in Amgen's takeover of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120052900"", ""headline"": ""Harpoon Therapeutics initiated with an Outperform at TD Cowen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231120115224"", ""headline"": ""20 Most Valuable Healthcare Companies in the World"", ""summary"": ""In this article, we will look into the 20 most valuable healthcare companies in the world. If you want to skip our detailed analysis, you can go directly to the 5 Most Valuable Healthcare Companies in the World. Healthcare Services Industry: A Market Analysis According to a report by Verified Market Research, the global healthcare [\u2026]""}, {""date"": ""20231120163800"", ""headline"": ""Amgen Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. dropped 0.02% to $265.35 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20231121000148"", ""headline"": ""Billionaire Steven Cohen\u2019s Top High Dividend Stock Picks"", ""summary"": ""In this article, we discuss billionaire Steve Cohen\u2019s top high-dividend stock picks. You can skip our detailed analysis of Point72 Asset Management\u2019s holding and recent developments, and go directly to read Billionaire Steven Cohen\u2019s Top 5 High Dividend Stock Picks. Steve Cohen is a prominent figure in the world of finance and investing, known for [\u2026]""}, {""date"": ""20231121080500"", ""headline"": ""Munger And Buffett Say Invest $100,000 For Financial Freedom: Consider SCHD"", ""summary"": ""Charlie Munger has emphasized the importance of investing $100,000. See why SCHD ETF is a strong investment option for reaching financial freedom.""}, {""date"": ""20231121115300"", ""headline"": ""AbbVie Vs. Amgen: How Peter Lynch Picks Dividend Stocks"", ""summary"": ""This article examines two healthcare stalwarts, AbbVie (ABBV) and Amgen (AMGN) through the lens of Lynch's approach. Check out which stock I prefer.""}, {""date"": ""20231121133210"", ""headline"": ""Bristol-Myers Squibb: A Tough But Cheap Spot"", ""summary"": ""Learn about the challenges facing Bristol-Myers Squibb as it deals with loss of exclusivity, growth concerns, and other issues. Click here for more on BMY stock.""}, {""date"": ""20231121163800"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.95% to $262.82 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231122035500"", ""headline"": ""Matrix Asset Advisors Q3 2023 Capital Markets Commentary And Quarterly Report"", ""summary"": ""For Q3 2023, Matrix\u00e2\u0080\u0099s LCV and MDI portfolios were down modestly, and bond returns mostly flat or down. Click here to read the full fund letter.""}, {""date"": ""20231122090000"", ""headline"": ""Merck: Keytruda Patent Expiry Nears With Replacement Yet To Be Found"", ""summary"": ""For now, Merck's prospects have somewhat dimmed, with management engaging on expensive partnerships to boost its pipelines. Learn why we rate MRK stock a hold.""}, {""date"": ""20231122101700"", ""headline"": ""P/E Ratio Insights for Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231122163800"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.67% higher to $264.59 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P...""}, {""date"": ""20231122210000"", ""headline"": ""AMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the Evercore ISI HealthCONx Conference at 9:10 a.m. EST on Wednesday, Nov. 29, 2023. Peter H. Griffith, executive vice president and chief financial officer at Amgen, and Paul Burton, senior vice president and chief medical officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20231124023000"", ""headline"": ""Mario Gabelli's Gabelli Asset Fund 3rd-Quarter Commentary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231124033900"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231124055300"", ""headline"": ""Innovent marks China's first regulatory review of a KRAS G12C inhibitor"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231124100200"", ""headline"": ""Investigating Amgen's Standing In Biotechnology Industry Compared To Competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231126115103"", ""headline"": ""15 Best Drug Stocks To Invest In"", ""summary"": ""In this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analysis of the drug and pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Drug Stocks To Invest In. Healthcare expands on the defensive concept, encompassing a myriad of companies. This [\u2026]""}]",{}
25,2023-11-26,265.4599914550781,2023-12-03,266.6000061035156,0.004294487625757348,U1,"[{""date"": ""20231126115103"", ""headline"": ""15 Best Drug Stocks To Invest In"", ""summary"": ""In this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analysis of the drug and pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Drug Stocks To Invest In. Healthcare expands on the defensive concept, encompassing a myriad of companies. This [\u2026]""}, {""date"": ""20231127104410"", ""headline"": ""Mastercard, Pfizer Among 18 Companies To Announce Dividend Increases In December"", ""summary"": ""2H of November saw announcements of annual dividend increases from 9 companies. 16 other companies will announce annual increases before Christmas. Read more here.""}, {""date"": ""20231127120300"", ""headline"": ""Novo falls as long-time investor cuts stake on weight loss hype"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231127163800"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.45% to $264.27 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20231128013500"", ""headline"": ""Amazon Web Services, Amgen to work on generative AI solutions to advance therapies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128023800"", ""headline"": ""Amgen (NASDAQ:AMGN) Gains with New AWS Partnership"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128031500"", ""headline"": ""Amgen (NASDAQ:AMGN) Gains on New AWS Partnership"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128062000"", ""headline"": ""Amgen receives Orphan Drug Designation for treatment of biliary tract cancers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231128140000"", ""headline"": ""1 Spectacular Dividend Stock Every Investor Should Consider"", ""summary"": ""Dividend stocks are versatile investments that can serve different purposes in a portfolio.  Others use them to boost their portfolio's performance by reinvesting the dividends to compound their returns over time.  Here is a brief overview of one blue-chip dividend stock that has successfully served both roles (income generation and above-average capital appreciation) over the past 12 years and that also appears more than capable of continuing this tradition for the foreseeable future.""}, {""date"": ""20231128140005"", ""headline"": ""Is Trending Stock Amgen Inc. (AMGN) a Buy Now?"", ""summary"": ""Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""20231128153617"", ""headline"": ""This Stock Hasn't Split Since 1999 \u2014 $1,000 Invested Then Would Be Worth A Boatload Today"", ""summary"": ""When investing in the stock market, a history of strong returns should be high on your priority list. Combine this with a positive outlook on the future, and you may have a winner to add to your portfolio. Amgen Inc., an American multinational biopharmaceutical company, fits this mold. The company has a 10-year annualized total return of 13.69% through the end of 2022. And if that's not enough to pique your interest, consider this: It pays out billions of dollars in dividends to investors every""}, {""date"": ""20231128183441"", ""headline"": ""AWS expands big pharma partnerships in manufacturing, AI, and R&D"", ""summary"": ""Pfizer and Amazon Web Services are just another example of how artificial intelligence is working in the background in healthcare.""}, {""date"": ""20231129050400"", ""headline"": ""The Art of Valuation: Discovering Amgen Inc's Intrinsic Value"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129072200"", ""headline"": ""Amazon cloud conference impresses, Rosenblatt sees AI boost"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129075700"", ""headline"": ""Amazon cloud conference impresses, Wall Street sees AI boost"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129112526"", ""headline"": ""Why I Made Big Changes To My Dividend Growth Portfolio"", ""summary"": ""How to make significant changes to your portfolio, for when buying a new house and selling stocks for cash? Click here to read about my strategy.""}, {""date"": ""20231129120600"", ""headline"": ""Analyst Ratings for Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231129124805"", ""headline"": ""Amgen Inc. (AMGN) Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) 6th Annual Evercore ISI HealthCONx Conference November 29, 2023 9:10 AM ETCompany ParticipantsPeter Griffith - EVP and...""}, {""date"": ""20231129195200"", ""headline"": ""Top Stock Reports for McDonald's, Amgen & NextEra Energy"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including McDonald's Corporation (MCD), Amgen Inc. (AMGN) and NextEra Energy, Inc. (NEE).""}, {""date"": ""20231130110200"", ""headline"": ""Looking Into Amgen's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231130134400"", ""headline"": ""Amazon (AMZN) Teams Up With Amgen, Expands Customer Base"", ""summary"": ""Amazon's (AMZN) AWS gets selected by Amgen. This highlights the efficiency and reliability of AWS' innovative cloud products and services.""}, {""date"": ""20231130151600"", ""headline"": ""The Zacks Analyst Blog Highlights McDonald's, Amgen, NextEra Energy, General Mills and Take-Two Interactive Software"", ""summary"": ""McDonald's, Amgen, NextEra Energy, General Mills and Take-Two Interactive Software are included in this Analyst Blog.""}, {""date"": ""20231130163055"", ""headline"": ""Amgen (AMGN) Up 2.2% Since Last Earnings Report: Can It Continue?"", ""summary"": ""Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""20231130163800"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains"", ""summary"": ""Shares of Amgen Inc. rallied 1.14% to $269.64 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231201061600"", ""headline"": ""Pfizer pulls back from twice-daily regime of weight-loss drug candidate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201090008"", ""headline"": ""Arrowhead Pharmaceuticals: Balance Sheet Concern Needs To Be Addressed"", ""summary"": ""Arrowhead Pharmaceuticals stock drops on balance sheet concerns following fiscal Q3 results. Read why I think positive preclinical results offer hope for ARWR.""}, {""date"": ""20231201093000"", ""headline"": ""Worried About a Weight-Loss Stock Bubble? Here Are Some Alternatives."", ""summary"": ""Eli Lilly and Novo Nordisk, riding the wave of enthusiasm for obesity meds, are seeing their stock prices soar. But behind them are coming new therapies from companies for investors that are drawn to the size of the obesity market but put off by the valuations.""}, {""date"": ""20231201115400"", ""headline"": ""Pfizer hits new 52-week low after weight loss setback"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231201134749"", ""headline"": ""\u2018From Hype to Clinical\u2018: Cowen Suggests 2 AI Healthcare Stocks to Consider"", ""summary"": ""Just over a year ago, AI technology burst into our collective consciousness with the launch of ChatGPT. Generative AI has quickly shown a high potential to change the way we communicate with the digital world \u2013 and it can bring a similar potential to other fields, from automobiles to healthcare. The magnitude of AI\u2019s potential is clear from the estimates: tech experts are predicting that AI\u2019s application to the healthcare market could exceed $100 billion before 2030. The gains will come on the h""}, {""date"": ""20231201145700"", ""headline"": ""Weight-Loss Stocks Are Getting Pricey. Time to Worry About a Bubble?"", ""summary"": ""Eli Lilly and Novo Nordisk, riding the wave of enthusiasm for obesity meds, are seeing their stock prices soar. But behind them are coming new therapies from companies for investors that are drawn to the size of the obesity market but put off by the valuations.""}, {""date"": ""20231201163800"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 1.04% to $272.45 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20231203071023"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of December 3"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the update for the week of December 3.""}, {""date"": ""20231203110400"", ""headline"": ""Biotechs post record gains in November amid improving outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20231203211400"", ""headline"": ""Obesity Drugs Have Multi-Billion-Dollar Market Potential, Says Oppenheimer \u2014 Here Are 2 Stocks to Take Advantage"", ""summary"": ""A key to success in the stock market is a touch of foresight. Not quite precognition, but an ability to spot and put together clues and trends, to discern the \u2018next big thing\u2019 before it hits. This is true in every stock sector, but today we\u2019ll focus on biotech. The biotech firms have famously high product lead times, paired with equally high overhead expenses; it\u2019s a combination that would make them unlikely investments, except that when a drug is approved, it can turn into a blockbuster. Succes""}]",{}
